Term,Overlap,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes
Defense Response To Virus (GO:0051607),48/189,1.04740202920795e-33,2.2938104439654e-30,0,0,13.8279992848203,1050.08437171058,IFITM3;RTP4;MARCHF2;IFIT5;IFI6;NLRC5;DDX60L;IFIT1;DDX60;SAMHD1;USP18;IFI44L;IFIT3;IFIT2;OASL;IFIH1;TRIM6;TRIM28;IFI16;TRIM5;DHX58;AZI2;MICA;GBP5;APOBEC3D;RSAD2;APOBEC3G;STAT1;MX2;STAT2;MX1;EIF2AK2;ISG15;PML;BST2;NT5C3A;SLFN13;MOV10;PLSCR1;AIM2;OAS1;OAS2;OAS3;DDIT4;IRF7;MAP3K14;SHFL;RIGI
Defense Response To Symbiont (GO:0140546),42/148,8.96834421350138e-32,9.82033691378401e-29,0,0,15.9230407891646,1138.32261182431,IFITM3;RTP4;IFIT5;IFI6;NLRC5;DDX60L;IFIT1;DDX60;SAMHD1;IFI44L;IFIT3;IFIT2;OASL;IFIH1;IFI16;TRIM5;AZI2;MICA;GBP5;APOBEC3D;RSAD2;APOBEC3G;STAT1;MX2;STAT2;MX1;EIF2AK2;ISG15;BST2;NT5C3A;SLFN13;MOV10;PLSCR1;AIM2;OAS1;OAS2;OAS3;DDIT4;IRF7;MAP3K14;SHFL;RIGI
Negative Regulation Of Viral Genome Replication (GO:0045071),20/53,1.47229906512102e-18,1.03165889749628e-15,0,0,23.3802308802309,959.985417961006,IFITM3;APOBEC3D;RSAD2;APOBEC3G;MX1;IFIT5;EIF2AK2;ISG15;ZC3HAV1;IFIT1;OASL;IFIH1;BST2;TRIM6;PLSCR1;OAS1;IFI16;OAS2;OAS3;SHFL
Negative Regulation Of Viral Process (GO:0048525),21/61,1.88430848857768e-18,1.03165889749628e-15,0,0,20.286083499006,827.93533287986,IFITM3;RSAD2;APOBEC3G;STAT1;MX1;IFIT5;EIF2AK2;ISG15;ZC3HAV1;IFIT1;OASL;IFIH1;BST2;TRIM6;PLSCR1;OAS1;IFI16;OAS2;OAS3;TRIM14;SHFL
Regulation Of Viral Genome Replication (GO:0045069),21/67,1.73514744483178e-17,7.59994580836321e-15,0,0,17.6346270204858,680.570589270169,IFITM3;CXCL8;RSAD2;APOBEC3G;MX1;IFIT5;EIF2AK2;ISG15;ZC3HAV1;IFIT1;OASL;IFIH1;BST2;TRIM6;PLSCR1;LARP1;OAS1;IFI16;OAS2;OAS3;SHFL
Response To Interferon-Beta (GO:0035456),11/29,8.12162640288715e-11,2.96439363705381e-08,0,0,23.1793372319688,538.546532953449,IFITM3;BST2;TRIM6;PLSCR1;PNPT1;AIM2;IFI16;OAS1;STAT1;XAF1;SHFL
Antiviral Innate Immune Response (GO:0140374),12/46,1.59659591197065e-09,4.99506435316533e-07,0,0,13.4021139705882,271.465072494007,IFIH1;MARCHF2;TRIM6;OAS1;DHX58;MX1;EIF2AK2;IFIT1;USP18;IFIT3;IFIT2;RIGI
Negative Regulation Of Innate Immune Response (GO:0045824),12/52,7.34001617862231e-09,2.00932942889786e-06,0,0,11.38828125,213.30165130158,OAS1;IFI16;OAS3;STAT2;TREX1;DHX58;NLRC5;TRAFD1;SERPING1;ISG15;SAMHD1;USP18
Interleukin-27-Mediated Signaling Pathway (GO:0070106),5/5,1.21155439829644e-08,2.94811570252135e-06,0,0,97380,1775118.26356288,OAS1;OAS2;STAT1;MX1;OASL
Response To Cytokine (GO:0034097),17/125,2.92634848236609e-08,6.40870317638175e-06,0,0,6.01314924391848,104.30965105202,IFITM3;CD274;SP100;GCH1;STAT1;MX2;MX1;EIF2AK2;ISG15;ADAR;PML;BST2;NUB1;PLSCR1;LAMP3;XAF1;SHFL
Negative Regulation Of Type I Interferon-Mediated Signaling Pathway (GO:0060339),7/15,4.36668227702633e-08,8.69366744244334e-06,0,0,32.9487427466151,558.371708379748,OAS1;STAT2;OAS3;NLRC5;ISG15;SAMHD1;USP18
Negative Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001960),11/59,3.22703487826893e-07,5.8893386528408e-05,0,0,8.67884990253411,129.718707181149,IL1RN;OAS1;OAS3;STAT2;NLRC5;ISG15;SAMHD1;PARP14;ZNF675;USP18;NAIP
Cytosolic Pattern Recognition Receptor Signaling Pathway (GO:0002753),7/23,1.3863071049371e-06,0.00021882956224339,0,0,16.4676015473888,222.12928881588,IFIH1;OAS3;DHX58;TIFA;IRF7;MAP2K6;RIGI
Response To Type I Interferon (GO:0034340),5/9,1.39891044356505e-06,0.00021882956224339,0,0,46.897880539499,632.1748416827,SP100;MX1;ISG15;IFIT1;SHFL
Regulation Of Type I Interferon-Mediated Signaling Pathway (GO:0060338),8/33,1.64048720610159e-06,0.000239511132090832,0,0,12.0626356589147,160.680546777395,TRIM6;OAS1;STAT2;OAS3;NLRC5;ISG15;SAMHD1;USP18
Regulation Of Ribonuclease Activity (GO:0060700),4/5,2.28116091817879e-06,0.000312233900675722,0,0,149.807692307692,1946.12567470885,OAS1;OAS2;OAS3;OASL
Regulation Of Innate Immune Response (GO:0045088),11/78,5.7267279021261e-06,0.000727055752739622,0,0,6.21160280469,74.9763207719828,GBP5;TASL;PLSCR1;IFI16;TREX1;DHX58;TRAFD1;IFI35;PARP9;SAMHD1;FCGR2B
Positive Regulation Of Defense Response To Virus By Host (GO:0002230),7/28,5.97580070744895e-06,0.000727055752739622,0,0,12.5435203094778,150.870858994051,TRIM6;APOBEC3G;DTX3L;STAT1;PARP9;TRIM22;RIGI
Regulation Of Nuclease Activity (GO:0032069),4/6,6.70131372942901e-06,0.000772414582497343,0,0,74.9,892.299202185504,OAS1;OAS2;OAS3;OASL
Response To Type II Interferon (GO:0034341),11/80,7.35852294631534e-06,0.00080575826262153,0,0,6.03093482498517,71.2835468373754,IFITM3;GBP6;BST2;GBP5;NUB1;SP100;GCH1;STAT1;GBP1;SHFL;GBP4
Cellular Response To Interferon-Beta (GO:0035458),6/22,1.6402841339624e-05,0.00171058202541793,0,0,14.0878378378378,155.220586015105,TRIM6;PNPT1;AIM2;IFI16;OAS1;STAT1
Defense Response To Protozoan (GO:0042832),5/15,2.92570752739338e-05,0.00291240885681432,0,0,18.7533718689788,195.773746324154,GBP6;BATF2;IRF4;GBP1;GBP4
Positive Regulation Of Interferon-Beta Production (GO:0032728),7/36,3.51367276817628e-05,0.00334562754882872,0,0,9.07950376842527,93.1217840230415,IFIH1;OAS1;OAS2;OAS3;IRF7;ISG15;RIGI
Positive Regulation Of Type I Interferon Production (GO:0032481),9/64,4.15281719663238e-05,0.0037111446630551,0,0,6.17083848190644,62.25844421909,IFIH1;OAS1;OAS2;STAT1;OAS3;DHX58;IRF7;ISG15;RIGI
Regulation Of Defense Response To Virus By Host (GO:0050691),7/37,4.23646651033688e-05,0.0037111446630551,0,0,8.77640232108317,88.3713143855936,TRIM6;APOBEC3G;DTX3L;STAT1;PARP9;TRIM22;RIGI
Response To Interferon-Alpha (GO:0035455),5/17,5.77239613882038e-05,0.00486213367077562,0,0,15.626204238921,152.509224978492,IFITM3;BST2;MX2;LAMP3;EIF2AK2
Positive Regulation Of Pattern Recognition Receptor Signaling Pathway (GO:0062208),7/39,6.04888569516423e-05,0.00490631839718876,0,0,8.22703094777563,79.9095744035039,TASL;RSAD2;DHX58;WDFY1;IFI35;DDX60;OASL
Modulation By Symbiont Of Entry Into Host (GO:0052372),5/21,0.000174052312241447,0.0136133772788846,0,0,11.7172447013487,101.426282310684,TRIM6;CXCL8;TRIM5;TRIM38;TRIM22
Suppression Of Viral Release By Host (GO:0044790),4/13,0.000275900467975624,0.0208352422367799,0,0,16.6384615384615,136.360018716616,MARCHF2;TRIM28;TRIM5;PML
Regulation Of Interferon-Beta Production (GO:0032648),7/50,0.000306410573457122,0.0223679718623699,0,0,6.11897800368854,49.5061092779386,IFIH1;OAS1;OAS2;OAS3;IRF7;ISG15;RIGI
Regulation Of Viral Life Cycle (GO:1903900),5/24,0.00034070434995322,0.0240691137547598,0,0,9.86563228881452,78.7720962761573,TRIM6;TRIM5;LAMP3;TRIM38;TRIM22
Negative Regulation Of Growth (GO:0045926),11/124,0.000422781782577188,0.0282294862868734,0,0,3.67425693042833,28.544032241607,BST2;DNAJB2;MT2A;PNPT1;SMAD3;BMPR2;HYAL2;SESN2;OSGIN1;INHBA;PML
Cellular Response To Type I Interferon (GO:0071357),6/38,0.000425375820761105,0.0282294862868734,0,0,7.03812741312741,54.6337279435282,IFITM3;SP100;STAT1;OAS2;STAT2;IFIT1
Regulation Of Cytokine Production (GO:0001817),13/167,0.000470867027562581,0.0303293761871192,0,0,3.19193331130709,24.4531930579486,BTN2A2;BTN3A1;EIF2AK2;ISG15;BTN3A3;BTN3A2;IFIH1;IFI16;IRF7;IGF2BP3;FCGR2B;BTN2A3P;RIGI
Negative Regulation Of Interleukin-10 Production (GO:0032693),4/16,0.000659732705126824,0.0412804178350784,0,0,12.4769230769231,91.3769395620799,CD274;MMP8;FCGR2B;TRIB2
Positive Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043123),13/175,0.000732616790485145,0.0445675214211796,0,0,3.03305066318765,21.8952523954398,IFIT5;SHISA5;DDX21;NOD1;BST2;TRIM6;CASP10;TRIM5;TIFA;TNFSF10;TRIM38;MAP3K14;TRIM22
Regulation Of Immune Response (GO:0050776),8/77,0.000907567889321644,0.0523090744302845,0,0,4.36063363667004,30.54511439009,PLSCR1;RSAD2;IRF4;SPPL2B;DHX58;IRF7;SAMHD1;FCGR2B
Protein poly-ADP-ribosylation (GO:0070212),3/8,0.000907646040342835,0.0523090744302845,0,0,22.4234165067178,157.068320740682,PARP10;ZC3HAV1;PARP9
Regulation Of Viral Entry Into Host Cell (GO:0046596),6/44,0.000952663594631848,0.0534957249293269,0,0,5.92501524080471,41.2158796422685,IFITM3;TRIM6;TRIM5;TRIM38;TRIM22;LY6E
Positive Regulation Of Innate Immune Response (GO:0045089),6/45,0.00107525401610984,0.0588701573820138,0,0,5.77279477279477,39.4581973131685,GBP5;TASL;TRIM6;PLSCR1;NLRC5;IFI35
Regulation Of Response To Biotic Stimulus (GO:0002831),5/31,0.00117114669767797,0.0610669349503513,0,0,7.20690677338076,48.6449770169872,HERC5;TRIM5;DHX58;SAMHD1;FCGR2B
Positive Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001238),5/31,0.00117114669767797,0.0610669349503513,0,0,7.20690677338076,48.6449770169872,HYAL2;TNFSF10;G0S2;INHBA;PML
Regulation Of Interleukin-10 Production (GO:0032653),6/46,0.00120958829533421,0.0616046131809746,0,0,5.62818532818533,37.8071955266561,CD274;IRF4;ISG15;MMP8;FCGR2B;TRIB2
Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043122),15/232,0.00124278493694941,0.0618567957254364,0,0,2.6154563479489,17.4984504600645,STAT1;IFIT5;SHISA5;RHOH;DDX21;NOD1;BST2;TRIM6;CASP10;TRIM5;TIFA;TNFSF10;TRIM38;MAP3K14;TRIM22
Intrinsic Apoptotic Signaling Pathway In Response To DNA Damage By P53 Class Mediator (GO:0042771),4/19,0.00132009075034585,0.0631868865351599,0,0,9.98,66.1679468489607,IFI16;DDIT4;CDIP1;PML
Positive Regulation Of RIG-I Signaling Pathway (GO:1900246),3/9,0.00133504163518478,0.0631868865351599,0,0,18.6852207293666,123.673604433902,DHX58;DDX60;OASL
Cellular Response To Cytokine Stimulus (GO:0071345),18/308,0.0013560656014395,0.0631868865351599,0,0,2.35346872018536,15.5403486643098,GBP6;CCR1;GBP5;PNPT1;CXCL8;STAT1;IFIT1;YBX3;MT2A;TRIM6;AIM2;OAS1;IFI16;HYAL2;ZNF675;GBP1;GBP4;GBP3
Negative Regulation Of Viral Life Cycle (GO:1903901),4/20,0.00161623595589436,0.0737407654876804,0,0,9.35576923076923,60.1356598429412,IFITM3;BST2;TRIM5;LY6E
Protein auto-ADP-ribosylation (GO:0070213),3/10,0.00187023009055703,0.0835878346595897,0,0,16.0150808884014,100.601834525059,PARP10;PARP11;PARP12
Positive Regulation Of Interferon-Alpha Production (GO:0032727),4/21,0.00195557478585508,0.0856541756204527,0,0,8.80497737556561,54.9172701070879,IFIH1;STAT1;IRF7;RIGI
Positive Regulation Of Cytokine Production (GO:0001819),18/320,0.00206545291654874,0.0877419045325948,0,0,2.25853990524304,13.9632100890337,GBP5;CD274;BTN3A1;EIF2AK2;ISG15;NOD1;BTN3A2;MMP8;IFIH1;C5;TRIM6;IFI16;IRF4;HYAL2;DHX58;IRF7;IL18R1;RIGI
RNA Modification (GO:0009451),6/51,0.00208336942269175,0.0877419045325948,0,0,5.0015444015444,30.8783786838401,SSB;APOBEC3G;MEPCE;TSR3;ADAR;ELP5
Regulation Of Type II Interferon-Mediated Signaling Pathway (GO:0060334),3/11,0.00252178085182868,0.104201888028393,0,0,14.0124760076775,83.8337004905768,NLRC5;PARP14;PARP9
Type I Interferon-Mediated Signaling Pathway (GO:0060337),5/37,0.00264136625413507,0.107122075862144,0,0,5.85380539499037,34.7508755760814,IFITM3;SP100;STAT1;OAS2;STAT2
Positive Regulation Of Protein Localization To Nucleus (GO:1900182),7/72,0.00275882628402986,0.10985144658228,0,0,4.04335664335664,23.8272983257061,SMAD3;TRIM28;DTX3L;HYAL2;SESN2;MEPCE;PARP9
Defense Response To Bacterium (GO:0042742),13/204,0.00290560107257318,0.11303368501889,0,0,2.56867245212652,15.0039111912751,GBP6;MARCHF2;ISG15;NOD1;RNF213;OAS1;OAS2;OAS3;GBP1;NAIP;MICA;GBP4;GBP3
DNA Damage Response (GO:0006974),20/384,0.00294197262377933,0.11303368501889,0,0,2.08355136926565,12.144343698404,PLK3;RMI2;CBX5;DTX3L;TREX1;NSMCE1;FANCA;ALKBH7;SAMHD1;PML;TNFSF13B;HELB;RECQL5;AIM2;TRIM28;IRF7;ZNF668;FBXO6;MICA;MAP2K6
Positive Regulation Of mRNA Metabolic Process (GO:1903313),3/12,0.00329736558892129,0.124503976547201,0,0,12.4548944337812,71.1751312597781,MOV10;PNPT1;ZC3HAV1
Pattern Recognition Receptor Signaling Pathway (GO:0002221),6/56,0.00336571591248857,0.124930810988983,0,0,4.50023166023166,25.6248347365313,IFIH1;DHX58;TIFA;NOD1;NAIP;RIGI
Regulation Of ERBB Signaling Pathway (GO:1901184),3/13,0.00420380892148452,0.153439025634185,0,0,11.2088291746641,61.3320710828318,CEACAM1;RHBDF2;IFI6
Regulation Of Interferon-Alpha Production (GO:0032647),4/26,0.00440528918618002,0.155606182544101,0,0,6.8020979020979,36.9010367437565,IFIH1;STAT1;IRF7;RIGI
Positive Regulation Of Erythrocyte Differentiation (GO:0045648),4/26,0.00440528918618002,0.155606182544101,0,0,6.8020979020979,36.9010367437565,PRMT1;STAT1;INHBA;ACVR1B
Cellular Response To Glucose Starvation (GO:0042149),5/42,0.0046319504039654,0.161015418804512,0,0,5.06144873196896,27.2041594765348,IFI16;HSPA5;SESN2;PICK1;KPTN
Cellular Response To Exogenous dsRNA (GO:0071360),3/14,0.00524713686319165,0.171510891498354,0,0,10.1893212353865,53.494677356759,IFIH1;IFIT1;RIGI
Histone H2A Monoubiquitination (GO:0035518),3/14,0.00524713686319165,0.171510891498354,0,0,10.1893212353865,53.494677356759,RING1;PCGF5;BRCA2
Negative Regulation Of Leukocyte Mediated Cytotoxicity (GO:0001911),3/14,0.00524713686319165,0.171510891498354,0,0,10.1893212353865,53.494677356759,CEACAM1;FCGR2B;MICA
Protein Localization To Vacuole (GO:0072665),3/14,0.00524713686319165,0.171510891498354,0,0,10.1893212353865,53.494677356759,GLMP;KPTN;GBP1
Protein Ubiquitination (GO:0016567),21/434,0.0054558784065048,0.175711378091846,0,0,1.92704788219834,10.0419653067847,MARCHF2;DTX3L;FANCA;FBXL15;UBE2L6;ISG15;BRCA2;TNFSF13B;HERC5;RNF144A;NUB1;RNF126;TRIM6;RNF213;TRIM5;TRIM69;TRIM14;TRIM38;ZNF598;TRIM22;HERC6
Negative Regulation Of Cell Growth (GO:0030308),9/125,0.00567703269724856,0.180184081260498,0,0,2.91663876799464,15.082891629552,BST2;DNAJB2;SMAD3;BMPR2;HYAL2;SESN2;OSGIN1;INHBA;PML
Cellular Response To Starvation (GO:0009267),9/126,0.00597617670038102,0.186968956769063,0,0,2.89156086631815,14.8047172161753,KLF10;BMPR2;MAP1LC3A;HSPA5;IFI16;SESN2;EIF2AK2;PICK1;KPTN
mRNA Methylation (GO:0080009),3/15,0.00643262307400005,0.187325926726488,0,0,9.33973128598848,47.13176667594,METTL14;METTL4;CMTR1
ISG15-protein Conjugation (GO:0032020),2/5,0.00650080841607905,0.187325926726488,0,0,24.8697318007663,125.239710111377,ISG15;UBE2L6
Regulation Of Interleukin-1-Mediated Signaling Pathway (GO:2000659),2/5,0.00650080841607905,0.187325926726488,0,0,24.8697318007663,125.239710111377,IL1RN;ZNF675
snRNA Modification (GO:0040031),2/5,0.00650080841607905,0.187325926726488,0,0,24.8697318007663,125.239710111377,MEPCE;METTL4
Positive Regulation Of Toll-Like Receptor 7 Signaling Pathway (GO:0034157),2/5,0.00650080841607905,0.187325926726488,0,0,24.8697318007663,125.239710111377,TASL;RSAD2
Radial Glial Cell Differentiation (GO:0060019),2/5,0.00650080841607905,0.187325926726488,0,0,24.8697318007663,125.239710111377,METTL14;HES1
Positive Regulation Of NF-kappaB Transcription Factor Activity (GO:0051092),10/152,0.0068406596825144,0.194559022139046,0,0,2.64892859100126,13.2045675982815,TRIM6;AIM2;TRIM5;ANKRD42;TRIM14;EIF2AK2;NOD1;TRIM38;TRIM22;IL18R1
Negative Regulation Of Myeloid Leukocyte Differentiation (GO:0002762),4/30,0.00743730875185466,0.201501354081879,0,0,5.75443786982249,28.2039168719481,CEACAM1;GPR137;INHBA;ZNF675
Cellular Response To Type II Interferon (GO:0071346),6/66,0.0075698544246408,0.201501354081879,0,0,3.74826254826255,18.3049454214894,GBP6;GBP5;SP100;STAT1;GBP1;GBP4
Negative Regulation Of Immune Response (GO:0050777),6/66,0.0075698544246408,0.201501354081879,0,0,3.74826254826255,18.3049454214894,IFI16;TREX1;DHX58;RHBDF2;TRAFD1;FCGR2B
Activin Receptor Signaling Pathway (GO:0032924),3/16,0.00776483300647263,0.201501354081879,0,0,8.6208474826517,41.8813730301401,SMAD3;INHBA;ACVR1B
Regulation Of Response To Cytokine Stimulus (GO:0060759),3/16,0.00776483300647263,0.201501354081879,0,0,8.6208474826517,41.8813730301401,IFIH1;PARP9;RIGI
Negative Regulation Of RNA Biosynthetic Process (GO:1902679),3/16,0.00776483300647263,0.201501354081879,0,0,8.6208474826517,41.8813730301401,APOBEC3D;APOBEC3G;ZNF653
Negative Regulation Of Natural Killer Cell Mediated Cytotoxicity (GO:0045953),3/16,0.00776483300647263,0.201501354081879,0,0,8.6208474826517,41.8813730301401,CEACAM1;SERPINB9;MICA
Protein Modification By Small Protein Conjugation (GO:0032446),18/364,0.00782082881139714,0.201501354081879,0,0,1.96680298841646,9.54089195506221,MARCHF2;GPS1;NSMCE1;UBE2L6;ISG15;FBXL15;PML;HERC5;IFIH1;RNF144A;NUB1;RNF126;RNF213;TRIM28;TRIM14;TRIM69;ZNF598;HERC6
Post-Translational Protein Modification (GO:0043687),5/48,0.00820497966039754,0.208940761119426,0,0,4.35385580499171,20.9116305306487,PARP10;PARP11;ZC3HAV1;PARP9;PARP12
Interferon-Mediated Signaling Pathway (GO:0140888),5/49,0.00894527532592596,0.216350611405349,0,0,4.25468558416535,20.0677767419855,IFITM3;SP100;OAS2;STAT1;STAT2
NAD Biosynthetic Process (GO:0009435),3/17,0.00924766603283025,0.216350611405349,0,0,8.00466136550589,37.4889036055709,PARP10;NAPRT;PARP9
Base Conversion Or Substitution Editing (GO:0016553),3/17,0.00924766603283025,0.216350611405349,0,0,8.00466136550589,37.4889036055709,APOBEC3D;APOBEC3G;ADAR
Regulation Of Single Stranded Viral RNA Replication Via Double Stranded DNA Intermediate (GO:0045091),3/17,0.00924766603283025,0.216350611405349,0,0,8.00466136550589,37.4889036055709,APOBEC3D;CXCL8;APOBEC3G
Cellular Response To dsRNA (GO:0071359),3/17,0.00924766603283025,0.216350611405349,0,0,8.00466136550589,37.4889036055709,IFIH1;IFIT1;RIGI
RIG-I Signaling Pathway (GO:0039529),2/6,0.00958265265128716,0.216350611405349,0,0,18.6513409961686,86.6877181741925,OAS3;RIGI
Regulation Of Hemoglobin Biosynthetic Process (GO:0046984),2/6,0.00958265265128716,0.216350611405349,0,0,18.6513409961686,86.6877181741925,PRMT1;EIF2AK2
Regulation Of Toll-Like Receptor 7 Signaling Pathway (GO:0034155),2/6,0.00958265265128716,0.216350611405349,0,0,18.6513409961686,86.6877181741925,TASL;RSAD2
Pharyngeal Arch Artery Morphogenesis (GO:0061626),2/6,0.00958265265128716,0.216350611405349,0,0,18.6513409961686,86.6877181741925,BMPR2;HES1
Regulation Of MDA-5 Signaling Pathway (GO:0039533),2/6,0.00958265265128716,0.216350611405349,0,0,18.6513409961686,86.6877181741925,DHX58;DDX60
Regulation Of Cell Adhesion Molecule Production (GO:0060353),2/6,0.00958265265128716,0.216350611405349,0,0,18.6513409961686,86.6877181741925,CXCL8;NOTCH4
Negative Regulation Of Viral Entry Into Host Cell (GO:0046597),3/18,0.0108843956323544,0.240776024594506,0,0,7.47063339731286,33.7704387879862,IFITM3;TRIM5;LY6E
Regulation Of RIG-I Signaling Pathway (GO:0039535),3/18,0.0108843956323544,0.240776024594506,0,0,7.47063339731286,33.7704387879862,DHX58;DDX60;OASL
Negative Regulation Of Cysteine-Type Endopeptidase Activity (GO:2000117),5/53,0.0123670071781957,0.270837457202486,0,0,3.89932562620424,17.1286576114584,GPX1;IFI16;LAMP3;IFI6;NAIP
Modification-Dependent Protein Catabolic Process (GO:0019941),11/192,0.0126315001102255,0.272197842217503,0,0,2.28581736723638,9.99259137259235,HERC5;RNF144A;UBL4A;NUB1;RNF126;RNF213;DTX3L;UBE2L6;ISG15;HERC6;TNFSF13B
rRNA Catabolic Process (GO:0016075),3/19,0.0126777077197193,0.272197842217503,0,0,7.00335892514395,30.5900423617699,SLFN12;SLFN13;XRN1
Intrinsic Apoptotic Signaling Pathway By P53 Class Mediator (GO:0072332),4/35,0.0128262320071957,0.272713088308335,0,0,4.82506203473945,21.0192383924487,IFI16;DDIT4;CDIP1;PML
Foam Cell Differentiation (GO:0090077),2/7,0.0131843174209358,0.277631299537014,0,0,14.92030651341,64.5859370827678,STAT1;SAMD1
Protein K63-linked Ubiquitination (GO:0070534),5/54,0.0133435113763393,0.27830752299222,0,0,3.81955094176399,16.487951235857,RNF126;RNF213;TRIM5;ZNF598;TRIM22
DNA Damage Response, Signal Transduction By P53 Class Mediator (GO:0030330),4/36,0.0141377746684617,0.286682652999362,0,0,4.67403846153846,19.9062858178204,PLK3;SP100;SESN2;PML
Regulation Of Erythrocyte Differentiation (GO:0045646),4/36,0.0141377746684617,0.286682652999362,0,0,4.67403846153846,19.9062858178204,PRMT1;STAT1;INHBA;ACVR1B
Positive Regulation Of Myeloid Cell Differentiation (GO:0045639),4/36,0.0141377746684617,0.286682652999362,0,0,4.67403846153846,19.9062858178204,PRMT1;STAT1;INHBA;ACVR1B
T Cell Mediated Immunity (GO:0002456),3/20,0.014629737176942,0.293936921261495,0,0,6.59105792028904,27.8452359944586,BTN3A3;BTN3A2;MICA
Negative Regulation Of Gene Expression (GO:0010629),16/336,0.0162508813557504,0.310128305863471,0,0,1.88543307086614,7.76724541560737,CCR1;PNPT1;SMAD3;CXCL8;BTN2A2;EIF4A3;EIF2AK2;PARP14;PARP9;MMP8;PARP10;OCLN;TRIM6;LARP1;IGF2BP3;FCGR2B
Positive Regulation Of Tumor Necrosis Factor Production (GO:0032760),6/78,0.0164918474560623,0.310128305863471,0,0,3.12162162162162,12.8139106118476,IFIH1;OAS1;OAS2;OAS3;MMP8;RIGI
Signal Transduction In Response To DNA Damage (GO:0042770),5/57,0.0165812954659822,0.310128305863471,0,0,3.59863643100637,14.7525380692375,DTX3L;SESN2;FBXO6;PARP9;MAP2K6
Post-Transcriptional Regulation Of Gene Expression (GO:0010608),5/57,0.0165812954659822,0.310128305863471,0,0,3.59863643100637,14.7525380692375,LARP1;RPL10;TDRD7;PARP9;ELP5
Retrotransposon Silencing (GO:0010526),3/21,0.0167421026929478,0.310128305863471,0,0,6.22456813819578,25.4574168746086,APOBEC3D;MOV10;APOBEC3G
Positive Regulation Of Blood Coagulation (GO:0030194),3/21,0.0167421026929478,0.310128305863471,0,0,6.22456813819578,25.4574168746086,PLAU;F12;ENPP4
DNA Cytosine Deamination (GO:0070383),2/8,0.017276554025271,0.310128305863471,0,0,12.4329501915709,50.4579466668033,APOBEC3D;APOBEC3G
Regulation Of Dendritic Cell Antigen Processing And Presentation (GO:0002604),2/8,0.017276554025271,0.310128305863471,0,0,12.4329501915709,50.4579466668033,NOD1;FCGR2B
Regulation Of Endothelial Cell Differentiation (GO:0045601),2/8,0.017276554025271,0.310128305863471,0,0,12.4329501915709,50.4579466668033,CEACAM1;NOTCH4
Cellular Response To Muramyl Dipeptide (GO:0071225),2/8,0.017276554025271,0.310128305863471,0,0,12.4329501915709,50.4579466668033,NOD1;CHMP5
Negative Regulation Of Leukocyte Degranulation (GO:0043301),2/8,0.017276554025271,0.310128305863471,0,0,12.4329501915709,50.4579466668033,CEACAM1;FCGR2B
Positive Regulation Of Chromatin Binding (GO:0035563),2/8,0.017276554025271,0.310128305863471,0,0,12.4329501915709,50.4579466668033,DTX3L;PARP9
Positive Regulation Of Monocyte Chemotactic Protein-1 Production (GO:0071639),2/8,0.017276554025271,0.310128305863471,0,0,12.4329501915709,50.4579466668033,OAS1;OAS3
Positive Regulation Of Immune Response (GO:0050778),6/80,0.0184781166746935,0.329000613964056,0,0,3.03694041531879,12.1209397968245,GBP5;TASL;PLSCR1;RSAD2;IFI35;FCGR2B
Glucose Metabolic Process (GO:0006006),5/59,0.0190067993402046,0.335684601250387,0,0,3.46499678869621,13.731638489478,OAS1;DCXR;GAA;GALM;PCK2
Negative Regulation Of Cytokine Production (GO:0001818),10/178,0.0191674420398831,0.335813584538752,0,0,2.23596442468038,8.84221559999218,CD274;CEACAM1;BTN2A2;DHX58;INHBA;XAF1;MMP8;FCGR2B;TRIB2;GBP1
Positive Regulation Of Wound Healing (GO:0090303),4/40,0.020217893820336,0.350094975382778,0,0,4.15384615384615,16.2049315873983,OCLN;F12;PRKCE;ENPP4
Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001236),5/60,0.0203024532327087,0.350094975382778,0,0,3.40182168505868,13.256945205896,SP100;HYAL2;TNFSF10;G0S2;PML
Positive Regulation Of Stress-Activated MAPK Cascade (GO:0032874),7/105,0.0205229392251109,0.350094975382778,0,0,2.67725891130146,10.4043957934663,PRMT1;EIF2AK2;TNIK;MMP8;FCGR2B;MAPK8IP3;NAIP
Positive Regulation Of Tumor Necrosis Factor Superfamily Cytokine Production (GO:1903557),6/82,0.0206220327965198,0.350094975382778,0,0,2.95671611461085,11.4761837986477,IFIH1;OAS1;OAS2;OAS3;MMP8;RIGI
Adaptive Immune Response Based On Somatic Recombination Of Immune Receptors Built From Immunoglobulin Superfamily Domains (GO:0002460),3/23,0.021451933163417,0.353507138550073,0,0,5.60153550863724,21.5207662084446,BTN3A3;BTN3A2;IL18BP
NAD Biosynthesis Via Nicotinamide Riboside Salvage Pathway (GO:0034356),2/9,0.0218312844631338,0.353507138550073,0,0,10.656267104543,40.7539480192225,PARP10;PARP9
Type II Interferon-Mediated Signaling Pathway (GO:0060333),2/9,0.0218312844631338,0.353507138550073,0,0,10.656267104543,40.7539480192225,SP100;STAT1
Positive Regulation Of T Cell Apoptotic Process (GO:0070234),2/9,0.0218312844631338,0.353507138550073,0,0,10.656267104543,40.7539480192225,CD274;IDO1
Positive Regulation Of Vasculogenesis (GO:2001214),2/9,0.0218312844631338,0.353507138550073,0,0,10.656267104543,40.7539480192225,CEACAM1;RIN2
Response To Amino Acid Starvation (GO:1990928),4/41,0.0219529547227443,0.353507138550073,0,0,4.04137214137214,15.4334082964354,LARP1;SESN2;EIF2AK2;KPTN
Positive Regulation Of Response To Biotic Stimulus (GO:0002833),4/41,0.0219529547227443,0.353507138550073,0,0,4.04137214137214,15.4334082964354,GBP5;TASL;PLSCR1;IFI35
Positive Regulation Of Autophagy (GO:0010508),7/107,0.0225022122121768,0.359706895946477,0,0,2.62344294003868,9.95371413586015,PLK3;TRIM6;LARP1;TRIM5;SESN2;TRIM38;TRIM22
Regulation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0043281),6/84,0.0229285899376441,0.363379445519617,0,0,2.88060588060588,10.875354977143,GPX1;LAMP3;TNFSF10;IFI6;NOD1;NAIP
Positive Regulation Of Apoptotic Signaling Pathway (GO:2001235),5/62,0.0230638095558113,0.363379445519617,0,0,3.28212148869283,12.3719260205395,HYAL2;TNFSF10;G0S2;SEPTIN4;PML
Response To Tumor Necrosis Factor (GO:0034612),7/108,0.02353969717579,0.368228120107001,0,0,2.59733420150526,9.73758005055335,NUB1;CXCL8;GCH1;HYAL2;YBX3;GBP1;GBP3
Negative Regulation Of Antigen Receptor-Mediated Signaling Pathway (GO:0050858),3/24,0.0240503453168012,0.373547916622657,0,0,5.33452152454072,19.8849940378984,CEACAM1;FCGR2B;GBP1
Regulation Of JNK Cascade (GO:0046328),7/110,0.0257125209047914,0.3965522590246,0,0,2.5466376218287,9.32267297062198,PRMT1;TNIK;MMP8;FCGR2B;MAPK8IP3;ZNF675;NAIP
Regulation Of Type II Interferon Production (GO:0032649),6/87,0.0267035021405957,0.396886603112531,0,0,2.77348777348777,10.0482368055146,CD274;BTN3A1;ISG15;BTN3A2;INHBA;IL18R1
Negative Regulation Of Transposition (GO:0010529),3/25,0.02681104665966,0.396886603112531,0,0,5.09178153899843,18.4268584389133,APOBEC3D;MOV10;APOBEC3G
Regulation Of Chromatin Binding (GO:0035561),2/10,0.026821560392993,0.396886603112531,0,0,9.32375478927203,33.7384656446191,DTX3L;PARP9
Aromatic Amino Acid Family Catabolic Process (GO:0009074),2/10,0.026821560392993,0.396886603112531,0,0,9.32375478927203,33.7384656446191,FANCA;IDO1
Negative Regulation Of Mitochondrial Outer Membrane Permeabilization Involved In Apoptotic Signaling Pathway (GO:1901029),2/10,0.026821560392993,0.396886603112531,0,0,9.32375478927203,33.7384656446191,SLC25A5;SLC25A6
Positive Regulation Of Toll-Like Receptor 4 Signaling Pathway (GO:0034145),2/10,0.026821560392993,0.396886603112531,0,0,9.32375478927203,33.7384656446191,WDFY1;IFI35
Positive Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001961),4/44,0.0276908023964995,0.404285714988893,0,0,3.73769230769231,13.4058126706914,TRIM6;NLRC5;PARP14;PARP9
Positive Regulation Of Nucleocytoplasmic Transport (GO:0046824),4/44,0.0276908023964995,0.404285714988893,0,0,3.73769230769231,13.4058126706914,SMAD3;TRIM28;HYAL2;EMD
Positive Regulation Of DNA-binding Transcription Factor Activity (GO:0051091),12/246,0.0293527187422867,0.412822457987892,0,0,1.92728365384615,6.80017002853622,TRIM6;SMAD3;AIM2;TRIM5;ANKRD42;TRIM14;EIF2AK2;NOD1;TRIM38;TRIM22;IL18R1;RIGI
Regulation Of Transcription By RNA Polymerase III (GO:0006359),3/26,0.0297335420468885,0.412822457987892,0,0,4.87014937828591,17.1209103430621,NAB2;DDX21;MAF1
Negative Regulation Of Catalytic Activity (GO:0043086),3/26,0.0297335420468885,0.412822457987892,0,0,4.87014937828591,17.1209103430621,HP;IFIT1;PARP9
Nuclear Membrane Organization (GO:0071763),3/26,0.0297335420468885,0.412822457987892,0,0,4.87014937828591,17.1209103430621,TOR1B;EMD;CHMP5
I-kappaB kinase/NF-kappaB Signaling (GO:0007249),4/45,0.0297835380648799,0.412822457987892,0,0,3.64634146341463,12.812512636089,TIFA;AZI2;MAP3K14;ZNF675
Hexose Metabolic Process (GO:0019318),4/45,0.0297835380648799,0.412822457987892,0,0,3.64634146341463,12.812512636089,OAS1;DCXR;GAA;GALM
Negative Regulation Of Response To Biotic Stimulus (GO:0002832),4/45,0.0297835380648799,0.412822457987892,0,0,3.64634146341463,12.812512636089,IFI16;TREX1;DHX58;TRAFD1
Positive Regulation Of mRNA Catabolic Process (GO:0061014),4/45,0.0297835380648799,0.412822457987892,0,0,3.64634146341463,12.812512636089,MOV10;METTL14;PNPT1;ZC3HAV1
Extrinsic Apoptotic Signaling Pathway (GO:0097191),5/67,0.0309934676464192,0.414264186024047,0,0,3.01665734352663,10.4798037119272,SMAD3;SIVA1;CASP10;G0S2;INHBA
Regulation Of Epidermal Growth Factor Receptor Signaling Pathway (GO:0042058),4/46,0.0319673261362056,0.414264186024047,0,0,3.55934065934066,12.2549556666833,CEACAM1;RNF126;RHBDF2;IFI6
Regulation Of mRNA Catabolic Process (GO:0061013),4/46,0.0319673261362056,0.414264186024047,0,0,3.55934065934066,12.2549556666833,MOV10;PNPT1;EIF4A3;ZC3HAV1
Protein Sumoylation (GO:0016925),4/46,0.0319673261362056,0.414264186024047,0,0,3.55934065934066,12.2549556666833,IFIH1;TRIM28;NSMCE1;PML
Regulation Of Monocyte Chemotactic Protein-1 Production (GO:0071637),2/11,0.0322215233922516,0.414264186024047,0,0,8.28735632183908,28.4680685980366,OAS1;OAS3
Cytidine To Uridine Editing (GO:0016554),2/11,0.0322215233922516,0.414264186024047,0,0,8.28735632183908,28.4680685980366,APOBEC3D;APOBEC3G
Histone H2A Ubiquitination (GO:0033522),2/11,0.0322215233922516,0.414264186024047,0,0,8.28735632183908,28.4680685980366,RING1;BRCA2
Positive Regulation Of Coagulation (GO:0050820),2/11,0.0322215233922516,0.414264186024047,0,0,8.28735632183908,28.4680685980366,F12;ENPP4
Positive Regulation Of Hemostasis (GO:1900048),2/11,0.0322215233922516,0.414264186024047,0,0,8.28735632183908,28.4680685980366,F12;ENPP4
Post-Transcriptional Gene Silencing (GO:0016441),2/11,0.0322215233922516,0.414264186024047,0,0,8.28735632183908,28.4680685980366,HELZ2;MOV10
Regulation Of T Cell Apoptotic Process (GO:0070232),2/11,0.0322215233922516,0.414264186024047,0,0,8.28735632183908,28.4680685980366,CD274;IDO1
rRNA Metabolic Process (GO:0016072),6/91,0.0323466556210557,0.414264186024047,0,0,2.64242561889621,9.06680875330218,SLFN12;SLFN13;DDX27;XRN1;SPPL2B;IGF2BP3
Regulation Of RNA Metabolic Process (GO:0051252),6/91,0.0323466556210557,0.414264186024047,0,0,2.64242561889621,9.06680875330218,OAS1;OAS2;OAS3;METTL4;HNRNPLL;OASL
mRNA Modification (GO:0016556),3/27,0.0328169968339555,0.41784432015327,0,0,4.66698656429942,15.9462003033918,METTL14;METTL4;CMTR1
Double-Strand Break Repair (GO:0006302),9/168,0.0332149863815335,0.420467168644846,0,0,2.12313610551383,7.22875637682498,ZFYVE26;RMI2;RECQL5;DTX3L;NSMCE1;BRCA2;PARP9;SAMHD1;MPND
Protein Monoubiquitination (GO:0006513),4/47,0.0342425920907568,0.428521581021471,0,0,3.47638640429338,11.7303185920345,RNF126;FANCA;ZNF598;TNFSF13B
Regulation Of T Cell Differentiation (GO:0045580),4/47,0.0342425920907568,0.428521581021471,0,0,3.47638640429338,11.7303185920345,SMARCD3;FANCA;RHOH;PRDM1
Glycosaminoglycan Metabolic Process (GO:0030203),3/28,0.0360602615125321,0.442733738078014,0,0,4.48007677543186,14.885340955964,HYAL2;GUSB;CLN6
Positive Regulation Of Protein Import Into Nucleus (GO:0042307),3/28,0.0360602615125321,0.442733738078014,0,0,4.48007677543186,14.885340955964,SMAD3;TRIM28;HYAL2
Protein Polyubiquitination (GO:0000209),11/226,0.0364704611749437,0.442733738078014,0,0,1.92094836574641,6.36074532609375,RNF144A;RNF126;TRIM6;RNF213;DTX3L;TRIM5;UBE2L6;TRIM38;ZNF598;TRIM22;TNFSF13B
Regulation Of DNA Binding (GO:0051101),4/48,0.0366096510058571,0.442733738078014,0,0,3.3972027972028,11.2360559179227,SP100;IFI16;HES1;MMP8
Cellular Response To Tumor Necrosis Factor (GO:0071356),7/119,0.0371819245124609,0.442733738078014,0,0,2.34090909090909,7.7061148001665,CXCL8;AIM2;STAT1;HYAL2;YBX3;GBP1;GBP3
Regulation Of Cell Growth (GO:0001558),11/227,0.0374656738163823,0.442733738078014,0,0,1.91195581546459,6.27949409215891,BST2;DNAJB2;CEACAM1;SMAD3;BMPR2;HYAL2;SESN2;OSGIN1;CHPT1;INHBA;PML
Regulation Of Chemokine (C-X-C Motif) Ligand 2 Production (GO:2000341),2/12,0.0380063665564687,0.442733738078014,0,0,7.45823754789272,24.3884486575806,OAS1;OAS3
Regulation Of Chromosome Separation (GO:1905818),2/12,0.0380063665564687,0.442733738078014,0,0,7.45823754789272,24.3884486575806,PLSCR1;NCAPH2
DNA Deamination (GO:0045006),2/12,0.0380063665564687,0.442733738078014,0,0,7.45823754789272,24.3884486575806,APOBEC3D;APOBEC3G
Response To Muramyl Dipeptide (GO:0032495),2/12,0.0380063665564687,0.442733738078014,0,0,7.45823754789272,24.3884486575806,NOD1;CHMP5
Detection Of Bacterium (GO:0016045),2/12,0.0380063665564687,0.442733738078014,0,0,7.45823754789272,24.3884486575806,NOD1;NAIP
Histone Monoubiquitination (GO:0010390),2/12,0.0380063665564687,0.442733738078014,0,0,7.45823754789272,24.3884486575806,RING1;BRCA2
Negative Regulation Of Mitochondrial Membrane Permeability (GO:0035795),2/12,0.0380063665564687,0.442733738078014,0,0,7.45823754789272,24.3884486575806,SLC25A5;SLC25A6
Positive Regulation Of Cellular Catabolic Process (GO:0031331),8/146,0.0386423102514102,0.445471909395559,0,0,2.17256488035052,7.0682388375362,MOV10;TRIM6;PNPT1;DTX3L;TRIM5;ZC3HAV1;TRIM38;TRIM22
Recombinational Repair (GO:0000725),6/95,0.0387129439520076,0.445471909395559,0,0,2.5231443321331,8.20420884133544,ZFYVE26;RMI2;RECQL5;NSMCE1;BRCA2;SAMHD1
Intrinsic Apoptotic Signaling Pathway In Response To DNA Damage (GO:0008630),4/49,0.0390687098558046,0.445471909395559,0,0,3.32153846153846,10.7698672198791,IFI16;DDIT4;CDIP1;PML
Negative Regulation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0043154),4/49,0.0390687098558046,0.445471909395559,0,0,3.32153846153846,10.7698672198791,GPX1;LAMP3;IFI6;NAIP
Negative Regulation Of DNA Binding (GO:0043392),3/29,0.0394618951702002,0.445471909395559,0,0,4.30754466263104,13.9237924497359,SP100;IFI16;ZNF675
Regulation Of Blood Coagulation (GO:0030193),3/29,0.0394618951702002,0.445471909395559,0,0,4.30754466263104,13.9237924497359,PLAU;F12;ENPP4
Regulation Of Cellular Localization (GO:0060341),5/72,0.0404475485701081,0.454257083941214,0,0,2.79081471256435,8.95223377674494,TRIM6;PARD6A;TRIM5;TRIM38;TRIM22
Regulation Of Translation (GO:0006417),10/202,0.0406791048652937,0.454526732933639,0,0,1.95403696498054,6.25690591528211,METTL14;LARP1;SSB;RPL10;PRMT1;EIF4A3;EIF2AK2;IGF2BP3;ELP5;SHFL
Blood Circulation (GO:0008015),4/50,0.0416198699665597,0.462677742267846,0,0,3.24916387959866,10.3296689673147,GPX1;STAT1;OLR1;SERPING1
Cytoplasmic Translational Initiation (GO:0002183),3/30,0.0430201876933727,0.469386073149476,0,0,4.14779270633397,13.0493117024677,EIF2S3B;EIF4A1;EIF3I
Regulation Of Immune Effector Process (GO:0002697),2/13,0.0441522972916858,0.469386073149476,0,0,6.77986764193661,21.1539349944445,IRF4;FCGR2B
Regulation Of Vasculogenesis (GO:2001212),2/13,0.0441522972916858,0.469386073149476,0,0,6.77986764193661,21.1539349944445,CEACAM1;RIN2
Negative Regulation Of Endoplasmic Reticulum Unfolded Protein Response (GO:1900102),2/13,0.0441522972916858,0.469386073149476,0,0,6.77986764193661,21.1539349944445,HSPA5;DNAJB9
Negative Regulation Of Translational Initiation (GO:0045947),2/13,0.0441522972916858,0.469386073149476,0,0,6.77986764193661,21.1539349944445,LARP1;EIF2AK2
Negative Regulation Of Viral Transcription (GO:0032897),2/13,0.0441522972916858,0.469386073149476,0,0,6.77986764193661,21.1539349944445,IFITM3;TRIM14
Positive Regulation Of Chromosome Separation (GO:1905820),2/13,0.0441522972916858,0.469386073149476,0,0,6.77986764193661,21.1539349944445,PLSCR1;NCAPH2
Regulation Of IRE1-mediated Unfolded Protein Response (GO:1903894),2/13,0.0441522972916858,0.469386073149476,0,0,6.77986764193661,21.1539349944445,HSPA5;DNAJB9
Regulation Of Cell Projection Organization (GO:0031344),2/13,0.0441522972916858,0.469386073149476,0,0,6.77986764193661,21.1539349944445,NTNG2;MOV10
Positive Regulation Of Defense Response (GO:0031349),7/124,0.0448122810871284,0.474100944834837,0,0,2.24029162327035,6.95671719229199,GBP5;TASL;PLSCR1;AIM2;HYAL2;IFI35;NAIP
Regulation Of Cell Morphogenesis (GO:0022604),3/31,0.0467331809236143,0.492046472224593,0,0,3.99945160405813,12.2515235155175,NTNG2;MOV10;FMNL2
Protein-Containing Complex Organization (GO:0043933),7/126,0.0481262298970236,0.49952224362763,0,0,2.20241210604164,6.68195960276853,NUP205;OCLN;FANCA;HES1;LLGL1;PML;CD2AP
mRNA Stabilization (GO:0048255),4/53,0.0498254411126541,0.49952224362763,0,0,3.04976452119309,9.14694390203494,LARP1;IGF2BP3;TENT5A;YBX3
Positive Regulation Of NIK/NF-kappaB Signaling (GO:1901224),4/53,0.0498254411126541,0.49952224362763,0,0,3.04976452119309,9.14694390203494,EIF2AK2;NOD1;IFI35;MMP8
Positive Regulation Of Chemokine Production (GO:0032722),4/53,0.0498254411126541,0.49952224362763,0,0,3.04976452119309,9.14694390203494,C5;OAS1;OAS3;EIF2AK2
Aminoglycan Catabolic Process (GO:0006026),2/14,0.0506365014088282,0.49952224362763,0,0,6.21455938697318,18.5385439182407,HYAL2;GUSB
Regulation Of Neuron Projection Arborization (GO:0150011),2/14,0.0506365014088282,0.49952224362763,0,0,6.21455938697318,18.5385439182407,NTNG2;MOV10
Regulation Of Transposition (GO:0010528),2/14,0.0506365014088282,0.49952224362763,0,0,6.21455938697318,18.5385439182407,APOBEC3D;APOBEC3G
Striated Muscle Tissue Development (GO:0014706),2/14,0.0506365014088282,0.49952224362763,0,0,6.21455938697318,18.5385439182407,BMPR2;PRMT1
Histone mRNA Catabolic Process (GO:0071044),2/14,0.0506365014088282,0.49952224362763,0,0,6.21455938697318,18.5385439182407,SSB;XRN1
Negative Regulation Of Single Stranded Viral RNA Replication Via Double Stranded DNA Intermediate (GO:0045869),2/14,0.0506365014088282,0.49952224362763,0,0,6.21455938697318,18.5385439182407,APOBEC3D;APOBEC3G
Negative Regulation Of Transcription Elongation By RNA Polymerase II (GO:0034244),2/14,0.0506365014088282,0.49952224362763,0,0,6.21455938697318,18.5385439182407,RECQL5;NELFA
Positive Regulation Of Response To Cytokine Stimulus (GO:0060760),2/14,0.0506365014088282,0.49952224362763,0,0,6.21455938697318,18.5385439182407,IFIH1;RIGI
Positive Regulation Of Type I Interferon-Mediated Signaling Pathway (GO:0060340),2/14,0.0506365014088282,0.49952224362763,0,0,6.21455938697318,18.5385439182407,TRIM6;NLRC5
Post-Translational Protein Targeting To Endoplasmic Reticulum Membrane (GO:0006620),2/14,0.0506365014088282,0.49952224362763,0,0,6.21455938697318,18.5385439182407,UBL4A;HSPA5
Positive Regulation Of JNK Cascade (GO:0046330),5/77,0.051473767542773,0.503247995172647,0,0,2.59633911368015,7.70251503078624,TNIK;MMP8;FCGR2B;MAPK8IP3;NAIP
Positive Regulation Of Response To Stimulus (GO:0048584),5/77,0.051473767542773,0.503247995172647,0,0,2.59633911368015,7.70251503078624,IFIH1;TRIM28;RSAD2;FCGR2B;RIGI
Positive Regulation Of Response To External Stimulus (GO:0032103),8/155,0.0517276992880308,0.503482939736833,0,0,2.03860148710647,6.03785215538249,GBP5;TASL;PLSCR1;AIM2;PLAU;HYAL2;IFI35;NAIP
Protein Homooligomerization (GO:0051260),7/129,0.0533826786213663,0.517292328233593,0,0,2.14792148904461,6.29398765931964,GBP5;PNPT1;PRMT1;TIFA;SAMHD1;SAMD1;KCNJ2
ncRNA Catabolic Process (GO:0034661),3/33,0.0546143158766269,0.520023268564404,0,0,3.73243761996161,10.8519102274275,SLFN12;SLFN13;XRN1
Negative Regulation Of Endocytosis (GO:0045806),3/33,0.0546143158766269,0.520023268564404,0,0,3.73243761996161,10.8519102274275,RUBCN;PLSCR1;FCGR2B
Positive Regulation Of DNA Binding (GO:0043388),3/33,0.0546143158766269,0.520023268564404,0,0,3.73243761996161,10.8519102274275,TRIM6;HES1;MMP8
Regulation Of Activated T Cell Proliferation (GO:0046006),3/33,0.0546143158766269,0.520023268564404,0,0,3.73243761996161,10.8519102274275,CD274;BTN2A2;IDO1
Negative Regulation Of Macromolecule Metabolic Process (GO:0010605),9/186,0.0567652702562531,0.538164250481361,0,0,1.90544676649663,5.46640395116467,CCR1;PARP10;OCLN;TRIM6;SMAD3;CXCL8;PARP14;MMP8;PARP9
Glycosaminoglycan Catabolic Process (GO:0006027),2/15,0.0574371083132287,0.539859515905454,0,0,5.73622163277336,16.3887563283099,HYAL2;GUSB
Negative Regulation Of Phagocytosis (GO:0050765),2/15,0.0574371083132287,0.539859515905454,0,0,5.73622163277336,16.3887563283099,PLSCR1;FCGR2B
DNA Damage Checkpoint Signaling (GO:0000077),3/34,0.0587774763726698,0.546145055825265,0,0,3.61185065940189,10.2359723163422,DTX3L;FBXO6;PARP9
Purine Nucleotide Metabolic Process (GO:0006163),3/34,0.0587774763726698,0.546145055825265,0,0,3.61185065940189,10.2359723163422,NMRK1;CD38;AMPD2
Cellular Response To Peptide (GO:1901653),4/56,0.0588539877510331,0.546145055825265,0,0,2.87337278106509,8.13939068204501,CACNA1A;NOD1;FCGR2B;CHMP5
Ubiquitin-Dependent Protein Catabolic Process (GO:0006511),15/367,0.0606330202298576,0.560279807187292,0,0,1.60106715484908,4.48765617866018,UBL4A;KLHDC3;DTX3L;UBE2L6;PML;TNFSF13B;HERC5;RNF144A;PSMB6;NUB1;RNF126;RNF213;UBXN11;HERC6;CHMP5
Positive Regulation Of Interleukin-1 Beta Production (GO:0032731),4/57,0.062044382653024,0.565454651536337,0,0,2.81901306240929,7.83658935519511,GBP5;AIM2;IFI16;NAIP
Response To Exogenous dsRNA (GO:0043330),3/35,0.0630854102646929,0.565454651536337,0,0,3.49880038387716,9.66811527476181,IFIH1;IFIT1;RIGI
Endoderm Formation (GO:0001706),3/35,0.0630854102646929,0.565454651536337,0,0,3.49880038387716,9.66811527476181,DUSP2;INHBA;MMP8
Establishment Of Spindle Orientation (GO:0051294),3/35,0.0630854102646929,0.565454651536337,0,0,3.49880038387716,9.66811527476181,NDC80;LLGL1;ENKD1
B Cell Activation Involved In Immune Response (GO:0002312),2/16,0.0645331573861635,0.565454651536337,0,0,5.32621784345922,14.5969054277905,FCGR2B;GAPT
Regulation Of Fibrinolysis (GO:0051917),2/16,0.0645331573861635,0.565454651536337,0,0,5.32621784345922,14.5969054277905,PLAU;F12
Regulation Of Natural Killer Cell Activation (GO:0032814),2/16,0.0645331573861635,0.565454651536337,0,0,5.32621784345922,14.5969054277905,PRDM1;MICA
Regulation Of Plasminogen Activation (GO:0010755),2/16,0.0645331573861635,0.565454651536337,0,0,5.32621784345922,14.5969054277905,PLAU;F12
Vasculature Development (GO:0001944),2/16,0.0645331573861635,0.565454651536337,0,0,5.32621784345922,14.5969054277905,BMPR2;NOTCH4
Innate Immune Response-Activating Signaling Pathway (GO:0002758),2/16,0.0645331573861635,0.565454651536337,0,0,5.32621784345922,14.5969054277905,NOD1;NAIP
Negative Regulation Of Chemokine Production (GO:0032682),2/16,0.0645331573861635,0.565454651536337,0,0,5.32621784345922,14.5969054277905,OAS1;OAS3
Pharyngeal System Development (GO:0060037),2/16,0.0645331573861635,0.565454651536337,0,0,5.32621784345922,14.5969054277905,BMPR2;HES1
Positive Regulation Of Translation (GO:0045727),6/108,0.0646280035550936,0.565454651536337,0,0,2.20009084714967,6.02628527533612,METTL14;LARP1;SSB;PRMT1;EIF4A3;YBX3
Renal System Development (GO:0072001),4/58,0.0653242131683531,0.565454651536337,0,0,2.76666666666667,7.54855261798825,STAT1;HYAL2;C1GALT1;PCSK5
mRNA Transport (GO:0051028),4/58,0.0653242131683531,0.565454651536337,0,0,2.76666666666667,7.54855261798825,NXT1;ALYREF;EIF4A3;THOC7
Regulation Of Bone Mineralization (GO:0030500),4/58,0.0653242131683531,0.565454651536337,0,0,2.76666666666667,7.54855261798825,CCR1;BMPR2;ISG15;TENT5A
Positive Regulation Of Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0032436),5/83,0.0668043609943405,0.573731570892572,0,0,2.39587965021491,6.48321898632901,RNF144A;DNAJB2;PLK3;NUB1;TRIB2
Regulation Of NIK/NF-kappaB Signaling (GO:1901222),5/83,0.0668043609943405,0.573731570892572,0,0,2.39587965021491,6.48321898632901,TRIM6;EIF2AK2;NOD1;IFI35;MMP8
Anterior/Posterior Pattern Specification (GO:0009952),4/59,0.0686927553023892,0.587645055125908,0,0,2.71622377622378,7.27435023877415,BMPR2;HES1;PCSK5;HES4
Double-Strand Break Repair Via Homologous Recombination (GO:0000724),6/111,0.0717667943184968,0.58959948520254,0,0,2.13690016547159,5.62930744540588,ZFYVE26;RMI2;RECQL5;NSMCE1;BRCA2;SAMHD1
DNA Damage Response, Signal Transduction By P53 Class Mediator Resulting In Cell Cycle Arrest (GO:0006977),2/17,0.0719045654778374,0.58959948520254,0,0,4.97088122605364,13.0854248809066,PLK3;PML
Regulation Of Hematopoietic Progenitor Cell Differentiation (GO:1901532),2/17,0.0719045654778374,0.58959948520254,0,0,4.97088122605364,13.0854248809066,METTL14;EIF2AK2
Carbohydrate Derivative Catabolic Process (GO:1901136),2/17,0.0719045654778374,0.58959948520254,0,0,4.97088122605364,13.0854248809066,FBXO6;SAMHD1
Regulation Of Receptor Signaling Pathway Via STAT (GO:1904892),2/17,0.0719045654778374,0.58959948520254,0,0,4.97088122605364,13.0854248809066,TP53INP2;HES1
Regulation Of Viral Transcription (GO:0046782),2/17,0.0719045654778374,0.58959948520254,0,0,4.97088122605364,13.0854248809066,IFITM3;TRIM14
Toll-Like Receptor 4 Signaling Pathway (GO:0034142),2/17,0.0719045654778374,0.58959948520254,0,0,4.97088122605364,13.0854248809066,OAS1;PRKCE
Motile Cilium Assembly (GO:0044458),2/17,0.0719045654778374,0.58959948520254,0,0,4.97088122605364,13.0854248809066,RSPH9;ENKD1
Negative Regulation Of Fibroblast Proliferation (GO:0048147),2/17,0.0719045654778374,0.58959948520254,0,0,4.97088122605364,13.0854248809066,PARP10;EMD
Nuclear Envelope Organization (GO:0006998),2/17,0.0719045654778374,0.58959948520254,0,0,4.97088122605364,13.0854248809066,TOR1B;EMD
Regulation Of DNA Methylation-Dependent Heterochromatin Formation (GO:0090308),2/17,0.0719045654778374,0.58959948520254,0,0,4.97088122605364,13.0854248809066,TRIM28;SAMD1
Positive Regulation Of Amide Metabolic Process (GO:0034250),5/85,0.0724211239814992,0.58959948520254,0,0,2.33574181117534,6.13192313430117,METTL14;LARP1;SSB;PRMT1;EIF4A3
Positive Regulation Of Protein Localization (GO:1903829),5/85,0.0724211239814992,0.58959948520254,0,0,2.33574181117534,6.13192313430117,NECAB2;PARD6A;DTX3L;SESN2;PARP9
Positive Regulation Of Protein Metabolic Process (GO:0051247),9/196,0.0736055674962595,0.596954547340033,0,0,1.80261668656871,4.70308932522492,METTL14;LARP1;SSB;PRMT1;EIF4A3;INHBA;CLN6;RIGI;TNFSF13B
Negative Regulation Of Cellular Process (GO:0048523),20/537,0.0738697179585155,0.596954547340033,0,0,1.45520555095023,3.79146865773988,KLF10;APOBEC3D;BMPR2;SMAD3;CXCL8;APOBEC3G;NOTCH4;OSGIN1;EIF2AK2;FUZ;IFI35;INHBA;ACVR1B;PML;IFIT3;DNAJB2;BST2;HYAL2;SESN2;CHMP5
Negative Regulation Of Binding (GO:0051100),5/86,0.0753235127956438,0.606465047876691,0,0,2.30678655534147,5.9652645379793,DNAJB2;SP100;IFI16;IFIT1;IFIT2
Cytokine-Mediated Signaling Pathway (GO:0019221),11/257,0.0766392711896303,0.606882540227489,0,0,1.67617553368516,4.30550100144107,CCR1;CEACAM1;CXCL8;AIM2;OAS1;STAT1;OAS2;MX1;ZNF675;IL18R1;OASL
Regulation Of Protein Import Into Nucleus (GO:0042306),3/38,0.0768479790511564,0.606882540227489,0,0,3.19840965176858,8.20688282526865,SMAD3;TRIM28;HYAL2
Response To Peptide (GO:1901652),3/38,0.0768479790511564,0.606882540227489,0,0,3.19840965176858,8.20688282526865,STAT1;STAT2;CACNA1A
Maturation Of SSU-rRNA (GO:0030490),3/38,0.0768479790511564,0.606882540227489,0,0,3.19840965176858,8.20688282526865,SPPL2B;TSR3;IGF2BP3
Positive Regulation Of Bone Mineralization (GO:0030501),3/38,0.0768479790511564,0.606882540227489,0,0,3.19840965176858,8.20688282526865,BMPR2;ISG15;TENT5A
Proteasome-Mediated Ubiquitin-Dependent Protein Catabolic Process (GO:0043161),13/319,0.0781766746970148,0.606882540227489,0,0,1.59376079198803,4.0621519322668,KLHDC3;HSPA5;FBXO39;FBXL15;PML;TNFSF13B;PSMB6;DNAJB2;RNF126;UBXN11;DNAJB9;FBXO6;ZNF598
RNA Methylation (GO:0001510),4/62,0.0793222792736577,0.606882540227489,0,0,2.57533156498674,6.52649858348284,METTL14;MEPCE;METTL4;CMTR1
mRNA Export From Nucleus (GO:0006406),4/62,0.0793222792736577,0.606882540227489,0,0,2.57533156498674,6.52649858348284,NXT1;ALYREF;EIF4A3;THOC7
Regulation Of Mitochondrial Outer Membrane Permeabilization Involved In Apoptotic Signaling Pathway (GO:1901028),2/18,0.07953209545447,0.606882540227489,0,0,4.65996168582376,11.7971339443514,SLC25A5;SLC25A6
Maintenance Of Protein Localization In Organelle (GO:0072595),2/18,0.07953209545447,0.606882540227489,0,0,4.65996168582376,11.7971339443514,HSPA5;PML
Maintenance Of Protein Location In Nucleus (GO:0051457),2/18,0.07953209545447,0.606882540227489,0,0,4.65996168582376,11.7971339443514,SP100;PML
ncRNA-mediated Post-Transcriptional Gene Silencing (GO:0035194),2/18,0.07953209545447,0.606882540227489,0,0,4.65996168582376,11.7971339443514,HELZ2;MOV10
Negative Regulation Of DNA-templated Transcription, Elongation (GO:0032785),2/18,0.07953209545447,0.606882540227489,0,0,4.65996168582376,11.7971339443514,RECQL5;NELFA
Negative Regulation Of T Cell Receptor Signaling Pathway (GO:0050860),2/18,0.07953209545447,0.606882540227489,0,0,4.65996168582376,11.7971339443514,CEACAM1;GBP1
Regulation Of Adaptive Immune Response (GO:0002819),2/18,0.07953209545447,0.606882540227489,0,0,4.65996168582376,11.7971339443514,IRF7;FCGR2B
Negative Regulation Of Mitochondrion Organization (GO:0010823),3/39,0.0817044788548208,0.6212944746252,0,0,3.10940499040307,7.78796019530985,GPX1;SLC25A5;SLC25A6
Positive Regulation Of Gene Expression (GO:0010628),18/480,0.0823977325116343,0.62243987597462,0,0,1.46404188696679,3.65453749391969,BMPR2;SSB;SMAD3;CXCL8;BTN3A1;PRMT1;EIF4A3;EIF2AK2;INHBA;HNRNPLL;MMP8;PLSCR1;METTL14;OCLN;LARP1;IFI16;LAMP3;RIGI
DNA Repair (GO:0006281),12/291,0.0824235452203834,0.62243987597462,0,0,1.61265120967742,4.02499057745286,RMI2;RECQL5;TRIM28;DTX3L;TREX1;FANCA;ZNF668;FBXO6;GTF2H2;BRCA2;PARP9;MPND
Regulation Of Secretion By Cell (GO:1903530),4/64,0.0868356031979588,0.63211435993988,0,0,2.48923076923077,6.08302923124697,RHBDF2;OTOF;SEPTIN4;LLGL1
Positive Regulation Of Cysteine-Type Endopeptidase Activity (GO:2001056),4/64,0.0868356031979588,0.63211435993988,0,0,2.48923076923077,6.08302923124697,AIM2;IFI16;TNFSF10;NOD1
Positive Regulation Of Interleukin-1 Production (GO:0032732),4/64,0.0868356031979588,0.63211435993988,0,0,2.48923076923077,6.08302923124697,GBP5;AIM2;IFI16;NAIP
Cortical Actin Cytoskeleton Organization (GO:0030866),2/19,0.0873973258051913,0.63211435993988,0,0,4.38562091503268,10.6890326049858,FMNL2;LLGL1
tRNA Metabolic Process (GO:0006399),2/19,0.0873973258051913,0.63211435993988,0,0,4.38562091503268,10.6890326049858,SLFN13;SSB
Positive Regulation Of Cellular Biosynthetic Process (GO:0031328),8/174,0.0878401851118288,0.63211435993988,0,0,1.80349304193518,4.38652105194785,METTL14;LARP1;SMAD3;CXCL8;SSB;PRMT1;EIF4A3;MMP8
RNA Export From Nucleus (GO:0006405),4/65,0.0907171310460053,0.63211435993988,0,0,2.44829760403531,5.8759364405038,NXT1;ALYREF;EIF4A3;THOC7
Positive Regulation Of Ossification (GO:0045778),3/41,0.091800695783235,0.63211435993988,0,0,2.94544903525609,7.03413111601831,BMPR2;ISG15;TENT5A
Protein Localization To Lysosome (GO:0061462),3/41,0.091800695783235,0.63211435993988,0,0,2.94544903525609,7.03413111601831,SCARB2;GLMP;KPTN
Inflammatory Response (GO:0006954),10/236,0.093043336088298,0.63211435993988,0,0,1.65713990565063,3.93519342155925,CCR1;GGT5;CXCL8;HP;OLR1;CYBB;NOD1;SIGLEC1;FCGR2B;NAIP
Regulation Of Gene Expression (GO:0010468),37/1127,0.0933310849267312,0.63211435993988,0,0,1.28154399713656,3.03931237697937,BMPR2;CXCL8;BNC2;NAB2;HNRNPLL;BRCA2;ACVR1B;YBX3;AFF1;TRIM6;LARP1;IFI16;LAMP3;METTL4;IGF2BP3;BTN2A3P;TRIM22;CCR1;GPX1;SMAD3;BTN2A2;BTN3A1;RHOH;BTN3A3;TDRD7;BTN3A2;INHBA;PARP14;PARP9;MMP8;PML;PARP10;PLSCR1;OCLN;ZNF675;GZF1;RIGI
Response To Reactive Oxygen Species (GO:0000302),4/66,0.0946803270987827,0.63211435993988,0,0,2.40868486352357,5.67787008114384,PLK3;GPX1;HYAL2;HP
Negative Regulation Of Endopeptidase Activity (GO:0010951),4/66,0.0946803270987827,0.63211435993988,0,0,2.40868486352357,5.67787008114384,SERPINB10;IFI16;SERPING1;SERPINB9
DNA Methylation (GO:0006306),2/20,0.0954826211679304,0.63211435993988,0,0,4.14176245210728,9.72821731190882,METTL4;PICK1
Fc-gamma Receptor Signaling Pathway Involved In Phagocytosis (GO:0038096),2/20,0.0954826211679304,0.63211435993988,0,0,4.14176245210728,9.72821731190882,PRKCE;FCGR2B
Regulation Of Fibroblast Migration (GO:0010762),2/20,0.0954826211679304,0.63211435993988,0,0,4.14176245210728,9.72821731190882,PRKCE;HYAL2
Response To Fibroblast Growth Factor (GO:0071774),2/20,0.0954826211679304,0.63211435993988,0,0,4.14176245210728,9.72821731190882,CXCL8;HYAL2
Mitochondrial RNA Metabolic Process (GO:0000959),2/20,0.0954826211679304,0.63211435993988,0,0,4.14176245210728,9.72821731190882,PNPT1;POLRMT
Monocarboxylic Acid Catabolic Process (GO:0072329),2/20,0.0954826211679304,0.63211435993988,0,0,4.14176245210728,9.72821731190882,FAAH;FANCA
Negative Regulation Of B Cell Activation (GO:0050869),2/20,0.0954826211679304,0.63211435993988,0,0,4.14176245210728,9.72821731190882,INHBA;FCGR2B
DNA Integrity Checkpoint Signaling (GO:0031570),3/42,0.0970333514999494,0.63211435993988,0,0,2.86977705595748,6.6943304584907,DTX3L;FBXO6;PARP9
Regulation Of Osteoclast Differentiation (GO:0045670),3/42,0.0970333514999494,0.63211435993988,0,0,2.86977705595748,6.6943304584907,CCR1;GPR137;ZNF675
Cellular Response To Amino Acid Starvation (GO:0034198),3/42,0.0970333514999494,0.63211435993988,0,0,2.86977705595748,6.6943304584907,SESN2;EIF2AK2;KPTN
Positive Regulation Of Intracellular Signal Transduction (GO:1902533),19/525,0.0984430407373516,0.63211435993988,0,0,1.41051931280085,3.26997471322127,BMPR2;VWF;IFIT5;SHISA5;EIF2AK2;DDX21;NOD1;SEPTIN4;IFI35;MMP8;BST2;TRIM6;CASP10;TRIM5;TIFA;TNFSF10;TRIM38;MAP3K14;TRIM22
Positive Regulation Of Macromolecule Biosynthetic Process (GO:0010557),6/122,0.101628699536702,0.63211435993988,0,0,1.93316469178538,4.42004440843394,METTL14;LARP1;SSB;PRMT1;EIF4A3;NLRC5
SCF-dependent Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0031146),3/43,0.102384212996679,0.63211435993988,0,0,2.7978886756238,6.37645193872384,FBXO39;FBXO6;FBXL15
Lysosome Organization (GO:0007040),3/43,0.102384212996679,0.63211435993988,0,0,2.7978886756238,6.37645193872384,TASL;ZFYVE26;GAA
Positive Regulation Of Biomineral Tissue Development (GO:0070169),3/43,0.102384212996679,0.63211435993988,0,0,2.7978886756238,6.37645193872384,BMPR2;ISG15;TENT5A
Antigen Processing And Presentation Of Endogenous Peptide Antigen (GO:0002483),2/21,0.103771104062407,0.63211435993988,0,0,3.92357330106876,8.88912104897959,TAP2;MICA
Sulfur Compound Transport (GO:0072348),2/21,0.103771104062407,0.63211435993988,0,0,3.92357330106876,8.88912104897959,SLC5A6;SLC26A8
Negative Regulation Of Double-Strand Break Repair Via Homologous Recombination (GO:2000042),2/21,0.103771104062407,0.63211435993988,0,0,3.92357330106876,8.88912104897959,RMI2;HELB
Negative Regulation Of Osteoclast Differentiation (GO:0045671),2/21,0.103771104062407,0.63211435993988,0,0,3.92357330106876,8.88912104897959,GPR137;ZNF675
Negative Regulation Of Tumor Necrosis Factor-Mediated Signaling Pathway (GO:0010804),2/21,0.103771104062407,0.63211435993988,0,0,3.92357330106876,8.88912104897959,ZNF675;NAIP
Positive Regulation Of T Cell Cytokine Production (GO:0002726),2/21,0.103771104062407,0.63211435993988,0,0,3.92357330106876,8.88912104897959,RSAD2;IL18R1
Positive Regulation Of DNA-templated Transcription (GO:0045893),40/1243,0.104172381582396,0.63211435993988,0,0,1.25533274252386,2.83919640367553,ZNF496;SP100;BMPR2;SMARCD3;NOTCH4;NLRC5;DDX21;BRCA2;HELZ2;IFI16;TRIM28;TP53INP2;HYAL2;CREB3L2;CD38;HES1;KLF10;SMAD3;DTX3L;STAT1;PCGF5;STAT2;ALYREF;LMO2;PTOV1;GLMP;INHBA;PARP9;NR4A2;PLSCR1;ELF1;IRF4;TFEC;IRF7;NCOA7;AGRN;SSBP3;ATF3;IRF9;RIGI
T Cell Receptor Signaling Pathway (GO:0050852),5/95,0.10419459204198,0.63211435993988,0,0,2.07514450867052,4.69292903605063,BTN3A1;BTN2A2;BTN3A3;BTN3A2;BTN2A3P
Response To Molecule Of Bacterial Origin (GO:0002237),4/69,0.107047149254543,0.63211435993988,0,0,2.29715976331361,5.13297108816506,TRIM6;CXCL8;GCH1;FCGR2B
Autophagosome Maturation (GO:0097352),3/44,0.107849588078782,0.63211435993988,0,0,2.7295070455503,6.07866057243865,MAP1LC3A;STX17;CHMP5
Embryonic Organ Morphogenesis (GO:0048562),3/44,0.107849588078782,0.63211435993988,0,0,2.7295070455503,6.07866057243865,PPP1R35;HES1;FUZ
Establishment Of Protein Localization To Mitochondrion (GO:0072655),3/44,0.107849588078782,0.63211435993988,0,0,2.7295070455503,6.07866057243865,DNLZ;TIMM10;DNAJC15
Regulation Of B Cell Proliferation (GO:0030888),3/44,0.107849588078782,0.63211435993988,0,0,2.7295070455503,6.07866057243865,CD38;FCGR2B;TNFSF13B
Positive Regulation Of Transcription By RNA Polymerase II (GO:0045944),31/938,0.109845190240807,0.63211435993988,0,0,1.28734812177542,2.84334425395343,BMPR2;NOTCH4;MEPCE;NLRC5;DDX21;HELZ2;IFI16;HYAL2;HES1;KLF10;SMAD3;STAT1;PCGF5;TAF13;STAT2;LMO2;PTOV1;GLMP;INHBA;NR4A2;PLSCR1;ELF1;IRF4;TFEC;IRF7;NCOA7;AGRN;SSBP3;ATF3;IRF9;RIGI
Regulation Of Defense Response (GO:0031347),5/97,0.11125976898837,0.63211435993988,0,0,2.02982323866968,4.45726357983419,HERC5;DHX58;SAMHD1;FCGR2B;USP18
Fc Receptor Mediated Stimulatory Signaling Pathway (GO:0002431),2/22,0.112246627257303,0.63211435993988,0,0,3.7272030651341,8.15160480678111,PRKCE;FCGR2B
Regulation Of Protein Export From Nucleus (GO:0046825),2/22,0.112246627257303,0.63211435993988,0,0,3.7272030651341,8.15160480678111,SP100;EMD
Positive Regulation Of Cilium Assembly (GO:0045724),2/22,0.112246627257303,0.63211435993988,0,0,3.7272030651341,8.15160480678111,PPP1R35;FUZ
Postreplication Repair (GO:0006301),2/22,0.112246627257303,0.63211435993988,0,0,3.7272030651341,8.15160480678111,PARP10;TNFSF13B
Regulation Of Catabolic Process (GO:0009894),2/22,0.112246627257303,0.63211435993988,0,0,3.7272030651341,8.15160480678111,SCARB2;NUB1
Zymogen Activation (GO:0031638),3/45,0.113425737940874,0.63211435993988,0,0,2.66438168357554,5.79931168318888,IFI16;PLAU;F12
Negative Regulation Of Macromolecule Biosynthetic Process (GO:0010558),5/98,0.114877172922058,0.63211435993988,0,0,2.00789359189508,4.34486444454054,LARP1;BMPR2;EIF4A3;EIF2AK2;IGF2BP3
Regulation Of Response To External Stimulus (GO:0032101),6/127,0.117059233376982,0.63211435993988,0,0,1.85280321643958,3.97440223769007,HERC5;TRIM5;DHX58;SAMHD1;FCGR2B;USP18
Regulation Of Tumor Necrosis Factor Production (GO:0032680),6/127,0.117059233376982,0.63211435993988,0,0,1.85280321643958,3.97440223769007,IFIH1;OAS1;OAS2;OAS3;MMP8;RIGI
Intracellular Protein Transmembrane Transport (GO:0065002),3/46,0.119108886226131,0.63211435993988,0,0,2.60228540820426,5.53692740655906,HSPA5;DNLZ;DNAJC15
Artery Development (GO:0060840),2/23,0.120893747282914,0.63211435993988,0,0,3.54953475643131,7.49961051807102,BMPR2;HES1
Bile Acid And Bile Salt Transport (GO:0015721),2/23,0.120893747282914,0.63211435993988,0,0,3.54953475643131,7.49961051807102,CEACAM1;SLC10A3
Regulation Of Toll-Like Receptor 4 Signaling Pathway (GO:0034143),2/23,0.120893747282914,0.63211435993988,0,0,3.54953475643131,7.49961051807102,WDFY1;IFI35
Translesion Synthesis (GO:0019985),2/23,0.120893747282914,0.63211435993988,0,0,3.54953475643131,7.49961051807102,PARP10;TNFSF13B
Histone mRNA Metabolic Process (GO:0008334),2/23,0.120893747282914,0.63211435993988,0,0,3.54953475643131,7.49961051807102,SSB;XRN1
Negative Regulation Of Lymphocyte Activation (GO:0051250),2/23,0.120893747282914,0.63211435993988,0,0,3.54953475643131,7.49961051807102,FCGR2B;MICA
Protein Complex Oligomerization (GO:0051259),5/100,0.122277980089958,0.63211435993988,0,0,1.96541932866849,4.13024676282993,PNPT1;FKRP;PRMT1;TIFA;SAMD1
CD4-positive, Alpha-Beta T Cell Activation (GO:0035710),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,RSAD2
DNA Methylation Involved In Embryo Development (GO:0043045),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,PICK1
Regulation Of Endothelial Cell-Matrix Adhesion Via Fibronectin (GO:1904904),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,RIN2
Golgi Disassembly (GO:0090166),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,PLK3
Regulation Of Glutamate Receptor Signaling Pathway (GO:1900449),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,NECAB2
PML Body Organization (GO:0030578),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,PML
Regulation Of Hematopoietic Stem Cell Proliferation (GO:1902033),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,EIF2AK2
Regulation Of Lysosome Organization (GO:1905671),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,SCARB2
Regulation Of Macrophage Apoptotic Process (GO:2000109),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,IRF7
Aminophospholipid Transport (GO:0015917),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,SCARB2
Aromatic Compound Biosynthetic Process (GO:0019438),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,GCH1
Attachment Of GPI Anchor To Protein (GO:0016255),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,TP53INP2
Regulation Of Neutrophil Activation (GO:1902563),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,FCGR2B
Axonemal Central Apparatus Assembly (GO:1904158),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,RSPH9
Basic Amino Acid Transport (GO:0015802),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,SLC7A7
Regulation Of pro-B Cell Differentiation (GO:2000973),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,HES1
Regulation Of Resting Membrane Potential (GO:0060075),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,KCNJ2
Regulation Of Superoxide Metabolic Process (GO:0090322),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,GCH1
Regulation Of Translation In Response To Endoplasmic Reticulum Stress (GO:0036490),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,SESN2
Chondrocyte Development (GO:0002063),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,BMPR2
Resolution Of Recombination Intermediates (GO:0071139),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,RMI2
Response To Lithium Ion (GO:0010226),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,IMPA2
Detection Of Virus (GO:0009597),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,RIGI
Embryonic Brain Development (GO:1990403),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,RPL10
Short-Chain Fatty Acid Catabolic Process (GO:0019626),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,PCK2
Establishment Of Protein Localization To Telomere (GO:0070200),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,BRCA2
tRNA Catabolic Process (GO:0016078),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,SLFN13
tRNA Transport (GO:0051031),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,SSB
Hepatocyte Differentiation (GO:0070365),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,PCK2
Lipoprotein Metabolic Process (GO:0042157),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,OLR1
Maintenance Of DNA Repeat Elements (GO:0043570),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,RMI2
Mesenchymal Cell Differentiation Involved In Kidney Development (GO:0072161),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,STAT1
Mitochondrial RNA 3'-End Processing (GO:0000965),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,PNPT1
Negative Regulation Of Arp2/3 Complex-Mediated Actin Nucleation (GO:0034316),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,PICK1
Negative Regulation Of B Cell Receptor Signaling Pathway (GO:0050859),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,FCGR2B
Negative Regulation Of Fibroblast Migration (GO:0010764),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,HYAL2
Negative Regulation Of Glial Cell Proliferation (GO:0060253),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,HES1
Negative Regulation Of Myeloid Cell Apoptotic Process (GO:0033033),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,IRF7
Negative Regulation Of Protein Polyubiquitination (GO:1902915),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,PARP10
Notochord Development (GO:0030903),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,PPP1R35
Nucleotide-Binding Domain, Leucine Rich Repeat Containing Receptor Signaling Pathway (GO:0035872),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,MAP2K6
Peptidyl-Diphthamide Biosynthetic Process From Peptidyl-Histidine (GO:0017183),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,DPH7
Peptidyl-Diphthamide Metabolic Process (GO:0017182),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,DPH7
Positive Regulation Of T-helper 1 Cell Cytokine Production (GO:2000556),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,IL18R1
Positive Regulation Of Antigen Processing And Presentation (GO:0002579),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,NOD1
Positive Regulation Of Dendritic Cell Antigen Processing And Presentation (GO:0002606),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,NOD1
Positive Regulation Of Hemoglobin Biosynthetic Process (GO:0046985),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,PRMT1
Positive Regulation Of Interleukin-18 Production (GO:0032741),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,GBP5
Positive Regulation Of Microglial Cell Activation (GO:1903980),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,MMP8
Positive Regulation Of Protein Catabolic Process In The Vacuole (GO:1904352),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,MARCHF2
Positive Regulation Of Tau-Protein Kinase Activity (GO:1902949),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,NAB2
Positive Regulation Of Transcription Of Notch Receptor Target (GO:0007221),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,NOTCH4
Positive Regulation Of Urine Volume (GO:0035810),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,HYAL2
Protection From Natural Killer Cell Mediated Cytotoxicity (GO:0042270),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,SERPINB9
Pteridine-Containing Compound Metabolic Process (GO:0042558),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,GCH1
Purine Deoxyribonucleotide Catabolic Process (GO:0009155),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,SAMHD1
Purine Ribonucleoside Catabolic Process (GO:0046130),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,ENPP4
Regulation Of T-helper 1 Cell Cytokine Production (GO:2000554),1/5,0.12432454489787,0.63211435993988,0,0,9.30783938814532,19.4055404907167,IL18R1
Ubiquitin-Dependent ERAD Pathway (GO:0030433),4/73,0.124598042081559,0.63211435993988,0,0,2.16354515050167,4.50593410619203,DNAJB2;HSPA5;DNAJB9;FBXO6
Protein Tetramerization (GO:0051262),4/73,0.124598042081559,0.63211435993988,0,0,2.16354515050167,4.50593410619203,GBP5;FKRP;SAMHD1;KCNJ2
Regulation Of Wound Healing (GO:0061041),3/47,0.124895227588867,0.63211435993988,0,0,2.5430116908044,5.29017654435616,OCLN;PLAU;PRKCE
Negative Regulation Of Cell Population Proliferation (GO:0008285),14/379,0.125444159459609,0.63211435993988,0,0,1.43730325006715,2.98369000359432,KLF10;SMAD3;BMPR2;CXCL8;EIF2AK2;FUZ;IFI35;INHBA;IFIT3;PML;PARP10;DNAJB2;HES1;EMD
Fc-gamma Receptor Signaling Pathway (GO:0038094),2/24,0.129697698762664,0.63211435993988,0,0,3.38801811215604,6.92019277179595,PRKCE;FCGR2B
Regulation Of Proteolysis Involved In Protein Catabolic Process (GO:1903050),2/24,0.129697698762664,0.63211435993988,0,0,3.38801811215604,6.92019277179595,NUB1;GPX1
Multivesicular Body Sorting Pathway (GO:0071985),2/24,0.129697698762664,0.63211435993988,0,0,3.38801811215604,6.92019277179595,RUBCN;CHMP5
Positive Regulation Of BMP Signaling Pathway (GO:0030513),2/24,0.129697698762664,0.63211435993988,0,0,3.38801811215604,6.92019277179595,BMPR2;FBXL15
Regulation Of Protein Secretion (GO:0050708),5/102,0.129894970513744,0.63211435993988,0,0,1.92469658145124,3.92836168174408,RSAD2;RHBDF2;PICK1;LLGL1;CD2AP
Regulation Of Tumor Necrosis Factor-Mediated Signaling Pathway (GO:0010803),3/48,0.130780935675683,0.63211435993988,0,0,2.48637236084453,5.05785723150727,SPPL2B;ZNF675;NAIP
Negative Regulation Of T Cell Activation (GO:0050868),3/49,0.136762170629164,0.63211435993988,0,0,2.43219561044813,4.83888197032111,CD274;CEACAM1;FCGR2B
Positive Regulation Of Inflammatory Response (GO:0050729),5/104,0.137721623238935,0.63211435993988,0,0,1.88561919775793,3.73827938238158,AIM2;HYAL2;IFI35;MMP8;NAIP
Positive Regulation Of Interleukin-6 Production (GO:0032755),4/76,0.138505050908663,0.63211435993988,0,0,2.07307692307692,4.09815897542996,IFIH1;HYAL2;MMP8;RIGI
Regulation Of Lysosomal Lumen pH (GO:0035751),2/25,0.138644369536473,0.63211435993988,0,0,3.24054639346993,6.40281128663027,TASL;CLN6
Negative Regulation Of TORC1 Signaling (GO:1904262),2/25,0.138644369536473,0.63211435993988,0,0,3.24054639346993,6.40281128663027,SESN2;KPTN
Negative Regulation Of Protein Transport (GO:0051224),2/25,0.138644369536473,0.63211435993988,0,0,3.24054639346993,6.40281128663027,RSAD2;RHBDF2
Negative Regulation Of Proteolysis Involved In Protein Catabolic Process (GO:1903051),2/25,0.138644369536473,0.63211435993988,0,0,3.24054639346993,6.40281128663027,LAMP3;PML
Phosphatidylethanolamine Metabolic Process (GO:0046337),2/25,0.138644369536473,0.63211435993988,0,0,3.24054639346993,6.40281128663027,NAAA;SELENOI
Antigen Receptor-Mediated Signaling Pathway (GO:0050851),6/134,0.140494870984194,0.63211435993988,0,0,1.75084459459459,3.43618010665731,BTN2A2;BTN3A1;CD38;BTN3A3;BTN3A2;BTN2A3P
Lysosomal Transport (GO:0007041),5/105,0.141711435505094,0.63211435993988,0,0,1.86666666666667,3.64739654219376,SCARB2;DTX3L;VPS51;ANKFY1;CHMP5
Regulation Of Epithelial Cell Migration (GO:0010632),3/50,0.142835086119639,0.63211435993988,0,0,2.38032425368563,4.63226466697463,CEACAM1;BMPR2;PRKCE
Regulation Of TORC1 Signaling (GO:1903432),3/50,0.142835086119639,0.63211435993988,0,0,2.38032425368563,4.63226466697463,SESN2;GPR137;KPTN
Apoptotic Process (GO:0006915),9/228,0.146072647035184,0.63211435993988,0,0,1.53666710998803,2.95601152796864,PLK3;PLSCR1;CASP10;PRKCE;DDIT4;MX1;IFI6;SEPTIN4;IFIT2
Regulation Of Centriole Elongation (GO:1903722),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,PPP1R35
DNA Strand Resection Involved In Replication Fork Processing (GO:0110025),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,SAMHD1
G Protein-Coupled Receptor Internalization (GO:0002031),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,GTF2H2
Regulation Of Entry Of Bacterium Into Host Cell (GO:2000535),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,CXCL8
Regulation Of Extracellular Matrix Assembly (GO:1901201),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,SMAD3
SMAD Protein Complex Assembly (GO:0007183),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,SMAD3
Adenosine To Inosine Editing (GO:0006382),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,ADAR
Antigen Processing And Presentation Of Endogenous Peptide Antigen Via MHC Class I (GO:0019885),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,TAP2
Autophagosome Membrane Docking (GO:0016240),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,STX17
Cellular Hyperosmotic Response (GO:0071474),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,YBX3
Regulation Of Skeletal Muscle Contraction (GO:0014819),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,KCNJ2
Cellular Response To Interleukin-9 (GO:0071355),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,STAT1
Regulation Of Transforming Growth Factor Beta2 Production (GO:0032909),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,SMAD3
Regulation Of Translational Termination (GO:0006449),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,SHFL
Response To Lead Ion (GO:0010288),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,PLSCR1
Development Of Primary Female Sexual Characteristics (GO:0046545),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,LHFPL2
Ribosome-Associated Ubiquitin-Dependent Protein Catabolic Process (GO:1990116),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,ZNF598
Spontaneous Synaptic Transmission (GO:0098814),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,RPH3A
tRNA 3'-End Processing (GO:0042780),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,SSB
Free Ubiquitin Chain Polymerization (GO:0010994),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,TRIM6
Galactose Metabolic Process (GO:0006012),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,GALM
Toll-Like Receptor 3 Signaling Pathway (GO:0034138),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,OAS1
Glucan Catabolic Process (GO:0009251),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,GAA
Glutathione Biosynthetic Process (GO:0006750),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,HAGH
Glycogen Catabolic Process (GO:0005980),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,GAA
Vacuole Organization (GO:0007033),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,ZFYVE26
Vascular Associated Smooth Muscle Cell Development (GO:0097084),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,HES1
Hemostasis (GO:0007599),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,VWF
Histone H2A-K119 Monoubiquitination (GO:0036353),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,PCGF5
Inositol Metabolic Process (GO:0006020),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,IMPA2
Interleukin-9-Mediated Signaling Pathway (GO:0038113),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,STAT1
Long-Term Synaptic Depression (GO:0060292),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,PICK1
Macrophage Derived Foam Cell Differentiation (GO:0010742),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,STAT1
Monoacylglycerol Catabolic Process (GO:0052651),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,FAAH
Negative Regulation Of RIG-I Signaling Pathway (GO:0039536),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,DHX58
Negative Regulation Of Acute Inflammatory Response (GO:0002674),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,FCGR2B
Negative Regulation Of Dendritic Spine Development (GO:0061000),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,SRGAP2C
Negative Regulation Of Hematopoietic Progenitor Cell Differentiation (GO:1901533),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,METTL14
Negative Regulation Of Lymphocyte Differentiation (GO:0045620),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,INHBA
Negative Regulation Of Oligodendrocyte Differentiation (GO:0048715),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,HES1
Negative Regulation Of Plasminogen Activation (GO:0010757),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,PLAU
Negative Regulation Of Response To Type II Interferon (GO:0060331),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,PARP14
Negative Regulation Of Type II Interferon-Mediated Signaling Pathway (GO:0060336),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,PARP14
Neurotrophin TRK Receptor Signaling Pathway (GO:0048011),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,DDIT4
Nucleotide Catabolic Process (GO:0009166),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,SAMHD1
Peptide Transport (GO:0015833),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,TAP2
Peptidyl-Arginine Modification (GO:0018195),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,PRMT1
Positive Regulation Of Helicase Activity (GO:0051096),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,GTF2H2
Positive Regulation Of Humoral Immune Response (GO:0002922),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,FCGR2B
Positive Regulation Of Lymphocyte Apoptotic Process (GO:0070230),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,IDO1
Positive Regulation Of Mitophagy (GO:1901526),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,SLC25A5
Positive Regulation Of Protein Localization To Centrosome (GO:1904781),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,PARD6A
Positive Regulation Of Receptor Catabolic Process (GO:2000646),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,DTX3L
Positive Regulation Of Toll-Like Receptor 3 Signaling Pathway (GO:0034141),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,WDFY1
Purine Ribonucleoside Metabolic Process (GO:0046128),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,ENPP4
Regulation Of MHC Class I Biosynthetic Process (GO:0045343),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,NLRC5
Regulation Of T-helper Cell Differentiation (GO:0045622),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,IRF4
Regulation Of Blood-Brain Barrier Permeability (GO:1905603),1/6,0.147272945175377,0.63211435993988,0,0,7.44588910133843,14.2623596541972,OCLN
Acute Inflammatory Response (GO:0002526),2/26,0.147720276783986,0.63211435993988,0,0,3.10536398467433,5.93880619844698,PLSCR1;HP
Establishment Or Maintenance Of Apical/Basal Cell Polarity (GO:0035088),2/26,0.147720276783986,0.63211435993988,0,0,3.10536398467433,5.93880619844698,PARD6A;LLGL1
Mitotic G1 DNA Damage Checkpoint Signaling (GO:0031571),2/26,0.147720276783986,0.63211435993988,0,0,3.10536398467433,5.93880619844698,PLK3;PML
Receptor Internalization (GO:0031623),3/51,0.148995835943494,0.63211435993988,0,0,2.33061420345489,4.4371093670822,CEACAM1;CXCL8;GTF2H2
Negative Regulation Of Translation (GO:0017148),5/107,0.149839573961181,0.63211435993988,0,0,1.82987645925422,3.47345331356367,METTL14;LARP1;EIF4A3;EIF2AK2;IGF2BP3
Negative Regulation Of Cellular Biosynthetic Process (GO:0031327),6/137,0.151157236833163,0.63211435993988,0,0,1.71048365704854,3.23184714191364,CEACAM1;LARP1;BMPR2;EIF4A3;EIF2AK2;IGF2BP3
Protein Localization To Organelle (GO:0033365),6/137,0.151157236833163,0.63211435993988,0,0,1.71048365704854,3.23184714191364,GBP5;SSB;TTC21A;ISG15;TOR1B;GBP1
DNA-templated Transcription (GO:0006351),8/199,0.152908221910987,0.63211435993988,0,0,1.56540444011526,2.93970022731132,NR4A2;ETV7;SNAPC2;TAF13;DDX21;GTF2H2;POLRMT;IRF9
Regulation Of Protein Localization To Nucleus (GO:1900180),3/52,0.155240580120519,0.63211435993988,0,0,2.28293313486623,4.25260043980436,DTX3L;SESN2;PARP9
Icosanoid Metabolic Process (GO:0006690),3/52,0.155240580120519,0.63211435993988,0,0,2.28293313486623,4.25260043980436,FAAH;GPX1;NAIP
DNA Synthesis Involved In DNA Repair (GO:0000731),2/27,0.156912543717888,0.63211435993988,0,0,2.98099616858238,5.52100366280389,PARP10;TNFSF13B
GPI Anchor Metabolic Process (GO:0006505),2/27,0.156912543717888,0.63211435993988,0,0,2.98099616858238,5.52100366280389,PIGQ;TP53INP2
Regulation Of Extrinsic Apoptotic Signaling Pathway In Absence Of Ligand (GO:2001239),2/27,0.156912543717888,0.63211435993988,0,0,2.98099616858238,5.52100366280389,IFI6;INHBA
Regulation Of Immunoglobulin Production (GO:0002637),2/27,0.156912543717888,0.63211435993988,0,0,2.98099616858238,5.52100366280389,DNAJB9;FCGR2B
Regulation Of Transcription Regulatory Region DNA Binding (GO:2000677),2/27,0.156912543717888,0.63211435993988,0,0,2.98099616858238,5.52100366280389,TRIM6;ZNF675
Chaperone Cofactor-Dependent Protein Refolding (GO:0051085),2/27,0.156912543717888,0.63211435993988,0,0,2.98099616858238,5.52100366280389,SDF2L1;HSPA5
Cortical Cytoskeleton Organization (GO:0030865),2/27,0.156912543717888,0.63211435993988,0,0,2.98099616858238,5.52100366280389,FMNL2;LLGL1
Ventricular Septum Morphogenesis (GO:0060412),2/27,0.156912543717888,0.63211435993988,0,0,2.98099616858238,5.52100366280389,BMPR2;HES1
Positive Regulation Of TORC1 Signaling (GO:1904263),2/27,0.156912543717888,0.63211435993988,0,0,2.98099616858238,5.52100366280389,SESN2;GPR137
Positive Regulation Of Nitric Oxide Biosynthetic Process (GO:0045429),2/27,0.156912543717888,0.63211435993988,0,0,2.98099616858238,5.52100366280389,SMAD3;MMP8
Positive Regulation Of Response To Wounding (GO:1903036),2/27,0.156912543717888,0.63211435993988,0,0,2.98099616858238,5.52100366280389,OCLN;PRKCE
Protein Homotetramerization (GO:0051289),3/53,0.16156549068832,0.63211435993988,0,0,2.23715930902111,4.07799399715699,GBP5;SAMHD1;KCNJ2
Cellular Response To Interleukin-1 (GO:0071347),4/81,0.162970344660364,0.63211435993988,0,0,1.93796203796204,3.51582559259784,CXCL8;HYAL2;GBP1;GBP3
Negative Regulation Of NF-kappaB Transcription Factor Activity (GO:0032088),4/81,0.162970344660364,0.63211435993988,0,0,1.93796203796204,3.51582559259784,PARP10;AIM2;NLRC5;ZNF675
Regulation Of Chromosome Segregation (GO:0051983),2/28,0.166208877217426,0.63211435993988,0,0,2.86619510757442,5.14341573986341,RMI2;NCAPH2
Regulation Of Plasma Membrane Bounded Cell Projection Organization (GO:0120035),2/28,0.166208877217426,0.63211435993988,0,0,2.86619510757442,5.14341573986341,NTNG2;FCGR2B
Regulation Of Protein Localization To Membrane (GO:1905475),2/28,0.166208877217426,0.63211435993988,0,0,2.86619510757442,5.14341573986341,NECAB2;GBP1
Regulation Of Protein Transport (GO:0051223),2/28,0.166208877217426,0.63211435993988,0,0,2.86619510757442,5.14341573986341,RHBDF2;LLGL1
Negative Regulation Of Type II Interferon Production (GO:0032689),2/28,0.166208877217426,0.63211435993988,0,0,2.86619510757442,5.14341573986341,CD274;INHBA
Positive Regulation Of Nitric Oxide Metabolic Process (GO:1904407),2/28,0.166208877217426,0.63211435993988,0,0,2.86619510757442,5.14341573986341,SMAD3;MMP8
Negative Regulation Of TOR Signaling (GO:0032007),3/54,0.167966756998647,0.63211435993988,0,0,2.19318053516992,3.91261037560004,SESN2;DDIT4;KPTN
Regulation Of Phosphorylation (GO:0042325),4/82,0.168041106112282,0.63211435993988,0,0,1.91301775147929,3.41195640255447,STAT2;SESN2;NLRC5;INHBA
Negative Regulation Of Apoptotic Signaling Pathway (GO:2001234),4/82,0.168041106112282,0.63211435993988,0,0,1.91301775147929,3.41195640255447,NR4A2;GPX1;SLC25A5;SLC25A6
ADP Transport (GO:0015866),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,SLC25A5
Regulation Of Chaperone-Mediated Autophagy (GO:1904714),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,PLK3
Regulation Of Chemokine (C-C Motif) Ligand 5 Production (GO:0071649),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,OAS3
Regulation Of Chromosome Condensation (GO:0060623),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,NCAPH2
Regulation Of Cytoplasmic Translational Elongation (GO:1900247),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,DPH7
IMP Biosynthetic Process (GO:0006188),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,AMPD2
Regulation Of Heterochromatin Formation (GO:0031445),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,SAMD1
T-helper 17 Cell Lineage Commitment (GO:0072540),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,IRF4
UV Protection (GO:0009650),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,GPX1
Regulation Of Lipase Activity (GO:0060191),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,PCSK5
Regulation Of Lymphocyte Apoptotic Process (GO:0070228),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,CD274
Regulation Of Mammary Gland Epithelial Cell Proliferation (GO:0033599),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,GPX1
Anterograde Axonal Protein Transport (GO:0099641),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,MAPK8IP3
Regulation Of Mitophagy (GO:1901524),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,SLC25A5
Regulation Of Myeloid Leukocyte Differentiation (GO:0002761),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,IRF7
Regulation Of Natural Killer Cell Mediated Cytotoxicity Directed Against Tumor Cell Target (GO:0002858),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,CEACAM1
Axo-Dendritic Protein Transport (GO:0099640),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,MAPK8IP3
Blood Coagulation, Intrinsic Pathway (GO:0007597),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,F12
Regulation Of Response To Wounding (GO:1903034),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,PLAU
Cellular Modified Amino Acid Biosynthetic Process (GO:0042398),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,PLSCR1
Dendritic Spine Maintenance (GO:0097062),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,PICK1
Somatic Hypermutation Of Immunoglobulin Genes (GO:0016446),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,SAMHD1
Establishment Of Planar Polarity (GO:0001736),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,FUZ
Translocation Of Molecules Into Host (GO:0044417),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,THOC7
Tryptophan Catabolic Process (GO:0006569),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,IDO1
Glutathione Catabolic Process (GO:0006751),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,GGT5
Tryptophan Metabolic Process (GO:0006568),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,IDO1
Glycoside Catabolic Process (GO:0016139),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,GUSB
Venous Blood Vessel Development (GO:0060841),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,BMPR2
Viral mRNA Export From Host Cell Nucleus (GO:0046784),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,THOC7
Histone H2A K63-linked Deubiquitination (GO:0070537),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,MPND
Hyperosmotic Response (GO:0006972),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,YBX3
Lipoxygenase Pathway (GO:0019372),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,GPX1
Lymphatic Endothelial Cell Differentiation (GO:0060836),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,BMPR2
Mitral Valve Development (GO:0003174),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,BMPR2
Myeloid Leukocyte Mediated Immunity (GO:0002444),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,SERPINB9
Negative Regulation Of T Cell Mediated Cytotoxicity (GO:0001915),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,FCGR2B
Negative Regulation Of Actin Nucleation (GO:0051126),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,PICK1
Negative Regulation Of Inflammatory Response To Wounding (GO:0106015),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,SIGLEC10
Negative Regulation Of Lipid Kinase Activity (GO:0090219),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,RUBCN
Negative Regulation Of Macrophage Migration (GO:1905522),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,C5
Negative Regulation Of Osteoblast Proliferation (GO:0033689),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,EIF2AK2
Negative Regulation Of Protein K63-linked Ubiquitination (GO:1900045),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,PARP10
Nonribosomal Peptide Biosynthetic Process (GO:0019184),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,HAGH
Plasma Membrane Phospholipid Scrambling (GO:0017121),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,PLSCR1
Positive Regulation Of T-helper 2 Cell Cytokine Production (GO:2000553),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,RSAD2
Positive Regulation Of Astrocyte Differentiation (GO:0048711),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,HES1
Positive Regulation Of Chromosome Condensation (GO:1905821),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,NCAPH2
Positive Regulation Of Fibroblast Migration (GO:0010763),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,PRKCE
Positive Regulation Of Isomerase Activity (GO:0010912),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,PLSCR1
Positive Regulation Of Plasminogen Activation (GO:0010756),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,F12
Positive Regulation Of Vascular Associated Smooth Muscle Cell Migration (GO:1904754),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,DOCK4
Postsynapse Organization (GO:0099173),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,PICK1
Protein Localization To Cytoplasmic Stress Granule (GO:1903608),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,SSB
Protein Localization To Presynapse (GO:1905383),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,MAPK8IP3
rRNA Pseudouridine Synthesis (GO:0031118),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,TSR3
Regulation Of Alpha-Beta T Cell Differentiation (GO:0046637),1/7,0.169621066642403,0.63211435993988,0,0,6.20458891013384,11.0081093586948,PRDM1
Positive Regulation Of Ubiquitin-Dependent Protein Catabolic Process (GO:2000060),4/83,0.173167018538179,0.63211435993988,0,0,1.88870496592016,3.31184174989004,RNF144A;DNAJB2;NUB1;TRIB2
Neuron Migration (GO:0001764),3/55,0.174440590733079,0.63211435993988,0,0,2.1508932526207,3.75582752841818,NR4A2;DDIT4;SEPTIN4
Positive Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042531),3/55,0.174440590733079,0.63211435993988,0,0,2.1508932526207,3.75582752841818,HES1;PARP9;PARP14
RNA Biosynthetic Process (GO:0032774),2/29,0.175597546262295,0.63211435993988,0,0,2.75989782886335,4.80100944398469,HELB;TAF13
RNA-mediated Gene Silencing (GO:0031047),2/29,0.175597546262295,0.63211435993988,0,0,2.75989782886335,4.80100944398469,HELZ2;MOV10
Alpha-Amino Acid Catabolic Process (GO:1901606),2/29,0.175597546262295,0.63211435993988,0,0,2.75989782886335,4.80100944398469,FANCA;IDO1
Regulation Of Neuron Migration (GO:2001222),2/29,0.175597546262295,0.63211435993988,0,0,2.75989782886335,4.80100944398469,SRGAP2C;NTNG2
Regulation Of Protein Modification By Small Protein Conjugation Or Removal (GO:1903320),2/29,0.175597546262295,0.63211435993988,0,0,2.75989782886335,4.80100944398469,DNAJB2;GPS1
Chondrocyte Differentiation (GO:0002062),2/29,0.175597546262295,0.63211435993988,0,0,2.75989782886335,4.80100944398469,BMPR2;CREB3L2
Establishment Of Mitotic Spindle Orientation (GO:0000132),2/29,0.175597546262295,0.63211435993988,0,0,2.75989782886335,4.80100944398469,NDC80;ENKD1
Integrated Stress Response Signaling (GO:0140467),2/29,0.175597546262295,0.63211435993988,0,0,2.75989782886335,4.80100944398469,BATF2;EIF2AK2
Modified Amino Acid Transport (GO:0072337),2/29,0.175597546262295,0.63211435993988,0,0,2.75989782886335,4.80100944398469,SLC5A6;SLC7A7
Positive Regulation Of B Cell Proliferation (GO:0030890),2/29,0.175597546262295,0.63211435993988,0,0,2.75989782886335,4.80100944398469,CD38;TNFSF13B
Positive Regulation Of Viral Genome Replication (GO:0045070),2/29,0.175597546262295,0.63211435993988,0,0,2.75989782886335,4.80100944398469,LARP1;IFIT1
Regulation Of Interleukin-1 Beta Production (GO:0032651),4/84,0.178346305135887,0.63211435993988,0,0,1.865,3.21531237725654,GBP5;AIM2;IFI16;NAIP
Ribosomal Small Subunit Biogenesis (GO:0042274),4/84,0.178346305135887,0.63211435993988,0,0,1.865,3.21531237725654,TBL3;SPPL2B;TSR3;IGF2BP3
Response To Endoplasmic Reticulum Stress (GO:0034976),5/114,0.179748145501781,0.63211435993988,0,0,1.71174276572802,2.93769053730042,CXCL8;HSPA5;CREB3L2;DNAJB9;ATF3
Positive Regulation Of Cellular Metabolic Process (GO:0031325),3/56,0.180983230417008,0.63211435993988,0,0,2.11020171658277,3.60707520687954,CXCL8;DCXR;PRKCE
Response To Interleukin-1 (GO:0070555),4/85,0.183577179407937,0.63211435993988,0,0,1.84188034188034,3.12220839610315,CXCL8;HYAL2;GBP1;GBP3
GPI Anchor Biosynthetic Process (GO:0006506),2/30,0.185067360904121,0.63211435993988,0,0,2.66119321291735,4.48952717554298,PIGQ;TP53INP2
Artery Morphogenesis (GO:0048844),2/30,0.185067360904121,0.63211435993988,0,0,2.66119321291735,4.48952717554298,BMPR2;HES1
Embryonic Skeletal System Morphogenesis (GO:0048704),2/30,0.185067360904121,0.63211435993988,0,0,2.66119321291735,4.48952717554298,EIF4A3;FUZ
Immunoglobulin Mediated Immune Response (GO:0016064),2/30,0.185067360904121,0.63211435993988,0,0,2.66119321291735,4.48952717554298,FCGR2B;GAPT
Negative Regulation Of Blood Coagulation (GO:0030195),2/30,0.185067360904121,0.63211435993988,0,0,2.66119321291735,4.48952717554298,PLAU;F12
Negative Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050732),2/30,0.185067360904121,0.63211435993988,0,0,2.66119321291735,4.48952717554298,HYAL2;PARP14
Nucleic Acid Metabolic Process (GO:0090304),2/30,0.185067360904121,0.63211435993988,0,0,2.66119321291735,4.48952717554298,RECQL5;TREX1
Positive Regulation Of Interleukin-10 Production (GO:0032733),2/30,0.185067360904121,0.63211435993988,0,0,2.66119321291735,4.48952717554298,IRF4;ISG15
Myeloid Cell Differentiation (GO:0030099),3/57,0.187590945817927,0.63211435993988,0,0,2.07101727447217,3.46582981927641,IFI16;INHBA;SLC25A5
Exocytosis (GO:0006887),4/86,0.188857847086061,0.63211435993988,0,0,1.81932457786116,3.03237866823572,RPH3A;CCR1;EXOC3L1;STX17
DNA Damage Response, Signal Transduction By P53 Class Mediator Resulting In Transcription Of P21 Class Mediator (GO:0006978),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,SP100
Regulation Of Dendritic Spine Maintenance (GO:1902950),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,FCGR2B
L-arginine Transmembrane Transport (GO:1903826),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,SLC7A7
Regulation Of Fertilization (GO:0080154),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,LHFPL2
N-acylphosphatidylethanolamine Metabolic Process (GO:0070292),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,NAAA
Regulation Of Generation Of Precursor Metabolites And Energy (GO:0043467),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,PNPT1
Regulation Of Glial Cell Proliferation (GO:0060251),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,HES1
Regulation Of Helicase Activity (GO:0051095),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,IFIT1
T Cell Mediated Cytotoxicity (GO:0001913),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,MICA
T-helper 17 Cell Differentiation (GO:0072539),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,IRF4
Regulation Of Interleukin-18 Production (GO:0032661),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,GBP5
Regulation Of Lysosomal Protein Catabolic Process (GO:1905165),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,MARCHF2
Regulation Of miRNA Metabolic Process (GO:2000628),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,SMAD3
Regulation Of Mitochondrial Gene Expression (GO:0062125),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,METTL4
Basic Amino Acid Transmembrane Transport (GO:1990822),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,SLC7A7
Bone Resorption (GO:0045453),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,ZNF675
Regulation Of Toll-Like Receptor 3 Signaling Pathway (GO:0034139),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,WDFY1
Regulation Of Urine Volume (GO:0035809),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,HYAL2
Cilium Movement Involved In Cell Motility (GO:0060294),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,RSPH9
Response To Misfolded Protein (GO:0051788),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,F12
Retrograde Transport, Vesicle Recycling Within Golgi (GO:0000301),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,COG6
Formation Of Translation Preinitiation Complex (GO:0001731),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,EIF2S3B
Ubiquitin-Dependent Protein Catabolic Process Via The C-end Degron Rule Pathway (GO:0140627),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,KLHDC3
Vascular Associated Smooth Muscle Cell Differentiation (GO:0035886),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,HES1
Hyaluronan Catabolic Process (GO:0030214),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,HYAL2
Kynurenine Metabolic Process (GO:0070189),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,IDO1
Modification-Dependent Macromolecule Catabolic Process (GO:0043632),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,ISG15
Monocyte Activation (GO:0042117),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,HYAL2
ncRNA Export From Nucleus (GO:0097064),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,SSB
Negative Regulation Of Cholesterol Storage (GO:0010887),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,TTC39B
Negative Regulation Of Glial Cell Differentiation (GO:0045686),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,HES1
Negative Regulation Of Platelet Aggregation (GO:0090331),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,CEACAM1
Negative Regulation Of Production Of Molecular Mediator Of Immune Response (GO:0002701),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,FCGR2B
Negative Regulation Of Protein-Containing Complex Disassembly (GO:0043242),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,RUBCN
Negative Regulation Of Systemic Arterial Blood Pressure (GO:0003085),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,BMPR2
Neuronal Ion Channel Clustering (GO:0045161),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,PICK1
p38MAPK Cascade (GO:0038066),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,MAP2K6
Plasminogen Activation (GO:0031639),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,PLAU
Positive Regulation Of Centriole Replication (GO:0046601),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,PPP1R35
Positive Regulation Of Dendritic Cell Cytokine Production (GO:0002732),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,RIGI
Positive Regulation Of Extracellular Matrix Assembly (GO:1901203),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,SMAD3
Proteasome Assembly (GO:0043248),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,NT5C3A
Pyrimidine-Containing Compound Metabolic Process (GO:0072527),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,NT5C3A
Regulation Of RNA Biosynthetic Process (GO:2001141),1/8,0.191384581416441,0.63211435993988,0,0,5.31794591641628,8.79306594925524,CXCL8
Cellular Response To Molecule Of Bacterial Origin (GO:0071219),5/117,0.19320169233321,0.63211435993988,0,0,1.66563446187724,2.73833736365411,CD274;CXCL8;FCGR2B;CHMP5;GBP3
Positive Regulation Of Type II Interferon Production (GO:0032729),3/58,0.194260041817104,0.63211435993988,0,0,2.03325772116559,3.3316098831218,ISG15;BTN3A2;IL18R1
Regulation Of Extrinsic Apoptotic Signaling Pathway Via Death Domain Receptors (GO:1902041),2/31,0.194607652127527,0.63211435993988,0,0,2.56929581186418,4.20534576042708,SP100;GPX1
Regulation Of Macrophage Activation (GO:0043030),2/31,0.194607652127527,0.63211435993988,0,0,2.56929581186418,4.20534576042708,MMP8;FCGR2B
Endodermal Cell Differentiation (GO:0035987),2/31,0.194607652127527,0.63211435993988,0,0,2.56929581186418,4.20534576042708,INHBA;MMP8
Negative Regulation Of DNA Biosynthetic Process (GO:2000279),2/31,0.194607652127527,0.63211435993988,0,0,2.56929581186418,4.20534576042708,BMPR2;XRN1
Non-Motile Cilium Assembly (GO:1905515),2/31,0.194607652127527,0.63211435993988,0,0,2.56929581186418,4.20534576042708,FUZ;ENKD1
Receptor Signaling Pathway Via STAT (GO:0097696),2/31,0.194607652127527,0.63211435993988,0,0,2.56929581186418,4.20534576042708,STAT1;STAT2
Negative Regulation Of DNA-binding Transcription Factor Activity (GO:0043433),6/149,0.197135277487076,0.63211435993988,0,0,1.56597456597457,2.54293144228398,PARP10;SP100;AIM2;NLRC5;HES1;ZNF675
Regulation Of Endothelial Cell Migration (GO:0010594),4/88,0.199561358547849,0.63211435993988,0,0,1.77582417582418,2.8619777821173,CEACAM1;SP100;BMPR2;RIN2
Negative Regulation Of Protein Kinase Activity (GO:0006469),4/88,0.199561358547849,0.63211435993988,0,0,1.77582417582418,2.8619777821173,CEACAM1;HYAL2;ADAR;TRIB2
Positive Regulation Of Plasma Membrane Bounded Cell Projection Assembly (GO:0120034),4/88,0.199561358547849,0.63211435993988,0,0,1.77582417582418,2.8619777821173,OCLN;PPP1R35;FUZ;AGRN
DNA-templated Transcription Initiation (GO:0006352),3/59,0.200986862082414,0.63211435993988,0,0,1.99684672333425,3.20397198963709,TAF13;GTF2H2;POLRMT
Regulation Of Type I Interferon Production (GO:0032479),3/59,0.200986862082414,0.63211435993988,0,0,1.99684672333425,3.20397198963709,DHX58;IRF7;XAF1
Protein Targeting To Mitochondrion (GO:0006626),3/59,0.200986862082414,0.63211435993988,0,0,1.99684672333425,3.20397198963709,DNLZ;TIMM10;DNAJC15
protein-RNA Complex Assembly (GO:0022618),6/150,0.201184723880756,0.63211435993988,0,0,1.55501930501931,2.49352285651685,EIF2S3B;TSSC4;RPL10;EIF3I;STRAP;ADAR
'De Novo' Post-Translational Protein Folding (GO:0051084),2/32,0.204208252257505,0.63211435993988,0,0,2.48352490421456,3.94536481995822,SDF2L1;HSPA5
Amide Transport (GO:0042886),2/32,0.204208252257505,0.63211435993988,0,0,2.48352490421456,3.94536481995822,SLC5A6;ABCA13
Regulation Of Transcription By RNA Polymerase I (GO:0006356),2/32,0.204208252257505,0.63211435993988,0,0,2.48352490421456,3.94536481995822,DDX21;MAF1
Regulation Of Transmembrane Transport (GO:0034762),2/32,0.204208252257505,0.63211435993988,0,0,2.48352490421456,3.94536481995822,OCLN;KCNJ2
Negative Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000134),2/32,0.204208252257505,0.63211435993988,0,0,2.48352490421456,3.94536481995822,PLK3;INHBA
Negative Regulation Of Fat Cell Differentiation (GO:0045599),2/32,0.204208252257505,0.63211435993988,0,0,2.48352490421456,3.94536481995822,SMAD3;TRIB2
Protein Transmembrane Import Into Intracellular Organelle (GO:0044743),2/32,0.204208252257505,0.63211435993988,0,0,2.48352490421456,3.94536481995822,DNLZ;DNAJC15
ERAD Pathway (GO:0036503),4/89,0.204980591935368,0.63211435993988,0,0,1.75484162895928,2.78114316830261,DNAJB2;HSPA5;DNAJB9;FBXO6
Macromolecule Biosynthetic Process (GO:0009059),7/183,0.205386949099922,0.63211435993988,0,0,1.4847459117285,2.35014420480579,RPL10;GCNT1;SRBD1;IGF2BP3;INHBA;GTPBP2;MRPL55
Negative Regulation Of Peptidase Activity (GO:0010466),3/60,0.207767792437814,0.63211435993988,0,0,1.96171330437418,3.08250721637193,SERPINB10;SERPING1;SERPINB9
protein-DNA Complex Organization (GO:0071824),3/60,0.207767792437814,0.63211435993988,0,0,1.96171330437418,3.08250721637193,PARP10;CBX5;TRIM28
Positive Regulation Of Proteasomal Protein Catabolic Process (GO:1901800),4/90,0.210442401518281,0.63211435993988,0,0,1.73434704830054,2.70305495516989,RNF144A;DNAJB2;NUB1;TRIB2
Regulation Of Cellular Response To Oxidative Stress (GO:1900407),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,GCH1
B Cell Homeostasis (GO:0001782),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,GAPT
DNA Damage Response, Signal Transduction Resulting In Transcription (GO:0042772),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,SP100
ESCRT III Complex Disassembly (GO:1904903),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,CHMP5
ESCRT Complex Disassembly (GO:1904896),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,CHMP5
Regulation Of Endoplasmic Reticulum Unfolded Protein Response (GO:1900101),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,HSPA5
Golgi Inheritance (GO:0048313),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,PLK3
IMP Metabolic Process (GO:0046040),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,AMPD2
Regulation Of Granulocyte Differentiation (GO:0030852),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,CEACAM1
Regulation Of Inflammatory Response To Wounding (GO:0106014),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,SIGLEC10
T-helper 1 Type Immune Response (GO:0042088),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,IL18BP
Regulation Of Mast Cell Activation (GO:0033003),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,PLSCR1
Aminoglycan Metabolic Process (GO:0006022),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,CLN6
Axon Regeneration (GO:0031103),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,MAPK8IP3
Regulation Of Protein Localization To Centrosome (GO:1904779),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,PARD6A
Cell Differentiation Involved In Metanephros Development (GO:0072202),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,STAT1
Regulation Of Tau-Protein Kinase Activity (GO:1902947),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,NAB2
Cellular Response To Oxygen Levels (GO:0071453),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,PICK1
Ether Lipid Biosynthetic Process (GO:0008611),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,CHPT1
Excitatory Synapse Assembly (GO:1904861),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,SRGAP2C
Vesicle Fusion With Vacuole (GO:0051469),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,CHMP5
Leucine Transport (GO:0015820),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,SLC7A7
Leukotriene D4 Biosynthetic Process (GO:1901750),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,GGT5
Mitochondrial RNA Processing (GO:0000963),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,PNPT1
Mitochondrion Morphogenesis (GO:0070584),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,PNPT1
Mitral Valve Morphogenesis (GO:0003183),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,BMPR2
Multivesicular Body-Lysosome Fusion (GO:0061763),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,CHMP5
Myeloid Dendritic Cell Differentiation (GO:0043011),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,BATF2
Negative Regulation Of Bone Resorption (GO:0045779),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,GPR137
Negative Regulation Of Cell-Cell Adhesion Mediated By Cadherin (GO:2000048),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,NOTCH4
Negative Regulation Of Heterotypic Cell-Cell Adhesion (GO:0034115),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,IL1RN
Negative Regulation Of Humoral Immune Response Mediated By Circulating Immunoglobulin (GO:0002924),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,FCGR2B
Negative Regulation Of Necroptotic Process (GO:0060546),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,YBX3
Negative Regulation Of Protein Localization To Cell Surface (GO:2000009),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,TAX1BP3
Negative Regulation Of Sodium Ion Transmembrane Transport (GO:1902306),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,PRKCE
Negative Regulation Of Transcription By RNA Polymerase I (GO:0016479),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,MAF1
Negative Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042532),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,PARP14
Neuron Projection Regeneration (GO:0031102),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,MAPK8IP3
Nuclear mRNA Surveillance (GO:0071028),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,XRN1
Nucleoside Metabolic Process (GO:0009116),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,NT5C3A
Peptidyl-Amino Acid Modification (GO:0018193),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,TTLL4
Phosphatidylethanolamine Biosynthetic Process (GO:0006646),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,SELENOI
Positive Regulation Of Mesenchymal Cell Proliferation (GO:0002053),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,STAT1
Regulation Of PERK-mediated Unfolded Protein Response (GO:1903897),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,HSPA5
Regulation Of Cell-Cell Adhesion Involved In Gastrulation (GO:0070587),1/9,0.212578753367238,0.63211435993988,0,0,4.65296367112811,7.20484788673582,IL1RN
Regulation Of Sprouting Angiogenesis (GO:1903670),2/33,0.213859476206693,0.63211435993988,0,0,2.40328760351007,3.70691763738345,CEACAM1;EPN2
Signal Transduction By P53 Class Mediator (GO:0072331),2/33,0.213859476206693,0.63211435993988,0,0,2.40328760351007,3.70691763738345,IFI16;SESN2
Ubiquitin-Dependent Protein Catabolic Process Via The Multivesicular Body Sorting Pathway (GO:0043162),2/33,0.213859476206693,0.63211435993988,0,0,2.40328760351007,3.70691763738345,RNF126;CHMP5
Negative Regulation Of Double-Strand Break Repair (GO:2000780),2/33,0.213859476206693,0.63211435993988,0,0,2.40328760351007,3.70691763738345,HELB;RMI2
Positive Regulation Of RNA Metabolic Process (GO:0051254),2/33,0.213859476206693,0.63211435993988,0,0,2.40328760351007,3.70691763738345,PNPT1;HNRNPLL
Positive Regulation Of Chromosome Organization (GO:2001252),2/33,0.213859476206693,0.63211435993988,0,0,2.40328760351007,3.70691763738345,NCAPH2;PML
Positive Regulation Of Reproductive Process (GO:2000243),2/33,0.213859476206693,0.63211435993988,0,0,2.40328760351007,3.70691763738345,INHBA;LHFPL2
Regulation Of NLRP3 Inflammasome Complex Assembly (GO:1900225),2/33,0.213859476206693,0.63211435993988,0,0,2.40328760351007,3.70691763738345,GBP5;EIF2AK2
Autophagosome Organization (GO:1905037),3/61,0.214599263893426,0.63211435993988,0,0,1.92779138261963,2.96683793198994,ZFYVE26;MAP1LC3A;TP53INP2
Positive Regulation Of Interleukin-8 Production (GO:0032757),3/61,0.214599263893426,0.63211435993988,0,0,1.92779138261963,2.96683793198994,HYAL2;NOD1;RIGI
Positive Regulation Of Binding (GO:0051099),4/91,0.215944981565627,0.63211435993988,0,0,1.71432360742706,2.62759799781694,DTX3L;HES1;MMP8;PARP9
Fatty Acid Metabolic Process (GO:0006631),5/122,0.216367277450014,0.63211435993988,0,0,1.59404179635394,2.4401240439268,GGT5;FAAH;GPX1;NAAA;ALKBH7
Organonitrogen Compound Biosynthetic Process (GO:1901566),5/123,0.221102143967607,0.63211435993988,0,0,1.5804513242546,2.3851072882567,GCH1;GCNT1;CHPT1;INHBA;PCSK5
Protein-Containing Complex Disassembly (GO:0032984),3/62,0.221477755575816,0.63211435993988,0,0,1.89501935651778,2.85661494263698,MAP1LC3A;STX17;CHMP5
Cellular Response To Growth Factor Stimulus (GO:0071363),6/155,0.221872311947824,0.63211435993988,0,0,1.50244875748231,2.26216683060838,SMAD3;BMPR2;CXCL8;HYAL2;ACVR1B;EMD
Apoptotic Mitochondrial Changes (GO:0008637),2/34,0.223552103067262,0.63211435993988,0,0,2.32806513409962,3.48769944775555,IFI6;IFIT2
Cellular Response To Amyloid-Beta (GO:1904646),2/34,0.223552103067262,0.63211435993988,0,0,2.32806513409962,3.48769944775555,CACNA1A;FCGR2B
Embryonic Skeletal System Development (GO:0048706),2/34,0.223552103067262,0.63211435993988,0,0,2.32806513409962,3.48769944775555,FUZ;PCSK5
Establishment Of Mitotic Spindle Localization (GO:0040001),2/34,0.223552103067262,0.63211435993988,0,0,2.32806513409962,3.48769944775555,NDC80;ENKD1
Membrane Protein Proteolysis (GO:0033619),2/34,0.223552103067262,0.63211435993988,0,0,2.32806513409962,3.48769944775555,SPPL2B;CLPP
Mitochondrial Electron Transport, NADH To Ubiquinone (GO:0006120),2/34,0.223552103067262,0.63211435993988,0,0,2.32806513409962,3.48769944775555,NDUFA6;NDUFS7
Negative Regulation Of JNK Cascade (GO:0046329),2/34,0.223552103067262,0.63211435993988,0,0,2.32806513409962,3.48769944775555,PRMT1;ZNF675
Regulation Of T Cell Receptor Signaling Pathway (GO:0050856),2/34,0.223552103067262,0.63211435993988,0,0,2.32806513409962,3.48769944775555,CEACAM1;GBP1
DNA Metabolic Process (GO:0006259),10/288,0.225330133766122,0.63211435993988,0,0,1.34353217814853,2.0021164578324,RMI2;SP100;HELB;RECQL5;TRIM28;TREX1;FANCA;ZNF668;FBXO6;SAMHD1
Cellular Response To Lipopolysaccharide (GO:0071222),5/124,0.225868379998149,0.63211435993988,0,0,1.56708926345105,2.33151985474204,CD274;CXCL8;PRKCE;CHMP5;GBP3
Negative Regulation Of Amide Metabolic Process (GO:0034249),4/93,0.22706524532063,0.63211435993988,0,0,1.67562662057044,2.48414642265142,LARP1;EIF4A3;EIF2AK2;IGF2BP3
Regulation Of Cellular Catabolic Process (GO:0031329),3/63,0.228399797127285,0.63211435993988,0,0,1.86333973128599,2.75151494223316,IFI16;LAMP3;GPR137
Peptidyl-Lysine Modification (GO:0018205),4/94,0.232679337166901,0.63211435993988,0,0,1.65692307692308,2.4159496112277,IFIH1;TRIM28;NSMCE1;PML
CRD-mediated mRNA Stabilization (GO:0070934),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,IGF2BP3
Regulation Of Dendritic Cell Differentiation (GO:2001198),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,FCGR2B
Regulation Of Gene Expression By Genomic Imprinting (GO:0006349),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,PCGF5
Regulation Of Glycoprotein Biosynthetic Process (GO:0010559),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,NECAB2
Regulation Of Inclusion Body Assembly (GO:0090083),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,DNAJB2
T-helper Cell Lineage Commitment (GO:0002295),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,IRF4
TORC1 Signaling (GO:0038202),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,LARP1
Regulation Of Mitochondrial Depolarization (GO:0051900),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,IFI6
Atrial Septum Morphogenesis (GO:0060413),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,BMPR2
Regulation Of Nuclear-Transcribed mRNA Catabolic Process, Nonsense-Mediated Decay (GO:2000622),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,EIF4A3
Branched-Chain Amino Acid Transport (GO:0015803),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,SLC7A7
Regulation Of Protein Localization To Cajal Body (GO:1904869),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,MEPCE
Cardiac Muscle Cell Membrane Repolarization (GO:0099622),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,KCNJ2
Cellular Response To Cholesterol (GO:0071397),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,GRAMD1B
Regulation Of Toll-Like Receptor 9 Signaling Pathway (GO:0034163),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,RSAD2
Cellular Response To Leucine (GO:0071233),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,SESN2
Response To Corticosteroid (GO:0031960),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,IL1RN
Response To Leucine (GO:0043201),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,SESN2
Diol Metabolic Process (GO:0034311),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,NAAA
Signal Release (GO:0023061),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,PCSK5
Endosomal Vesicle Fusion (GO:0034058),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,SAMD9
Epithelial Cell Apoptotic Process (GO:1904019),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,BMPR2
Surfactant Homeostasis (GO:0043129),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,OAS1
Vacuole Fusion (GO:0097576),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,CHMP5
Heparan Sulfate Proteoglycan Biosynthetic Process, Enzymatic Modification (GO:0015015),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,HS6ST1
Induction Of Positive Chemotaxis (GO:0050930),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,CXCL8
Lens Fiber Cell Differentiation (GO:0070306),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,TDRD7
Metanephric Mesenchyme Development (GO:0072075),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,STAT1
Midbrain Dopaminergic Neuron Differentiation (GO:1904948),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,NR4A2
Mitotic DNA Replication (GO:1902969),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,RECQL5
Mitotic G1/S Transition Checkpoint Signaling (GO:0044819),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,PLK3
Monocyte Differentiation (GO:0030224),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,IFI16
Negative Regulation Of B Cell Proliferation (GO:0030889),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,FCGR2B
Negative Regulation Of Activated T Cell Proliferation (GO:0046007),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,CD274
Negative Regulation Of Homotypic Cell-Cell Adhesion (GO:0034111),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,CEACAM1
Negative Regulation Of Inclusion Body Assembly (GO:0090084),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,DNAJB2
Negative Regulation Of Natural Killer Cell Mediated Immunity (GO:0002716),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,MICA
Negative Regulation Of Oxidoreductase Activity (GO:0051354),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,HP
Negative Regulation Of Programmed Necrotic Cell Death (GO:0062099),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,YBX3
Negative Regulation Of Sodium Ion Transmembrane Transporter Activity (GO:2000650),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,PRKCE
Negative Regulation Of Sprouting Angiogenesis (GO:1903671),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,EPN2
Negative Regulation Of Vascular Endothelial Growth Factor Receptor Signaling Pathway (GO:0030948),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,EPN2
Nuclear RNA Surveillance (GO:0071027),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,XRN1
Nuclear Pore Complex Assembly (GO:0051292),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,NUP205
Positive Regulation Of DNA Methylation-Dependent Heterochromatin Formation (GO:0090309),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,TRIM28
Positive Regulation Of Autophagy Of Mitochondrion (GO:1903599),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,SLC25A5
Positive Regulation Of Interleukin-13 Production (GO:0032736),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,IRF4
Positive Regulation Of Protein Localization To Cajal Body (GO:1904871),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,MEPCE
Positive Regulation Of Transcription From RNA Polymerase II Promoter In Response To Endoplasmic Reticulum Stress (GO:1990440),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,HSPA5
Protein Deneddylation (GO:0000338),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,GPS1
Protein Kinase C-activating G Protein-Coupled Receptor Signaling Pathway (GO:0007205),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,PICK1
Protein Prenylation (GO:0018342),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,RCE1
Receptor-Mediated Endocytosis Of Virus By Host Cell (GO:0019065),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,SIGLEC1
Regulation Of T-helper 2 Cell Cytokine Production (GO:2000551),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,RSAD2
Regulation Of Amyloid Precursor Protein Biosynthetic Process (GO:0042984),1/10,0.233218448781472,0.63211435993988,0,0,4.13575525812619,6.02074861603907,NECAB2
Peptide Biosynthetic Process (GO:0043043),6/158,0.234610831615968,0.635102251222459,0,0,1.47256655151392,2.13496700081503,GGT5;RPL10;SRBD1;IGF2BP3;PCSK5;MRPL55
Cellular Response To Virus (GO:0098586),3/64,0.235361971235008,0.63512848875166,0,0,1.83269878229131,2.65123822474309,IFIH1;OAS1;IFI6
Positive Regulation Of Macroautophagy (GO:0016239),3/64,0.235361971235008,0.63512848875166,0,0,1.83269878229131,2.65123822474309,LARP1;SESN2;SLC25A5
Positive Regulation Of Intracellular Protein Transport (GO:0090316),5/126,0.23549056295267,0.63512848875166,0,0,1.54102772337139,2.22845621039792,PLK3;SMAD3;TRIM28;HYAL2;EMD
Positive Regulation Of Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0090100),4/95,0.238327018597438,0.63693081621392,0,0,1.63863060016906,2.34997902187829,BMPR2;FBXL15;INHBA;ACVR1B
Response To Lipopolysaccharide (GO:0032496),6/159,0.238906875138683,0.63693081621392,0,0,1.46286622757211,2.09435843709608,CD274;TRIM6;CXCL8;GCH1;CHMP5;GBP3
Regulation Of Anatomical Structure Morphogenesis (GO:0022603),5/127,0.240344306138109,0.63693081621392,0,0,1.52831738210304,2.17889576609109,CEACAM1;SP100;FMNL2;STAT2;TNIK
Autophagosome Assembly (GO:0000045),3/65,0.242360915655532,0.63693081621392,0,0,1.80304625100613,2.55550663294107,MAP1LC3A;STX17;TP53INP2
Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042509),3/65,0.242360915655532,0.63693081621392,0,0,1.80304625100613,2.55550663294107,HES1;PARP9;PARP14
Lytic Vacuole Organization (GO:0080171),2/36,0.243026898756493,0.63693081621392,0,0,2.19089474870408,3.09920278901742,ZFYVE26;GAA
Negative Regulation Of T Cell Proliferation (GO:0042130),2/36,0.243026898756493,0.63693081621392,0,0,2.19089474870408,3.09920278901742,CD274;BTN2A2
Receptor Signaling Pathway Via JAK-STAT (GO:0007259),2/36,0.243026898756493,0.63693081621392,0,0,2.19089474870408,3.09920278901742,STAT1;STAT2
Regulation Of T Cell Mediated Cytotoxicity (GO:0001914),2/36,0.243026898756493,0.63693081621392,0,0,2.19089474870408,3.09920278901742,CEACAM1;MICA
Protein-Containing Complex Assembly (GO:0065003),11/328,0.243593408709138,0.63693081621392,0,0,1.29595193732667,1.83021434581714,NT5C3A;OCLN;SMAD3;AIM2;FANCA;RSPH9;HES1;GBP1;LLGL1;PML;CD2AP
Regulation Of Protein Localization (GO:0032880),4/97,0.249716049487817,0.63693081621392,0,0,1.60322580645161,2.22436487714276,TRIM6;TRIM5;TRIM38;TRIM22
Gene Expression (GO:0010467),10/296,0.250352500727311,0.63693081621392,0,0,1.30540665560121,1.80783855487252,NXT1;RPL10;CASP10;ALYREF;EIF4A3;SRBD1;ADAR;IGF2BP3;THOC7;MRPL55
RNA Stabilization (GO:0043489),2/37,0.252792791874597,0.63693081621392,0,0,2.12818828680898,2.92665288643497,LARP1;TENT5A
Regulation Of Ossification (GO:0030278),2/37,0.252792791874597,0.63693081621392,0,0,2.12818828680898,2.92665288643497,BMPR2;TENT5A
Spliceosomal snRNP Assembly (GO:0000387),2/37,0.252792791874597,0.63693081621392,0,0,2.12818828680898,2.92665288643497,TSSC4;STRAP
Ventricular Septum Development (GO:0003281),2/37,0.252792791874597,0.63693081621392,0,0,2.12818828680898,2.92665288643497,BMPR2;HES1
Negative Regulation Of Stress-Activated MAPK Cascade (GO:0032873),2/37,0.252792791874597,0.63693081621392,0,0,2.12818828680898,2.92665288643497,PRMT1;ZNF675
Positive Regulation Of Immune Effector Process (GO:0002699),2/37,0.252792791874597,0.63693081621392,0,0,2.12818828680898,2.92665288643497,DHX58;DDX60
AMP Metabolic Process (GO:0046033),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,AMPD2
Regulation Of Mesenchymal Cell Proliferation (GO:0010464),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,STAT1
Brain Morphogenesis (GO:0048854),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,VPS51
cGMP Metabolic Process (GO:0046068),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,PDE9A
Regulation Of Protein K63-linked Ubiquitination (GO:1900044),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,PARP10
Catecholamine Biosynthetic Process (GO:0042423),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,GCH1
Cell Part Morphogenesis (GO:0032990),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,PNPT1
Cellular Response To UV-B (GO:0071493),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,HYAL2
Cellular Response To Nitrogen Levels (GO:0043562),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,MAP1LC3A
Cellular Response To Nitrogen Starvation (GO:0006995),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,MAP1LC3A
Cellular Response To Thyroid Hormone Stimulus (GO:0097067),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,LMO2
Desensitization Of G Protein-Coupled Receptor Signaling Pathway (GO:0002029),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,GTF2H2
Dosage Compensation By Inactivation Of X Chromosome (GO:0009048),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,PCGF5
Sphingoid Metabolic Process (GO:0046519),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,NAAA
Sulfate Transport (GO:0008272),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,SLC26A8
Tyrosine Metabolic Process (GO:0006570),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,FANCA
Heterocycle Biosynthetic Process (GO:0018130),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,GCH1
Intracellular Copper Ion Homeostasis (GO:0006878),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,MT2A
Leukotriene D4 Metabolic Process (GO:1901748),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,GGT5
Lysosomal Membrane Organization (GO:0097212),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,CHMP5
Macrophage Activation Involved In Immune Response (GO:0002281),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,IFI35
Maintenance Of Protein Localization In Endoplasmic Reticulum (GO:0035437),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,HSPA5
Mast Cell Mediated Immunity (GO:0002448),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,SERPINB9
Negative Regulation Of CD4-positive, Alpha-Beta T Cell Activation (GO:2000515),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,CD274
Negative Regulation Of Bone Remodeling (GO:0046851),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,GPR137
Negative Regulation Of Fibrinolysis (GO:0051918),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,PLAU
Negative Regulation Of Leukocyte Apoptotic Process (GO:2000107),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,IRF7
Negative Regulation Of Leukocyte Chemotaxis (GO:0002689),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,C5
Negative Regulation Of Vascular Permeability (GO:0043116),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,CEACAM1
Nucleotide-Binding Oligomerization Domain Containing Signaling Pathway (GO:0070423),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,MAP2K6
Organic Cyclic Compound Catabolic Process (GO:1901361),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,STS
Pentose-Phosphate Shunt (GO:0006098),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,RBKS
Positive Regulation Of Mitotic Cell Cycle Spindle Assembly Checkpoint (GO:0090267),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,NDC80
Positive Regulation Of Spindle Checkpoint (GO:0090232),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,NDC80
Positive Regulation Of Vascular Permeability (GO:0043117),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,OCLN
Protein Polyglutamylation (GO:0018095),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,TTLL4
Purine Ribonucleoside Monophosphate Biosynthetic Process (GO:0009168),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,AMPD2
Purine Ribonucleoside Monophosphate Metabolic Process (GO:0009167),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,AMPD2
Regulation Of CD4-positive, Alpha-Beta T Cell Differentiation (GO:0043370),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,IRF4
Regulation Of Astrocyte Differentiation (GO:0048710),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,HES1
Regulation Of Cell Cycle Checkpoint (GO:1901976),1/11,0.253318146539874,0.63693081621392,0,0,3.72198852772467,5.11069625809552,BRCA2
Golgi Organization (GO:0007030),5/130,0.255062903997121,0.640582293295521,0,0,1.49140655105973,2.03762686550349,PI4K2B;PLK3;COG6;STX17;VPS51
MAPK Cascade (GO:0000165),4/98,0.255453874089638,0.640829306135519,0,0,1.5860883797054,2.16455609324379,TNIK;RCE1;RASGRP3;MAP2K6
Activation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0006919),3/67,0.256455952688158,0.642296692999674,0,0,1.74652111324376,2.37666305530798,SMAD3;CASP10;NOD1
Negative Regulation Of Intracellular Signal Transduction (GO:1902532),8/231,0.260673256866969,0.642296692999674,0,0,1.33854764139465,1.79966063268084,DUSP2;AIM2;STAT1;HYAL2;DDIT4;RHOH;IFI35;CD2AP
G2/M Transition Of Mitotic Cell Cycle (GO:0000086),2/38,0.262567504342089,0.642296692999674,0,0,2.06896551724138,2.76671807712793,PLK3;FBXL15
RNA 3'-End Processing (GO:0031123),2/38,0.262567504342089,0.642296692999674,0,0,2.06896551724138,2.76671807712793,PNPT1;SSB
Regulation Of Telomere Maintenance (GO:0032204),2/38,0.262567504342089,0.642296692999674,0,0,2.06896551724138,2.76671807712793,NSMCE1;PML
Connective Tissue Development (GO:0061448),2/38,0.262567504342089,0.642296692999674,0,0,2.06896551724138,2.76671807712793,HYAL2;CREB3L2
Response To Transforming Growth Factor Beta (GO:0071559),2/38,0.262567504342089,0.642296692999674,0,0,2.06896551724138,2.76671807712793,SMAD3;HYAL2
Tumor Necrosis Factor-Mediated Signaling Pathway (GO:0033209),2/38,0.262567504342089,0.642296692999674,0,0,2.06896551724138,2.76671807712793,AIM2;STAT1
Negative Regulation Of Type I Interferon Production (GO:0032480),2/38,0.262567504342089,0.642296692999674,0,0,2.06896551724138,2.76671807712793,DHX58;XAF1
Positive Regulation Of Production Of Molecular Mediator Of Immune Response (GO:0002702),2/38,0.262567504342089,0.642296692999674,0,0,2.06896551724138,2.76671807712793,TRIM6;DNAJB9
Aerobic Electron Transport Chain (GO:0019646),3/68,0.263545612227793,0.642296692999674,0,0,1.71956297061863,2.29308678694412,NDUFA6;NDUFS7;CYC1
Cell-Cell Junction Organization (GO:0045216),3/68,0.263545612227793,0.642296692999674,0,0,1.71956297061863,2.29308678694412,OCLN;PARD6A;SMAD3
ncRNA Processing (GO:0034470),4/100,0.267007418421732,0.642296692999674,0,0,1.55288461538462,2.05055127032322,DDX27;SSB;SPPL2B;IGF2BP3
Regulation Of Endopeptidase Activity (GO:0052548),3/69,0.270659178706728,0.642296692999674,0,0,1.69342174140639,2.21312422511221,SERPINB10;SERPING1;SERPINB9
Anterograde Axonal Transport (GO:0008089),2/39,0.272343884473351,0.642296692999674,0,0,2.01294397846122,2.6182155599798,BLOC1S4;MAPK8IP3
Regulation Of Nitric Oxide Biosynthetic Process (GO:0045428),2/39,0.272343884473351,0.642296692999674,0,0,2.01294397846122,2.6182155599798,SMAD3;MMP8
Carboxylic Acid Transmembrane Transport (GO:1905039),2/39,0.272343884473351,0.642296692999674,0,0,2.01294397846122,2.6182155599798,SLC5A6;SLC7A7
Digestive Tract Development (GO:0048565),2/39,0.272343884473351,0.642296692999674,0,0,2.01294397846122,2.6182155599798,CXCL8;PCSK5
Negative Regulation Of Lymphocyte Proliferation (GO:0050672),2/39,0.272343884473351,0.642296692999674,0,0,2.01294397846122,2.6182155599798,CD274;FCGR2B
Negative Regulation Of Protein Secretion (GO:0050709),2/39,0.272343884473351,0.642296692999674,0,0,2.01294397846122,2.6182155599798,RSAD2;RHBDF2
Positive Regulation Of ATP-dependent Activity (GO:0032781),2/39,0.272343884473351,0.642296692999674,0,0,2.01294397846122,2.6182155599798,DNAJB2;PLSCR1
Positive Regulation Of Lymphocyte Differentiation (GO:0045621),2/39,0.272343884473351,0.642296692999674,0,0,2.01294397846122,2.6182155599798,SMARCD3;RHOH
rRNA Processing (GO:0006364),4/101,0.272819689071767,0.642296692999674,0,0,1.53679619349722,1.99621247384903,DDX27;SPPL2B;TSR3;IGF2BP3
NADPH Regeneration (GO:0006740),1/12,0.27289194817338,0.642296692999674,0,0,3.3834521119416,4.39401941108257,RBKS
Regulation Of Hematopoietic Stem Cell Differentiation (GO:1902036),1/12,0.27289194817338,0.642296692999674,0,0,3.3834521119416,4.39401941108257,EIF2AK2
Attachment Of Mitotic Spindle Microtubules To Kinetochore (GO:0051315),1/12,0.27289194817338,0.642296692999674,0,0,3.3834521119416,4.39401941108257,NDC80
Cell-Cell Junction Maintenance (GO:0045217),1/12,0.27289194817338,0.642296692999674,0,0,3.3834521119416,4.39401941108257,PARD6A
Cellular Component Maintenance (GO:0043954),1/12,0.27289194817338,0.642296692999674,0,0,3.3834521119416,4.39401941108257,PICK1
Cellular Response To Leucine Starvation (GO:1990253),1/12,0.27289194817338,0.642296692999674,0,0,3.3834521119416,4.39401941108257,SESN2
Regulation Of Vascular Associated Smooth Muscle Cell Migration (GO:1904752),1/12,0.27289194817338,0.642296692999674,0,0,3.3834521119416,4.39401941108257,DOCK4
Relaxation Of Cardiac Muscle (GO:0055119),1/12,0.27289194817338,0.642296692999674,0,0,3.3834521119416,4.39401941108257,KCNJ2
Response To Thyroid Hormone (GO:0097066),1/12,0.27289194817338,0.642296692999674,0,0,3.3834521119416,4.39401941108257,LMO2
Endochondral Bone Morphogenesis (GO:0060350),1/12,0.27289194817338,0.642296692999674,0,0,3.3834521119416,4.39401941108257,BMPR2
Steroid Catabolic Process (GO:0006706),1/12,0.27289194817338,0.642296692999674,0,0,3.3834521119416,4.39401941108257,STS
tRNA 5'-Leader Removal (GO:0001682),1/12,0.27289194817338,0.642296692999674,0,0,3.3834521119416,4.39401941108257,SSB
Fibrinolysis (GO:0042730),1/12,0.27289194817338,0.642296692999674,0,0,3.3834521119416,4.39401941108257,PLAU
Gamma-Delta T Cell Activation (GO:0046629),1/12,0.27289194817338,0.642296692999674,0,0,3.3834521119416,4.39401941108257,MICA
Granulocyte Activation (GO:0036230),1/12,0.27289194817338,0.642296692999674,0,0,3.3834521119416,4.39401941108257,CXCL8
Lipid Droplet Formation (GO:0140042),1/12,0.27289194817338,0.642296692999674,0,0,3.3834521119416,4.39401941108257,RNF213
Mesoderm Morphogenesis (GO:0048332),1/12,0.27289194817338,0.642296692999674,0,0,3.3834521119416,4.39401941108257,BMPR2
Mitochondrial Transcription (GO:0006390),1/12,0.27289194817338,0.642296692999674,0,0,3.3834521119416,4.39401941108257,POLRMT
Morphogenesis Of A Polarized Epithelium (GO:0001738),1/12,0.27289194817338,0.642296692999674,0,0,3.3834521119416,4.39401941108257,FUZ
Negative Regulation Of JUN Kinase Activity (GO:0043508),1/12,0.27289194817338,0.642296692999674,0,0,3.3834521119416,4.39401941108257,ZNF675
Negative Regulation Of Complement Activation (GO:0045916),1/12,0.27289194817338,0.642296692999674,0,0,3.3834521119416,4.39401941108257,SERPING1
Negative Regulation Of Stem Cell Differentiation (GO:2000737),1/12,0.27289194817338,0.642296692999674,0,0,3.3834521119416,4.39401941108257,HES1
Negative Regulation Of Substrate Adhesion-Dependent Cell Spreading (GO:1900025),1/12,0.27289194817338,0.642296692999674,0,0,3.3834521119416,4.39401941108257,GBP1
Nuclear Body Organization (GO:0030575),1/12,0.27289194817338,0.642296692999674,0,0,3.3834521119416,4.39401941108257,PML
Positive Regulation By Symbiont Of Entry Into Host (GO:0075294),1/12,0.27289194817338,0.642296692999674,0,0,3.3834521119416,4.39401941108257,TRIM38
Positive Regulation Of T-helper 1 Type Immune Response (GO:0002827),1/12,0.27289194817338,0.642296692999674,0,0,3.3834521119416,4.39401941108257,IL18R1
Positive Regulation Of Myeloid Leukocyte Mediated Immunity (GO:0002888),1/12,0.27289194817338,0.642296692999674,0,0,3.3834521119416,4.39401941108257,RIGI
Positive Regulation Of Neuroinflammatory Response (GO:0150078),1/12,0.27289194817338,0.642296692999674,0,0,3.3834521119416,4.39401941108257,MMP8
Positive Regulation Of Neuron Migration (GO:2001224),1/12,0.27289194817338,0.642296692999674,0,0,3.3834521119416,4.39401941108257,SRGAP2C
Positive Regulation Of Protein Export From Nucleus (GO:0046827),1/12,0.27289194817338,0.642296692999674,0,0,3.3834521119416,4.39401941108257,EMD
Positive Regulation Of Reactive Oxygen Species Biosynthetic Process (GO:1903428),1/12,0.27289194817338,0.642296692999674,0,0,3.3834521119416,4.39401941108257,MMP8
Positive Regulation Of Viral Entry Into Host Cell (GO:0046598),1/12,0.27289194817338,0.642296692999674,0,0,3.3834521119416,4.39401941108257,TRIM38
Primary miRNA Processing (GO:0031053),1/12,0.27289194817338,0.642296692999674,0,0,3.3834521119416,4.39401941108257,SMAD3
Protein Insertion Into Mitochondrial Inner Membrane (GO:0045039),1/12,0.27289194817338,0.642296692999674,0,0,3.3834521119416,4.39401941108257,TIMM10
Negative Regulation Of Transcription By RNA Polymerase II (GO:0000122),23/763,0.273493657704765,0.642296692999674,0,0,1.16234557911205,1.50695413126222,KLF10;PLK3;SP100;CBX5;SMAD3;RPL10;STAT1;NOTCH4;PRDM1;PARP9;NR4A2;ETV7;IFI16;TFEC;IRF7;HES1;ZNF589;SAMD1;ZNF675;ATF3;GZF1;ZNF684;MXD4
Membrane Organization (GO:0061024),6/167,0.274063969634905,0.642296692999674,0,0,1.38960166910477,1.79869169327594,RTP4;OTOF;PICK1;TOR1B;EMD;CHMP5
Mitochondrial ATP Synthesis Coupled Electron Transport (GO:0042775),3/70,0.277793589889625,0.642296692999674,0,0,1.66806084739451,2.13658064638729,NDUFA6;NDUFS7;CYC1
Negative Regulation Of Epithelial Cell Proliferation (GO:0050680),3/70,0.277793589889625,0.642296692999674,0,0,1.66806084739451,2.13658064638729,CEACAM1;STAT1;BRCA2
Protein K48-linked Ubiquitination (GO:0070936),3/70,0.277793589889625,0.642296692999674,0,0,1.66806084739451,2.13658064638729,TRIM6;RNF126;DTX3L
Regulation Of Cellular Biosynthetic Process (GO:0031326),3/70,0.277793589889625,0.642296692999674,0,0,1.66806084739451,2.13658064638729,CXCL8;RPL10;ELP5
Protein Catabolic Process (GO:0030163),4/102,0.278653350809258,0.642296692999674,0,0,1.52103610675039,1.94355976809127,CEACAM1;CLPP;FBXO6;CLN6
Notch Signaling Pathway (GO:0007219),2/40,0.282115147872651,0.642296692999674,0,0,1.95987094172212,2.48009901706695,NOTCH4;HES1
Cell Cycle G2/M Phase Transition (GO:0044839),2/40,0.282115147872651,0.642296692999674,0,0,1.95987094172212,2.48009901706695,PLK3;FBXL15
Establishment Or Maintenance Of Epithelial Cell Apical/Basal Polarity (GO:0045197),2/40,0.282115147872651,0.642296692999674,0,0,1.95987094172212,2.48009901706695,PARD6A;LLGL1
Negative Regulation Of Cell-Cell Adhesion (GO:0022408),2/40,0.282115147872651,0.642296692999674,0,0,1.95987094172212,2.48009901706695,IL1RN;NOTCH4
Negative Regulation Of Secretion By Cell (GO:1903531),2/40,0.282115147872651,0.642296692999674,0,0,1.95987094172212,2.48009901706695,RSAD2;RHBDF2
Vesicle-Mediated Transport (GO:0016192),13/411,0.283039202217081,0.642296692999674,0,0,1.21947309935195,1.53918219985955,CCR1;EXOC3L1;RUBCN;DTX3L;STX17;AP4E1;MAPK8IP3;EPN2;RPH3A;VPS51;HEATR5B;ANKFY1;CHMP5
Kidney Development (GO:0001822),3/71,0.284945847168427,0.642296692999674,0,0,1.64344586203003,2.06327417639031,HYAL2;C1GALT1;PCSK5
Myeloid Leukocyte Differentiation (GO:0002573),3/71,0.284945847168427,0.642296692999674,0,0,1.64344586203003,2.06327417639031,BATF2;IFI16;CASP10
Negative Regulation Of Protein Binding (GO:0032091),3/71,0.284945847168427,0.642296692999674,0,0,1.64344586203003,2.06327417639031,DNAJB2;IFIT1;IFIT2
Protein Autoubiquitination (GO:0051865),3/71,0.284945847168427,0.642296692999674,0,0,1.64344586203003,2.06327417639031,RNF213;DTX3L;BRCA2
Macroautophagy (GO:0016236),4/104,0.290378121179218,0.642296692999674,0,0,1.49046153846154,1.84306202058434,ZFYVE26;MAP1LC3A;STX17;CHMP5
Regulation Of Chemokine Production (GO:0032642),2/41,0.291874863222691,0.642296692999674,0,0,1.90951959917477,2.35143994757904,C5;EIF2AK2
O-glycan Processing (GO:0016266),2/41,0.291874863222691,0.642296692999674,0,0,1.90951959917477,2.35143994757904,GCNT1;C1GALT1
Regulation Of Release Of Cytochrome C From Mitochondria (GO:0090199),2/41,0.291874863222691,0.642296692999674,0,0,1.90951959917477,2.35143994757904,GPX1;TNFSF10
Heart Contraction (GO:0060047),2/41,0.291874863222691,0.642296692999674,0,0,1.90951959917477,2.35143994757904,GPX1;GAA
Negative Regulation Of DNA Recombination (GO:0045910),2/41,0.291874863222691,0.642296692999674,0,0,1.90951959917477,2.35143994757904,HELB;RMI2
Negative Regulation Of mRNA Catabolic Process (GO:1902373),2/41,0.291874863222691,0.642296692999674,0,0,1.90951959917477,2.35143994757904,LARP1;TENT5A
Positive Regulation Of Viral Process (GO:0048524),2/41,0.291874863222691,0.642296692999674,0,0,1.90951959917477,2.35143994757904,LARP1;IFIT1
Regulation Of Amide Metabolic Process (GO:0034248),2/41,0.291874863222691,0.642296692999674,0,0,1.90951959917477,2.35143994757904,RPL10;ELP5
ATP Transport (GO:0015867),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,SLC25A5
Regulation Of Humoral Immune Response (GO:0002920),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,FCGR2B
Acute-Phase Response (GO:0006953),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,PLSCR1
Antigen Processing And Presentation Of Endogenous Peptide Antigen Via MHC Class I Via ER Pathway (GO:0002484),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,MICA
Antigen Processing And Presentation Of Endogenous Peptide Antigen Via MHC Class I Via ER Pathway, TAP-independent (GO:0002486),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,MICA
Antigen Processing And Presentation Of Endogenous Peptide Antigen Via MHC Class Ib (GO:0002476),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,MICA
Antigen Processing And Presentation Of Peptide Antigen Via MHC Class Ib (GO:0002428),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,MICA
Atrial Septum Development (GO:0003283),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,BMPR2
Atrioventricular Valve Development (GO:0003171),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,BMPR2
Regulation Of Oxidoreductase Activity (GO:0051341),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,HP
Branching Involved In Blood Vessel Morphogenesis (GO:0001569),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,NOTCH4
Regulation Of Response To Endoplasmic Reticulum Stress (GO:1905897),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,FCGR2B
Relaxation Of Muscle (GO:0090075),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,KCNJ2
Signal Peptide Processing (GO:0006465),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,PCSK5
Endolysosomal Toll-Like Receptor Signaling Pathway (GO:0140894),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,OAS1
Endonucleolytic Cleavage Of Tricistronic rRNA Transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,TBL3
Endothelial Cell Differentiation (GO:0045446),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,BMPR2
Spliceosomal tri-snRNP Complex Assembly (GO:0000244),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,TSSC4
Substrate-Dependent Cell Migration (GO:0006929),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,CD2AP
Thymus Development (GO:0048538),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,HES1
Heparan Sulfate Proteoglycan Metabolic Process (GO:0030201),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,HS6ST1
Immune Response-Regulating Cell Surface Receptor Signaling Pathway (GO:0002768),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,BTLA
Inhibitory Synapse Assembly (GO:1904862),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,SRGAP2C
Intracellular Potassium Ion Homeostasis (GO:0030007),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,KCNJ2
Intraciliary Retrograde Transport (GO:0035721),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,TTC21A
Lipid Oxidation (GO:0034440),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,SAMD1
Mature B Cell Differentiation Involved In Immune Response (GO:0002313),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,FCGR2B
Membrane Depolarization During Action Potential (GO:0086010),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,KCNJ2
Membrane Protein Intracellular Domain Proteolysis (GO:0031293),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,SPPL2B
Microvillus Organization (GO:0032528),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,TNIK
Monoacylglycerol Metabolic Process (GO:0046462),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,FAAH
Myeloid Dendritic Cell Activation (GO:0001773),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,BATF2
Negative Regulation Of Bone Mineralization (GO:0030502),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,CCR1
Negative Regulation Of Fibroblast Growth Factor Receptor Signaling Pathway (GO:0040037),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,FUZ
Negative Regulation Of Receptor Internalization (GO:0002091),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,NECAB2
Positive Regulation Of Granulocyte Macrophage Colony-Stimulating Factor Production (GO:0032725),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,RIGI
Positive Regulation Of Heterochromatin Formation (GO:0031453),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,TRIM28
Positive Regulation Of Type 2 Immune Response (GO:0002830),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,RSAD2
Protein Localization To Phagophore Assembly Site (GO:0034497),1/13,0.29195358771067,0.642296692999674,0,0,3.10133843212237,3.8182451748595,STX17
Protein Targeting To Membrane (GO:0006612),3/72,0.292113016542318,0.642296692999674,0,0,1.61954435450221,1.9930347800405,RTP4;UBL4A;YIF1B
Positive Regulation Of Nucleic Acid-Templated Transcription (GO:1903508),17/557,0.29375975404753,0.645269670375216,0,0,1.17580539119001,1.44035338392518,ZNF496;SP100;SMARCD3;SMAD3;DTX3L;STAT1;NOTCH4;INHBA;BRCA2;PARP9;ELF1;TRIM28;IRF4;TP53INP2;CREB3L2;IRF7;CD38
Regulation Of Autophagy (GO:0010506),8/241,0.298332859845451,0.650596354911143,0,0,1.28043384236617,1.54874291075735,RUBCN;TRIM6;IFI16;TRIM5;LAMP3;GPR137;TRIM38;TRIM22
DNA Replication (GO:0006260),3/73,0.299292229252881,0.650596354911143,0,0,1.59632574718947,1.92570334491979,HELB;RECQL5;TREX1
Monocarboxylic Acid Transport (GO:0015718),3/73,0.299292229252881,0.650596354911143,0,0,1.59632574718947,1.92570334491979,SLC5A6;CEACAM1;SLC10A3
DNA Recombination (GO:0006310),2/42,0.301616938387655,0.650596354911143,0,0,1.86168582375479,2.23141194186108,RMI2;TREX1
Regulation Of Ubiquitin-Dependent Protein Catabolic Process (GO:2000058),2/42,0.301616938387655,0.650596354911143,0,0,1.86168582375479,2.23141194186108,NUB1;PML
Stress-Activated MAPK Cascade (GO:0051403),2/42,0.301616938387655,0.650596354911143,0,0,1.86168582375479,2.23141194186108,GPS1;MAP2K6
Substantia Nigra Development (GO:0021762),2/42,0.301616938387655,0.650596354911143,0,0,1.86168582375479,2.23141194186108,CNP;HSPA5
Translational Elongation (GO:0006414),2/42,0.301616938387655,0.650596354911143,0,0,1.86168582375479,2.23141194186108,GTPBP2;ZNF598
Negative Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043124),2/42,0.301616938387655,0.650596354911143,0,0,1.86168582375479,2.23141194186108,STAT1;RHOH
Regulation Of mRNA Stability (GO:0043488),3/74,0.306480682296128,0.650596354911143,0,0,1.57376118515315,1.86113084684239,METTL14;LARP1;TENT5A
Positive Regulation Of Lymphocyte Proliferation (GO:0050671),3/74,0.306480682296128,0.650596354911143,0,0,1.57376118515315,1.86113084684239,CD274;CD38;TNFSF13B
Regulation Of Cholesterol Storage (GO:0010885),1/14,0.310516441207868,0.650596354911143,0,0,2.86262685689072,3.34789486236703,TTC39B
Regulation Of Exit From Mitosis (GO:0007096),1/14,0.310516441207868,0.650596354911143,0,0,2.86262685689072,3.34789486236703,MAD2L1BP
Regulation Of Leukocyte Activation (GO:0002694),1/14,0.310516441207868,0.650596354911143,0,0,2.86262685689072,3.34789486236703,PLSCR1
Regulation Of Macrophage Differentiation (GO:0045649),1/14,0.310516441207868,0.650596354911143,0,0,2.86262685689072,3.34789486236703,INHBA
Regulation Of Microglial Cell Activation (GO:1903978),1/14,0.310516441207868,0.650596354911143,0,0,2.86262685689072,3.34789486236703,MMP8
Regulation Of Non-Canonical Wnt Signaling Pathway (GO:2000050),1/14,0.310516441207868,0.650596354911143,0,0,2.86262685689072,3.34789486236703,RNF213
Blood Coagulation, Fibrin Clot Formation (GO:0072378),1/14,0.310516441207868,0.650596354911143,0,0,2.86262685689072,3.34789486236703,F12
Bone Morphogenesis (GO:0060349),1/14,0.310516441207868,0.650596354911143,0,0,2.86262685689072,3.34789486236703,BMPR2
Ceramide Transport (GO:0035627),1/14,0.310516441207868,0.650596354911143,0,0,2.86262685689072,3.34789486236703,ABCA13
Copper Ion Homeostasis (GO:0055070),1/14,0.310516441207868,0.650596354911143,0,0,2.86262685689072,3.34789486236703,MT2A
Endoderm Development (GO:0007492),1/14,0.310516441207868,0.650596354911143,0,0,2.86262685689072,3.34789486236703,DUSP2
Establishment Of Chromosome Localization (GO:0051303),1/14,0.310516441207868,0.650596354911143,0,0,2.86262685689072,3.34789486236703,NDC80
Establishment Of Protein Localization To Chromosome (GO:0070199),1/14,0.310516441207868,0.650596354911143,0,0,2.86262685689072,3.34789486236703,BRCA2
Striated Muscle Cell Development (GO:0055002),1/14,0.310516441207868,0.650596354911143,0,0,2.86262685689072,3.34789486236703,TMOD2
Establishment Of Spindle Localization (GO:0051293),1/14,0.310516441207868,0.650596354911143,0,0,2.86262685689072,3.34789486236703,LLGL1
tRNA 5'-End Processing (GO:0099116),1/14,0.310516441207868,0.650596354911143,0,0,2.86262685689072,3.34789486236703,SSB
Formation Of Cytoplasmic Translation Initiation Complex (GO:0001732),1/14,0.310516441207868,0.650596354911143,0,0,2.86262685689072,3.34789486236703,EIF3I
Hyaluronan Metabolic Process (GO:0030212),1/14,0.310516441207868,0.650596354911143,0,0,2.86262685689072,3.34789486236703,HYAL2
Membrane Repolarization During Cardiac Muscle Cell Action Potential (GO:0086013),1/14,0.310516441207868,0.650596354911143,0,0,2.86262685689072,3.34789486236703,KCNJ2
Microvillus Assembly (GO:0030033),1/14,0.310516441207868,0.650596354911143,0,0,2.86262685689072,3.34789486236703,TNIK
Negative Regulation Of T Cell Mediated Immunity (GO:0002710),1/14,0.310516441207868,0.650596354911143,0,0,2.86262685689072,3.34789486236703,CEACAM1
Negative Regulation Of Blood Pressure (GO:0045776),1/14,0.310516441207868,0.650596354911143,0,0,2.86262685689072,3.34789486236703,BMPR2
Negative Regulation Of Fatty Acid Biosynthetic Process (GO:0045717),1/14,0.310516441207868,0.650596354911143,0,0,2.86262685689072,3.34789486236703,CEACAM1
Negative Regulation Of Nucleocytoplasmic Transport (GO:0046823),1/14,0.310516441207868,0.650596354911143,0,0,2.86262685689072,3.34789486236703,SP100
Negative Regulation Of Transcription Regulatory Region DNA Binding (GO:2000678),1/14,0.310516441207868,0.650596354911143,0,0,2.86262685689072,3.34789486236703,ZNF675
Nuclear Pore Organization (GO:0006999),1/14,0.310516441207868,0.650596354911143,0,0,2.86262685689072,3.34789486236703,NUP205
Positive Regulation Of Cytoplasmic Translation (GO:2000767),1/14,0.310516441207868,0.650596354911143,0,0,2.86262685689072,3.34789486236703,YBX3
Positive Regulation Of Histone Acetylation (GO:0035066),1/14,0.310516441207868,0.650596354911143,0,0,2.86262685689072,3.34789486236703,DDX21
Primary Alcohol Metabolic Process (GO:0034308),1/14,0.310516441207868,0.650596354911143,0,0,2.86262685689072,3.34789486236703,NAAA
Protein Activation Cascade (GO:0072376),1/14,0.310516441207868,0.650596354911143,0,0,2.86262685689072,3.34789486236703,F12
Protein Homotrimerization (GO:0070207),1/14,0.310516441207868,0.650596354911143,0,0,2.86262685689072,3.34789486236703,PNPT1
Protein Trimerization (GO:0070206),1/14,0.310516441207868,0.650596354911143,0,0,2.86262685689072,3.34789486236703,PNPT1
Regulation Of Carbohydrate Catabolic Process (GO:0043470),1/14,0.310516441207868,0.650596354911143,0,0,2.86262685689072,3.34789486236703,SCARB2
Regulation Of Chromosome Organization (GO:0033044),2/43,0.31133560728168,0.650596354911143,0,0,1.81618540323334,2.11927737122476,RMI2;NSMCE1
Regulation Of Filopodium Assembly (GO:0051489),2/43,0.31133560728168,0.650596354911143,0,0,1.81618540323334,2.11927737122476,SRGAP2C;AGRN
Response To Amyloid-Beta (GO:1904645),2/43,0.31133560728168,0.650596354911143,0,0,1.81618540323334,2.11927737122476,CACNA1A;FCGR2B
Glycolipid Biosynthetic Process (GO:0009247),2/43,0.31133560728168,0.650596354911143,0,0,1.81618540323334,2.11927737122476,PIGQ;TP53INP2
mRNA Catabolic Process (GO:0006402),2/43,0.31133560728168,0.650596354911143,0,0,1.81618540323334,2.11927737122476,PNPT1;XRN1
mRNA Destabilization (GO:0061157),2/43,0.31133560728168,0.650596354911143,0,0,1.81618540323334,2.11927737122476,MOV10;METTL14
Neurotransmitter Secretion (GO:0007269),2/43,0.31133560728168,0.650596354911143,0,0,1.81618540323334,2.11927737122476,RPH3A;OTOF
Glycerophospholipid Biosynthetic Process (GO:0046474),4/108,0.314011370171209,0.655562345733983,0,0,1.43284023668639,1.65969621891591,PI4K2B;PLSCR1;CHPT1;SELENOI
Regulation Of Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0032434),4/109,0.319948581061171,0.657787791462053,0,0,1.41912087912088,1.61722303026137,RNF144A;DNAJB2;NUB1;TRIB2
Positive Regulation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0043280),4/109,0.319948581061171,0.657787791462053,0,0,1.41912087912088,1.61722303026137,SMAD3;CASP10;TNFSF10;NOD1
Cellular Response To Ketone (GO:1901655),2/44,0.321025416847942,0.657787791462053,0,0,1.77285166940339,2.01437607895588,LARP1;PCK2
Response To Unfolded Protein (GO:0006986),2/44,0.321025416847942,0.657787791462053,0,0,1.77285166940339,2.01437607895588,DNAJB2;TOR1B
Nucleobase-Containing Compound Catabolic Process (GO:0034655),2/44,0.321025416847942,0.657787791462053,0,0,1.77285166940339,2.01437607895588,PNPT1;TREX1
Nucleus Organization (GO:0006997),2/44,0.321025416847942,0.657787791462053,0,0,1.77285166940339,2.01437607895588,NUP205;CHMP5
Positive Regulation Of Biosynthetic Process (GO:0009891),2/44,0.321025416847942,0.657787791462053,0,0,1.77285166940339,2.01437607895588,CXCL8;MMP8
Positive Regulation Of Osteoblast Differentiation (GO:0045669),2/44,0.321025416847942,0.657787791462053,0,0,1.77285166940339,2.01437607895588,BMPR2;TENT5A
Embryonic Organ Development (GO:0048568),3/77,0.328074450467673,0.657787791462053,0,0,1.50972661721222,1.68261252782532,CXCL8;RPL10;PCSK5
3'-UTR-mediated mRNA Destabilization (GO:0061158),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,MOV10
B Cell Mediated Immunity (GO:0019724),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,FCGR2B
Regulation Of Granulocyte Macrophage Colony-Stimulating Factor Production (GO:0032645),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,RIGI
Regulation Of Interleukin-13 Production (GO:0032656),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,IRF4
Regulation Of Lipoprotein Lipase Activity (GO:0051004),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,PCSK5
Alpha-Beta T Cell Activation (GO:0046631),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,RSAD2
Anterograde Synaptic Vesicle Transport (GO:0048490),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,BLOC1S4
Regulation Of Monocyte Differentiation (GO:0045655),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,IRF7
Cardiac Myofibril Assembly (GO:0055003),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,NEBL
Cellular Response To Estrogen Stimulus (GO:0071391),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,SERPINB9
Regulation Of Systemic Arterial Blood Pressure (GO:0003073),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,BMPR2
Cellular Response To Sterol (GO:0036315),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,GRAMD1B
Cellular Response To Zinc Ion (GO:0071294),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,MT2A
Dendritic Cell Chemotaxis (GO:0002407),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,CCR1
Endosome To Lysosome Transport Via Multivesicular Body Sorting Pathway (GO:0032510),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,CHMP5
Epiboly Involved In Wound Healing (GO:0090505),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,CEACAM1
Synaptic Vesicle Transport Along Microtubule (GO:0099517),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,BLOC1S4
tRNA Wobble Base Modification (GO:0002097),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,ELP5
tRNA Wobble Uridine Modification (GO:0002098),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,ELP5
Intracellular Sterol Transport (GO:0032366),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,GRAMD1B
Keratan Sulfate Biosynthetic Process (GO:0018146),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,B4GALT4
Membrane Repolarization During Action Potential (GO:0086011),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,KCNJ2
Midbody Abscission (GO:0061952),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,CHMP5
Mitotic Chromosome Condensation (GO:0007076),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,NCAPH2
Negative Regulation Of Epithelial Cell Differentiation (GO:0030857),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,NOTCH4
Negative Regulation Of Macrophage Activation (GO:0043031),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,FCGR2B
Negative Regulation Of Platelet Activation (GO:0010544),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,CEACAM1
Negative Regulation Of Protein Processing (GO:0010955),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,PLAU
Negative Regulation Of Synaptic Transmission (GO:0050805),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,PICK1
Neurotrophin Signaling Pathway (GO:0038179),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,DDIT4
Nitric Oxide Biosynthetic Process (GO:0006809),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,GCH1
Positive Regulation Of Transcription By RNA Polymerase III (GO:0045945),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,DDX21
Protein Localization To Chromosome, Telomeric Region (GO:0070198),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,BRCA2
Regulation Of Rac Protein Signal Transduction (GO:0035020),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,STMN3
Regulation Of Activin Receptor Signaling Pathway (GO:0032925),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,ACVR1B
Regulation Of Carbohydrate Metabolic Process (GO:0006109),1/15,0.328593536008898,0.657787791462053,0,0,2.65801693526359,2.95819674171286,SCARB2
Regulation Of Protein Modification Process (GO:0031399),2/45,0.330681214751581,0.660156663906984,0,0,1.73153345807716,1.91611573005936,STAT2;SESN2
Regulation Of Stem Cell Differentiation (GO:2000736),2/45,0.330681214751581,0.660156663906984,0,0,1.73153345807716,1.91611573005936,EIF2AK2;HES1
Organic Hydroxy Compound Transport (GO:0015850),2/45,0.330681214751581,0.660156663906984,0,0,1.73153345807716,1.91611573005936,CEACAM1;SLC10A3
Cellular Response To Nutrient Levels (GO:0031669),3/78,0.33527316557796,0.665063733549742,0,0,1.48952015355086,1.62776201226023,KLF10;BMPR2;MAP1LC3A
Negative Regulation Of Defense Response (GO:0031348),4/112,0.337804694542693,0.665063733549742,0,0,1.37948717948718,1.49714002304755,IFI16;TREX1;DHX58;TRAFD1
Regulation Of Fibroblast Proliferation (GO:0048145),2/46,0.34029813745315,0.665063733549742,0,0,1.69209334726576,1.82396354700605,PARP10;EMD
Replication Fork Processing (GO:0031297),2/46,0.34029813745315,0.665063733549742,0,0,1.69209334726576,1.82396354700605,BRCA2;SAMHD1
Response To Hydrogen Peroxide (GO:0042542),2/46,0.34029813745315,0.665063733549742,0,0,1.69209334726576,1.82396354700605,GPX1;HP
Development Of Primary Male Sexual Characteristics (GO:0046546),2/46,0.34029813745315,0.665063733549742,0,0,1.69209334726576,1.82396354700605,INHBA;LHFPL2
Negative Regulation Of Cold-Induced Thermogenesis (GO:0120163),2/46,0.34029813745315,0.665063733549742,0,0,1.69209334726576,1.82396354700605,IL18R1;MAP2K6
Vesicle Fusion (GO:0006906),3/79,0.342468105643619,0.665063733549742,0,0,1.46984543893323,1.57505219525661,SAMD9;STX17;CHMP5
Negative Regulation Of Cellular Component Organization (GO:0051129),3/79,0.342468105643619,0.665063733549742,0,0,1.46984543893323,1.57505219525661,DNAJB2;RUBCN;HSPA5
DNA Repair-Dependent Chromatin Remodeling (GO:0140861),1/16,0.346197559930002,0.665063733549742,0,0,2.48068833652008,2.63137944734532,DTX3L
Regulation Of Interleukin-1 Production (GO:0032652),1/16,0.346197559930002,0.665063733549742,0,0,2.48068833652008,2.63137944734532,CEACAM1
Activation Of Cysteine-Type Endopeptidase Activity (GO:0097202),1/16,0.346197559930002,0.665063733549742,0,0,2.48068833652008,2.63137944734532,IFI16
Regulation Of Nucleocytoplasmic Transport (GO:0046822),1/16,0.346197559930002,0.665063733549742,0,0,2.48068833652008,2.63137944734532,MX2
Regulation Of Osteoblast Proliferation (GO:0033688),1/16,0.346197559930002,0.665063733549742,0,0,2.48068833652008,2.63137944734532,EIF2AK2
Cell Surface Toll-Like Receptor Signaling Pathway (GO:0140895),1/16,0.346197559930002,0.665063733549742,0,0,2.48068833652008,2.63137944734532,OAS1
Regulation Of Secretion (GO:0051046),1/16,0.346197559930002,0.665063733549742,0,0,2.48068833652008,2.63137944734532,OAS2
Regulation Of Stem Cell Proliferation (GO:0072091),1/16,0.346197559930002,0.665063733549742,0,0,2.48068833652008,2.63137944734532,EIF2AK2
Regulation Of Transforming Growth Factor Beta Production (GO:0071634),1/16,0.346197559930002,0.665063733549742,0,0,2.48068833652008,2.63137944734532,SMAD3
Response To UV-B (GO:0010224),1/16,0.346197559930002,0.665063733549742,0,0,2.48068833652008,2.63137944734532,HYAL2
Tail-Anchored Membrane Protein Insertion Into ER Membrane (GO:0071816),1/16,0.346197559930002,0.665063733549742,0,0,2.48068833652008,2.63137944734532,UBL4A
Glycoprotein Catabolic Process (GO:0006516),1/16,0.346197559930002,0.665063733549742,0,0,2.48068833652008,2.63137944734532,FBXO6
Heart Process (GO:0003015),1/16,0.346197559930002,0.665063733549742,0,0,2.48068833652008,2.63137944734532,GPX1
Late Endosome To Lysosome Transport (GO:1902774),1/16,0.346197559930002,0.665063733549742,0,0,2.48068833652008,2.63137944734532,CHMP5
Lymphocyte Mediated Immunity (GO:0002449),1/16,0.346197559930002,0.665063733549742,0,0,2.48068833652008,2.63137944734532,BTN3A3
Membrane Depolarization During Cardiac Muscle Cell Action Potential (GO:0086012),1/16,0.346197559930002,0.665063733549742,0,0,2.48068833652008,2.63137944734532,KCNJ2
Negative Regulation Of ATP-dependent Activity (GO:0032780),1/16,0.346197559930002,0.665063733549742,0,0,2.48068833652008,2.63137944734532,IFIT1
Negative Regulation Of Biosynthetic Process (GO:0009890),1/16,0.346197559930002,0.665063733549742,0,0,2.48068833652008,2.63137944734532,CEACAM1
Negative Regulation Of Inflammatory Response To Antigenic Stimulus (GO:0002862),1/16,0.346197559930002,0.665063733549742,0,0,2.48068833652008,2.63137944734532,RHBDF2
Negative Regulation Of Receptor Signaling Pathway Via JAK-STAT (GO:0046426),1/16,0.346197559930002,0.665063733549742,0,0,2.48068833652008,2.63137944734532,PARP14
Negative Regulation Of Release Of Cytochrome C From Mitochondria (GO:0090201),1/16,0.346197559930002,0.665063733549742,0,0,2.48068833652008,2.63137944734532,GPX1
Negative Regulation Of Viral-Induced Cytoplasmic Pattern Recognition Receptor Signaling Pathway (GO:0039532),1/16,0.346197559930002,0.665063733549742,0,0,2.48068833652008,2.63137944734532,DHX58
Neuron Projection Organization (GO:0106027),1/16,0.346197559930002,0.665063733549742,0,0,2.48068833652008,2.63137944734532,PICK1
Nitric Oxide Metabolic Process (GO:0046209),1/16,0.346197559930002,0.665063733549742,0,0,2.48068833652008,2.63137944734532,GCH1
Nuclear Chromosome Segregation (GO:0098813),1/16,0.346197559930002,0.665063733549742,0,0,2.48068833652008,2.63137944734532,NDC80
Positive Regulation Of Muscle Hypertrophy (GO:0014742),1/16,0.346197559930002,0.665063733549742,0,0,2.48068833652008,2.63137944734532,PDE9A
Positive Regulation Of Myeloid Leukocyte Cytokine Production Involved In Immune Response (GO:0061081),1/16,0.346197559930002,0.665063733549742,0,0,2.48068833652008,2.63137944734532,RIGI
Positive Regulation Of Positive Chemotaxis (GO:0050927),1/16,0.346197559930002,0.665063733549742,0,0,2.48068833652008,2.63137944734532,CXCL8
Positive Regulation Of Smooth Muscle Cell Migration (GO:0014911),1/16,0.346197559930002,0.665063733549742,0,0,2.48068833652008,2.63137944734532,DOCK4
Protein O-linked Mannosylation (GO:0035269),1/16,0.346197559930002,0.665063733549742,0,0,2.48068833652008,2.63137944734532,FKRP
Protein Localization To Endoplasmic Reticulum (GO:0070972),1/16,0.346197559930002,0.665063733549742,0,0,2.48068833652008,2.63137944734532,HSPA5
Protein Localization To Mitochondrion (GO:0070585),1/16,0.346197559930002,0.665063733549742,0,0,2.48068833652008,2.63137944734532,ISG15
Regulation Of B Cell Receptor Signaling Pathway (GO:0050855),1/16,0.346197559930002,0.665063733549742,0,0,2.48068833652008,2.63137944734532,FCGR2B
Regulation Of Autophagosome Maturation (GO:1901096),1/16,0.346197559930002,0.665063733549742,0,0,2.48068833652008,2.63137944734532,RUBCN
Regulation Of Cytokinesis (GO:0032465),3/80,0.349656868295988,0.668019878763041,0,0,1.4506817558641,1.52438071452935,PLK3;ZFYVE26;PRKCE
Regulation Of Interleukin-6 Production (GO:0032675),4/114,0.349730847542671,0.668019878763041,0,0,1.35426573426573,1.42277997078318,IFIH1;HYAL2;MMP8;RIGI
Golgi To Plasma Membrane Transport (GO:0006893),2/47,0.349871598603291,0.668019878763041,0,0,1.6544061302682,1.73743920712803,VAMP5;LLGL1
Regulation Of Interleukin-2 Production (GO:0032663),2/47,0.349871598603291,0.668019878763041,0,0,1.6544061302682,1.73743920712803,IRF4;GBP1
Regulation Of Signal Transduction By P53 Class Mediator (GO:1901796),2/47,0.349871598603291,0.668019878763041,0,0,1.6544061302682,1.73743920712803,PLK3;MAP2K6
Epithelial To Mesenchymal Transition (GO:0001837),2/47,0.349871598603291,0.668019878763041,0,0,1.6544061302682,1.73743920712803,TRIM28;NOTCH4
Positive Regulation Of TOR Signaling (GO:0032008),2/47,0.349871598603291,0.668019878763041,0,0,1.6544061302682,1.73743920712803,SESN2;GPR137
Regulation Of Interleukin-8 Production (GO:0032677),3/81,0.35683711780891,0.668496182245968,0,0,1.43200944928392,1.47565116012034,HYAL2;NOD1;RIGI
Cellular Response To Radiation (GO:0071478),2/48,0.359397277863889,0.668496182245968,0,0,1.61835748792271,1.6561087168566,IFI16;BRCA2
Cytoplasmic Microtubule Organization (GO:0031122),2/48,0.359397277863889,0.668496182245968,0,0,1.61835748792271,1.6561087168566,PLK3;STMN3
Positive Regulation Of Reactive Oxygen Species Metabolic Process (GO:2000379),2/48,0.359397277863889,0.668496182245968,0,0,1.61835748792271,1.6561087168566,DCXR;MMP8
Negative Regulation Of DNA-templated Transcription (GO:0045892),29/1025,0.361115822243424,0.668496182245968,0,0,1.08701472556894,1.10718595222503,SP100;RPL10;NOTCH4;NAB2;PRDM1;IFI16;TRIM28;CD38;HES1;ZNF589;SAMD1;MAF1;ZNF684;KLF10;PLK3;CBX5;SMAD3;RING1;STAT1;PARP9;PML;NR4A2;ETV7;TFEC;IRF7;ZNF675;ATF3;GZF1;MXD4
Regulation Of Cellular Respiration (GO:0043457),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,PNPT1
Regulation Of Glucose Transmembrane Transport (GO:0010827),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,OCLN
Regulation Of Inflammatory Response To Antigenic Stimulus (GO:0002861),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,RHBDF2
Regulation Of Mitotic Cell Cycle Spindle Assembly Checkpoint (GO:0090266),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,NDC80
cGMP-mediated Signaling (GO:0019934),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,PDE9A
Carboxylic Acid Biosynthetic Process (GO:0046394),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,NAIP
Cellular Response To Glucocorticoid Stimulus (GO:0071385),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,PCK2
Regulation Of Vacuole Organization (GO:0044088),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,SCARB2
Diol Biosynthetic Process (GO:0034312),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,GCH1
Embryonic Heart Tube Development (GO:0035050),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,HES1
Triglyceride Biosynthetic Process (GO:0019432),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,PCK2
Keratan Sulfate Metabolic Process (GO:0042339),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,B4GALT4
Leukocyte Tethering Or Rolling (GO:0050901),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,GCNT1
Membrane Lipid Metabolic Process (GO:0006643),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,B4GALT4
Mesenchyme Development (GO:0060485),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,BMPR2
Microtubule Depolymerization (GO:0007019),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,STMN3
Myeloid Cell Activation Involved In Immune Response (GO:0002275),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,IFI35
ncRNA Metabolic Process (GO:0034660),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,MEPCE
Negative Regulation Of Leukocyte Activation (GO:0002695),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,FCGR2B
Negative Regulation Of Ubiquitin-Protein Transferase Activity (GO:0051444),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,DTX3L
Neural Tube Development (GO:0021915),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,FUZ
Neuron Maturation (GO:0042551),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,PICK1
Nicotinamide Nucleotide Metabolic Process (GO:0046496),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,NMRK1
Peptidyl-Threonine Dephosphorylation (GO:0035970),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,PPM1K
Polyol Metabolic Process (GO:0019751),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,IMPA2
Positive Regulation Of SMAD Protein Signal Transduction (GO:0060391),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,BMPR2
Positive Regulation Of Cardiac Muscle Hypertrophy (GO:0010613),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,PDE9A
Positive Regulation Of Cartilage Development (GO:0061036),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,BMPR2
Positive Regulation Of Glial Cell Differentiation (GO:0045687),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,HES1
Positive Regulation Of Macrophage Activation (GO:0043032),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,MMP8
Positive Regulation Of Nitric-Oxide Synthase Activity (GO:0051000),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,GCH1
Positive Regulation Of Peptidyl-Lysine Acetylation (GO:2000758),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,DDX21
Positive Regulation Of Transcription From RNA Polymerase II Promoter In Response To Stress (GO:0036003),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,HSPA5
rRNA Modification (GO:0000154),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,TSR3
Regulation Of DNA-templated DNA Replication (GO:0090329),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,METTL4
Regulation Of Cartilage Development (GO:0061035),1/17,0.363340869932309,0.668496182245968,0,0,2.3255258126195,2.3543945405523,BMPR2
Erythrocyte Differentiation (GO:0030218),2/49,0.368871110305353,0.668496182245968,0,0,1.58384283035787,1.57957911045101,INHBA;SLC25A5
Unsaturated Fatty Acid Metabolic Process (GO:0033559),2/49,0.368871110305353,0.668496182245968,0,0,1.58384283035787,1.57957911045101,FAAH;GPX1
Neurogenesis (GO:0022008),2/49,0.368871110305353,0.668496182245968,0,0,1.58384283035787,1.57957911045101,METTL14;BTBD6
Positive Regulation Of miRNA Metabolic Process (GO:2000630),2/49,0.368871110305353,0.668496182245968,0,0,1.58384283035787,1.57957911045101,PNPT1;SMAD3
Positive Regulation Of Pathway-Restricted SMAD Protein Phosphorylation (GO:0010862),2/49,0.368871110305353,0.668496182245968,0,0,1.58384283035787,1.57957911045101,BMPR2;INHBA
Cellular Component Assembly (GO:0022607),8/260,0.372700061878288,0.668496182245968,0,0,1.18272425249169,1.16732672791785,OCLN;MYO7B;FANCA;RSPH9;HES1;LLGL1;PML;CD2AP
Regulation Of Protein Binding (GO:0043393),4/118,0.373584305220229,0.668496182245968,0,0,1.30647773279352,1.28637310875989,DNAJB2;DTX3L;IFIT1;IFIT2
Positive Regulation Of Cell Cycle Process (GO:0090068),4/118,0.373584305220229,0.668496182245968,0,0,1.30647773279352,1.28637310875989,PLSCR1;PRKCE;NCAPH2;NDC80
tRNA Processing (GO:0008033),2/50,0.378289275900843,0.668496182245968,0,0,1.5507662835249,1.50749384983556,SSB;ELP5
Mitotic Metaphase Plate Congression (GO:0007080),2/50,0.378289275900843,0.668496182245968,0,0,1.5507662835249,1.50749384983556,NDC80;CHMP5
Purine Ribonucleotide Metabolic Process (GO:0009150),3/84,0.378304427198528,0.668496182245968,0,0,1.3787587971849,1.3402308227583,ACOT9;AMPD2;PDE9A
3'-UTR-mediated mRNA Stabilization (GO:0070935),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,YBX3
Regulation Of Defense Response To Virus (GO:0050688),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,HERC5
Regulation Of Epithelial Cell Differentiation (GO:0030856),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,CEACAM1
Regulation Of Establishment Or Maintenance Of Cell Polarity (GO:0032878),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,LLGL1
Regulation Of Mitochondrial Membrane Permeability (GO:0046902),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,SLC25A5
Antigen Processing And Presentation Of Peptide Antigen Via MHC Class I (GO:0002474),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,TAP2
Regulation Of Oligodendrocyte Differentiation (GO:0048713),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,HES1
Cardiac Atrium Morphogenesis (GO:0003209),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,BMPR2
Cardiac Muscle Cell Contraction (GO:0086003),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,KCNJ2
Regulation Of Protein Neddylation (GO:2000434),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,GPS1
Cell Junction Maintenance (GO:0034331),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,PARD6A
Renal Absorption (GO:0070293),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,HYAL2
Response To Axon Injury (GO:0048678),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,MAPK8IP3
Response To Cholesterol (GO:0070723),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,GRAMD1B
Dendritic Cell Migration (GO:0036336),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,CCR1
Response To Organophosphorus (GO:0046683),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,STAT1
Endothelial Cell Proliferation (GO:0001935),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,BMPR2
Glucose 6-Phosphate Metabolic Process (GO:0051156),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,RBKS
Vesicle Transport Along Actin Filament (GO:0030050),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,MYO7B
Vesicle-Mediated Transport In Synapse (GO:0099003),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,OTOF
Icosanoid Biosynthetic Process (GO:0046456),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,NAIP
Intracellular Lipid Transport (GO:0032365),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,GRAMD1B
Lysosomal Lumen Acidification (GO:0007042),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,CLN6
Maintenance Of Gastrointestinal Epithelium (GO:0030277),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,STRAP
Membrane Repolarization (GO:0086009),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,KCNJ2
Mitotic Cytokinetic Process (GO:1902410),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,CHMP5
Negative Regulation Of ERBB Signaling Pathway (GO:1901185),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,RNF126
Negative Regulation Of Lipid Storage (GO:0010888),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,TTC39B
Neuromuscular Process (GO:0050905),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,GCH1
Neutrophil Activation (GO:0042119),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,CXCL8
Nucleosome Disassembly (GO:0006337),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,SMARCD3
Positive Regulation Of G Protein-Coupled Receptor Signaling Pathway (GO:0045745),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,NECAB2
Positive Regulation Of NLRP3 Inflammasome Complex Assembly (GO:1900227),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,GBP5
Positive Regulation Of Chromosome Segregation (GO:0051984),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,NCAPH2
Positive Regulation Of Cytokine Production Involved In Inflammatory Response (GO:1900017),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,GBP5
Positive Regulation Of Extracellular Matrix Organization (GO:1903055),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,SMAD3
Positive Regulation Of Interleukin-4 Production (GO:0032753),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,IRF4
Positive Regulation Of Monocyte Chemotaxis (GO:0090026),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,CCR1
Positive Regulation Of Neuroblast Proliferation (GO:0002052),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,SMARCD3
Positive Regulation Of Neutrophil Chemotaxis (GO:0090023),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,CXCL8
Positive Regulation Of Response To Endoplasmic Reticulum Stress (GO:1905898),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,FCGR2B
Positive Regulation Of Stress-Activated Protein Kinase Signaling Cascade (GO:0070304),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,EIF2AK2
Protein Autoprocessing (GO:0016540),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,F12
Protein Import Into Mitochondrial Matrix (GO:0030150),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,DNLZ
Regulation Of DNA Damage Checkpoint (GO:2000001),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,BRCA2
Regulation Of Cell-Cell Adhesion Mediated By Cadherin (GO:2000047),1/18,0.380035500865859,0.668496182245968,0,0,2.18861770329547,2.11746707089614,NOTCH4
Cellular Respiration (GO:0045333),3/85,0.3854285930646,0.672318976281154,0,0,1.36187444408033,1.29841018952321,NDUFA6;NDUFS7;CYC1
Macromolecule Catabolic Process (GO:0009057),3/85,0.3854285930646,0.672318976281154,0,0,1.36187444408033,1.29841018952321,PNPT1;TREX1;CLN6
SMAD Protein Signal Transduction (GO:0060395),2/51,0.387648189558133,0.672318976281154,0,0,1.51903979982798,1.43952881902504,SMAD3;INHBA
Regulation Of Stress-Activated MAPK Cascade (GO:0032872),2/51,0.387648189558133,0.672318976281154,0,0,1.51903979982798,1.43952881902504,EIF2AK2;MAPK8IP3
Metaphase Plate Congression (GO:0051310),2/51,0.387648189558133,0.672318976281154,0,0,1.51903979982798,1.43952881902504,NDC80;CHMP5
Negative Regulation Of MAP Kinase Activity (GO:0043407),2/51,0.387648189558133,0.672318976281154,0,0,1.51903979982798,1.43952881902504,HYAL2;ZNF675
Transcription By RNA Polymerase II (GO:0006366),6/192,0.389435479124079,0.672318976281154,0,0,1.20127039481878,1.13286654831608,ETV7;SNAPC2;TAF13;DDX21;GTF2H2;IRF9
Negative Regulation Of Angiogenesis (GO:0016525),3/86,0.392533557907746,0.672318976281154,0,0,1.3453969428578,1.25812541243229,STAT1;PML;EPN2
DNA Catabolic Process (GO:0006308),1/19,0.396293173814433,0.672318976281154,0,0,2.06692160611855,1.91314471324908,TREX1
RNA Destabilization (GO:0050779),1/19,0.396293173814433,0.672318976281154,0,0,2.06692160611855,1.91314471324908,METTL14
Regulation Of Lymphocyte Differentiation (GO:0045619),1/19,0.396293173814433,0.672318976281154,0,0,2.06692160611855,1.91314471324908,PRDM1
Regulation Of Megakaryocyte Differentiation (GO:0045652),1/19,0.396293173814433,0.672318976281154,0,0,2.06692160611855,1.91314471324908,PRMT1
Regulation Of Neuroinflammatory Response (GO:0150077),1/19,0.396293173814433,0.672318976281154,0,0,2.06692160611855,1.91314471324908,MMP8
Atrioventricular Valve Morphogenesis (GO:0003181),1/19,0.396293173814433,0.672318976281154,0,0,2.06692160611855,1.91314471324908,BMPR2
Cardiac Ventricle Development (GO:0003231),1/19,0.396293173814433,0.672318976281154,0,0,2.06692160611855,1.91314471324908,HES1
Regulation Of Protein-Containing Complex Disassembly (GO:0043244),1/19,0.396293173814433,0.672318976281154,0,0,2.06692160611855,1.91314471324908,SHFL
Regulation Of Smooth Muscle Cell Migration (GO:0014910),1/19,0.396293173814433,0.672318976281154,0,0,2.06692160611855,1.91314471324908,PLAU
Regulation Of Transcription Involved In G1/S Transition Of Mitotic Cell Cycle (GO:0000083),1/19,0.396293173814433,0.672318976281154,0,0,2.06692160611855,1.91314471324908,CDK17
Cellular Response To Misfolded Protein (GO:0071218),1/19,0.396293173814433,0.672318976281154,0,0,2.06692160611855,1.91314471324908,RNF126
Release Of Cytochrome C From Mitochondria (GO:0001836),1/19,0.396293173814433,0.672318976281154,0,0,2.06692160611855,1.91314471324908,IFI6
Dopamine Metabolic Process (GO:0042417),1/19,0.396293173814433,0.672318976281154,0,0,2.06692160611855,1.91314471324908,GCH1
Dopaminergic Neuron Differentiation (GO:0071542),1/19,0.396293173814433,0.672318976281154,0,0,2.06692160611855,1.91314471324908,NR4A2
Embryonic Digestive Tract Development (GO:0048566),1/19,0.396293173814433,0.672318976281154,0,0,2.06692160611855,1.91314471324908,PCSK5
Sphingosine Metabolic Process (GO:0006670),1/19,0.396293173814433,0.672318976281154,0,0,2.06692160611855,1.91314471324908,NAAA
Epithelial Structure Maintenance (GO:0010669),1/19,0.396293173814433,0.672318976281154,0,0,2.06692160611855,1.91314471324908,STRAP
Superoxide Anion Generation (GO:0042554),1/19,0.396293173814433,0.672318976281154,0,0,2.06692160611855,1.91314471324908,CYBB
Ganglioside Metabolic Process (GO:0001573),1/19,0.396293173814433,0.672318976281154,0,0,2.06692160611855,1.91314471324908,CLN6
Glycogen Metabolic Process (GO:0005977),1/19,0.396293173814433,0.672318976281154,0,0,2.06692160611855,1.91314471324908,GAA
Glycosphingolipid Biosynthetic Process (GO:0006688),1/19,0.396293173814433,0.672318976281154,0,0,2.06692160611855,1.91314471324908,B4GALT4
Vesicle Docking (GO:0048278),1/19,0.396293173814433,0.672318976281154,0,0,2.06692160611855,1.91314471324908,STX17
Immunoglobulin Production Involved In Immunoglobulin-Mediated Immune Response (GO:0002381),1/19,0.396293173814433,0.672318976281154,0,0,2.06692160611855,1.91314471324908,GAPT
Leukocyte Adhesion To Vascular Endothelial Cell (GO:0061756),1/19,0.396293173814433,0.672318976281154,0,0,2.06692160611855,1.91314471324908,GCNT1
Leukotriene Biosynthetic Process (GO:0019370),1/19,0.396293173814433,0.672318976281154,0,0,2.06692160611855,1.91314471324908,GGT5
Negative Regulation Of Fatty Acid Metabolic Process (GO:0045922),1/19,0.396293173814433,0.672318976281154,0,0,2.06692160611855,1.91314471324908,CEACAM1
Negative Regulation Of Telomere Maintenance Via Telomerase (GO:0032211),1/19,0.396293173814433,0.672318976281154,0,0,2.06692160611855,1.91314471324908,XRN1
Phosphatidylcholine Biosynthetic Process (GO:0006656),1/19,0.396293173814433,0.672318976281154,0,0,2.06692160611855,1.91314471324908,CHPT1
Pore Complex Assembly (GO:0046931),1/19,0.396293173814433,0.672318976281154,0,0,2.06692160611855,1.91314471324908,NUP205
Protein Insertion Into Membrane (GO:0051205),1/19,0.396293173814433,0.672318976281154,0,0,2.06692160611855,1.91314471324908,RTP4
Receptor Clustering (GO:0043113),1/19,0.396293173814433,0.672318976281154,0,0,2.06692160611855,1.91314471324908,PICK1
Regulation Of B Cell Differentiation (GO:0045577),1/19,0.396293173814433,0.672318976281154,0,0,2.06692160611855,1.91314471324908,INHBA
Regulation Of Acute Inflammatory Response (GO:0002673),1/19,0.396293173814433,0.672318976281154,0,0,2.06692160611855,1.91314471324908,F12
Regulation Of Behavior (GO:0050795),1/19,0.396293173814433,0.672318976281154,0,0,2.06692160611855,1.91314471324908,AIM2
Rho Protein Signal Transduction (GO:0007266),2/52,0.396944491475585,0.672318976281154,0,0,1.48858237547893,1.37538882707572,ARHGEF3;TAX1BP3
Arachidonic Acid Metabolic Process (GO:0019369),2/52,0.396944491475585,0.672318976281154,0,0,1.48858237547893,1.37538882707572,FAAH;GPX1
Cardiac Muscle Tissue Development (GO:0048738),2/52,0.396944491475585,0.672318976281154,0,0,1.48858237547893,1.37538882707572,BMPR2;PRMT1
Cartilage Development (GO:0051216),2/52,0.396944491475585,0.672318976281154,0,0,1.48858237547893,1.37538882707572,HYAL2;CREB3L2
Cellular Response To Ionizing Radiation (GO:0071479),2/52,0.396944491475585,0.672318976281154,0,0,1.48858237547893,1.37538882707572,IFI16;BRCA2
Positive Regulation Of B Cell Activation (GO:0050871),2/52,0.396944491475585,0.672318976281154,0,0,1.48858237547893,1.37538882707572,CD38;TNFSF13B
NADH Dehydrogenase Complex Assembly (GO:0010257),2/53,0.406175037930066,0.679634349369985,0,0,1.45931935992788,1.31480454617499,NDUFA6;NDUFS7
Regulation Of Macromolecule Biosynthetic Process (GO:0010556),2/53,0.406175037930066,0.679634349369985,0,0,1.45931935992788,1.31480454617499,RPL10;ELP5
Regulation Of Proteasomal Protein Catabolic Process (GO:0061136),2/53,0.406175037930066,0.679634349369985,0,0,1.45931935992788,1.31480454617499,GPX1;LAMP3
Regulation Of Receptor Signaling Pathway Via JAK-STAT (GO:0046425),2/53,0.406175037930066,0.679634349369985,0,0,1.45931935992788,1.31480454617499,TP53INP2;HES1
Cellular Response To Alcohol (GO:0097306),2/53,0.406175037930066,0.679634349369985,0,0,1.45931935992788,1.31480454617499,GRAMD1B;LARP1
Glycoprotein Metabolic Process (GO:0009100),2/53,0.406175037930066,0.679634349369985,0,0,1.45931935992788,1.31480454617499,GCNT1;FBXO6
Mitochondrial Respiratory Chain Complex I Assembly (GO:0032981),2/53,0.406175037930066,0.679634349369985,0,0,1.45931935992788,1.31480454617499,NDUFA6;NDUFS7
Mitochondrial Transport (GO:0006839),2/53,0.406175037930066,0.679634349369985,0,0,1.45931935992788,1.31480454617499,TIMM10;SLC25A5
Negative Regulation Of Metabolic Process (GO:0009892),2/53,0.406175037930066,0.679634349369985,0,0,1.45931935992788,1.31480454617499,IL18R1;MAP2K6
Proton Motive Force-Driven Mitochondrial ATP Synthesis (GO:0042776),2/53,0.406175037930066,0.679634349369985,0,0,1.45931935992788,1.31480454617499,NDUFA6;NDUFS7
DNA Unwinding Involved In DNA Replication (GO:0006268),1/20,0.412125304092849,0.679634349369985,0,0,1.95803562443393,1.73565728867145,RECQL5
Actin Filament-Based Transport (GO:0099515),1/20,0.412125304092849,0.679634349369985,0,0,1.95803562443393,1.73565728867145,MYO7B
Adenine Nucleotide Transport (GO:0051503),1/20,0.412125304092849,0.679634349369985,0,0,1.95803562443393,1.73565728867145,SLC25A5
Regulation Of Macrophage Chemotaxis (GO:0010758),1/20,0.412125304092849,0.679634349369985,0,0,1.95803562443393,1.73565728867145,C5
Regulation Of Mitotic Spindle Assembly (GO:1901673),1/20,0.412125304092849,0.679634349369985,0,0,1.95803562443393,1.73565728867145,CHMP5
Regulation Of Necroptotic Process (GO:0060544),1/20,0.412125304092849,0.679634349369985,0,0,1.95803562443393,1.73565728867145,YBX3
Regulation Of Protein Localization To Cell Periphery (GO:1904375),1/20,0.412125304092849,0.679634349369985,0,0,1.95803562443393,1.73565728867145,GBP1
Cellular Response To Copper Ion (GO:0071280),1/20,0.412125304092849,0.679634349369985,0,0,1.95803562443393,1.73565728867145,MT2A
Regulation Of Toll-Like Receptor Signaling Pathway (GO:0034121),1/20,0.412125304092849,0.679634349369985,0,0,1.95803562443393,1.73565728867145,IRF7
Cilium-Dependent Cell Motility (GO:0060285),1/20,0.412125304092849,0.679634349369985,0,0,1.95803562443393,1.73565728867145,RSPH9
Endoplasmic Reticulum Calcium Ion Homeostasis (GO:0032469),1/20,0.412125304092849,0.679634349369985,0,0,1.95803562443393,1.73565728867145,PML
Stress-Activated Protein Kinase Signaling Cascade (GO:0031098),1/20,0.412125304092849,0.679634349369985,0,0,1.95803562443393,1.73565728867145,MAP2K6
Hydrogen Peroxide Catabolic Process (GO:0042744),1/20,0.412125304092849,0.679634349369985,0,0,1.95803562443393,1.73565728867145,GPX1
Late Endosome To Vacuole Transport (GO:0045324),1/20,0.412125304092849,0.679634349369985,0,0,1.95803562443393,1.73565728867145,CHMP5
Limb Morphogenesis (GO:0035108),1/20,0.412125304092849,0.679634349369985,0,0,1.95803562443393,1.73565728867145,PCSK5
Lipopolysaccharide-Mediated Signaling Pathway (GO:0031663),1/20,0.412125304092849,0.679634349369985,0,0,1.95803562443393,1.73565728867145,PRKCE
Mesoderm Formation (GO:0001707),1/20,0.412125304092849,0.679634349369985,0,0,1.95803562443393,1.73565728867145,BMPR2
Negative Regulation Of Phosphate Metabolic Process (GO:0045936),1/20,0.412125304092849,0.679634349369985,0,0,1.95803562443393,1.73565728867145,INHBA
Negative Regulation Of Protein Localization To Cell Periphery (GO:1904376),1/20,0.412125304092849,0.679634349369985,0,0,1.95803562443393,1.73565728867145,GBP1
Negative Regulation Of Protein Localization To Plasma Membrane (GO:1903077),1/20,0.412125304092849,0.679634349369985,0,0,1.95803562443393,1.73565728867145,GBP1
Negative Regulation Of Small GTPase Mediated Signal Transduction (GO:0051058),1/20,0.412125304092849,0.679634349369985,0,0,1.95803562443393,1.73565728867145,CD2AP
Phosphatidylserine Metabolic Process (GO:0006658),1/20,0.412125304092849,0.679634349369985,0,0,1.95803562443393,1.73565728867145,PLSCR1
Positive Regulation Of Protein Processing (GO:0010954),1/20,0.412125304092849,0.679634349369985,0,0,1.95803562443393,1.73565728867145,F12
protein-DNA Complex Disassembly (GO:0032986),1/20,0.412125304092849,0.679634349369985,0,0,1.95803562443393,1.73565728867145,SMARCD3
Pulmonary Valve Development (GO:0003177),1/20,0.412125304092849,0.679634349369985,0,0,1.95803562443393,1.73565728867145,BMPR2
Regulation Of Transcription By RNA Polymerase II (GO:0006357),55/2028,0.413687992347754,0.680716725979339,0,0,1.04033989778859,0.918248968680263,ZNF496;BMPR2;PRDM1;HYAL2;CREB3L2;ZNF524;ZNF684;ZNF441;KLF10;BATF2;SP110;LMO2;PTOV1;PARP9;ETV7;PLSCR1;ELF1;IRF4;TFEC;IRF7;NCOA7;ZNF675;ATF3;IRF9;SP100;SMARCD3;RPL10;NOTCH4;SP140;NLRC5;DDX21;HELZ2;IFI16;HES1;ZNF589;SAMD1;ZSCAN18;HES4;PLK3;CBX5;SMAD3;STAT1;PCGF5;STAT2;GLMP;GTF2H2;INHBA;NR4A2;AGRN;SP140L;ZNF653;SSBP3;GZF1;RIGI;MXD4
Cellular Response To Chemical Stress (GO:0062197),3/89,0.413714138026712,0.680716725979339,0,0,1.29826362540731,1.14582155142227,GPX1;PNPT1;SESN2
Cellular Response To Peptide Hormone Stimulus (GO:0071375),3/89,0.413714138026712,0.680716725979339,0,0,1.29826362540731,1.14582155142227,NR4A2;CEACAM1;PCK2
Regulation Of Smooth Muscle Cell Proliferation (GO:0048660),2/54,0.415336892114918,0.681339171334584,0,0,1.43118184497495,1.25752982494702,BMPR2;STAT1
Mesenchymal Cell Differentiation (GO:0048762),2/54,0.415336892114918,0.681339171334584,0,0,1.43118184497495,1.25752982494702,TRIM28;NOTCH4
Monoatomic Anion Transmembrane Transport (GO:0098656),2/54,0.415336892114918,0.681339171334584,0,0,1.43118184497495,1.25752982494702,SLC5A6;APOL1
Negative Regulation Of Protein Ubiquitination (GO:0031397),2/54,0.415336892114918,0.681339171334584,0,0,1.43118184497495,1.25752982494702,DTX3L;ISG15
Positive Regulation Of Cell Migration (GO:0030335),8/272,0.42045601269389,0.689220559730253,0,0,1.12825933756166,0.97754127901041,CCR1;SRGAP2C;BMPR2;HSPA5;PLAU;PRKCE;ELP5;ACVR1B
Cellular Response To Fibroblast Growth Factor Stimulus (GO:0044344),2/55,0.424427315701822,0.690252801556077,0,0,1.40410612303911,1.20333932272106,CXCL8;HYAL2
Response To Peptide Hormone (GO:0043434),2/55,0.424427315701822,0.690252801556077,0,0,1.40410612303911,1.20333932272106,STAT1;STAT2
Regulation Of DNA-templated Transcription (GO:0006355),52/1922,0.424523016191342,0.690252801556077,0,0,1.03724281700353,0.888698293160816,ZNF496;BNC2;NAB2;PRDM1;BRCA2;TRIM28;CREB3L2;CD38;ZNF524;TRIM22;ZNF441;KLF10;BATF2;RING1;DTX3L;SP110;RHOH;PARP9;ETV7;ELF1;IRF4;TFEC;IRF7;NCOA7;ZNF675;ATF3;IRF9;SP100;SMARCD3;NOTCH4;SP140;ACVR1B;IFI16;TP53INP2;METTL4;HES1;ZSCAN18;HES4;CDK17;CBX5;SMAD3;STAT1;PCGF5;STAT2;GTF2H2;INHBA;PML;NR4A2;SP140L;ZNF653;GZF1;MXD4
Cytosolic Transport (GO:0016482),4/127,0.426871907414103,0.690252801556077,0,0,1.21031894934334,1.03030977742685,RNF126;VPS51;HEATR5B;ANKFY1
Regulation Of Dendritic Spine Development (GO:0060998),1/21,0.427543009591529,0.690252801556077,0,0,1.86003824091778,1.58047521581039,SRGAP2C
Regulation Of Lipopolysaccharide-Mediated Signaling Pathway (GO:0031664),1/21,0.427543009591529,0.690252801556077,0,0,1.86003824091778,1.58047521581039,TRIM5
Regulation Of Neurotransmitter Transport (GO:0051588),1/21,0.427543009591529,0.690252801556077,0,0,1.86003824091778,1.58047521581039,OTOF
Regulation Of Steroid Metabolic Process (GO:0019218),1/21,0.427543009591529,0.690252801556077,0,0,1.86003824091778,1.58047521581039,TTC39B
Regulation Of Transferase Activity (GO:0051338),1/21,0.427543009591529,0.690252801556077,0,0,1.86003824091778,1.58047521581039,NLRC5
snRNA Metabolic Process (GO:0016073),1/21,0.427543009591529,0.690252801556077,0,0,1.86003824091778,1.58047521581039,MEPCE
Lipid Catabolic Process (GO:0016042),1/21,0.427543009591529,0.690252801556077,0,0,1.86003824091778,1.58047521581039,STS
Macrophage Differentiation (GO:0030225),1/21,0.427543009591529,0.690252801556077,0,0,1.86003824091778,1.58047521581039,CASP10
Negative Regulation Of Biomineral Tissue Development (GO:0070168),1/21,0.427543009591529,0.690252801556077,0,0,1.86003824091778,1.58047521581039,CCR1
Negative Regulation Of Interleukin-2 Production (GO:0032703),1/21,0.427543009591529,0.690252801556077,0,0,1.86003824091778,1.58047521581039,GBP1
Plasma Membrane Repair (GO:0001778),1/21,0.427543009591529,0.690252801556077,0,0,1.86003824091778,1.58047521581039,CHMP5
Positive Regulation Of G2/M Transition Of Mitotic Cell Cycle (GO:0010971),1/21,0.427543009591529,0.690252801556077,0,0,1.86003824091778,1.58047521581039,TNFSF13B
Positive Regulation Of Granulocyte Chemotaxis (GO:0071624),1/21,0.427543009591529,0.690252801556077,0,0,1.86003824091778,1.58047521581039,CXCL8
Positive Regulation Of Transcription Regulatory Region DNA Binding (GO:2000679),1/21,0.427543009591529,0.690252801556077,0,0,1.86003824091778,1.58047521581039,TRIM6
Positive Regulation Of Translational Initiation (GO:0045948),1/21,0.427543009591529,0.690252801556077,0,0,1.86003824091778,1.58047521581039,LARP1
Protein Mannosylation (GO:0035268),1/21,0.427543009591529,0.690252801556077,0,0,1.86003824091778,1.58047521581039,FKRP
Lymphocyte Differentiation (GO:0030098),3/91,0.427704589822647,0.690252801556077,0,0,1.26862676670738,1.07747329817053,RHOH;DNAJB9;SLC25A5
Nucleotide-Excision Repair (GO:0006289),2/56,0.433443760229026,0.698999878425307,0,0,1.37803320561941,1.15202642422839,GTF2H2;BRCA2
Protein Targeting (GO:0006605),4/129,0.438574677607517,0.702828200600806,0,0,1.19083076923077,0.981512704235221,RTP4;AP4E1;TIMM10;YIF1B
Cytoplasmic Translation (GO:0002181),3/93,0.441575439297956,0.702828200600806,0,0,1.24030710172745,1.01383496675965,EIF4A1;RPL10;EIF3I
Chemokine-Mediated Signaling Pathway (GO:0070098),2/57,0.442383859351159,0.702828200600806,0,0,1.3529083942877,1.10340139393214,CCR1;CXCL8
NAD Metabolic Process (GO:0019674),1/22,0.442557118095211,0.702828200600806,0,0,1.77137394154603,1.44399878164824,NMRK1
Regulation Of Histone Acetylation (GO:0035065),1/22,0.442557118095211,0.702828200600806,0,0,1.77137394154603,1.44399878164824,DDX21
Regulation Of Regulatory T Cell Differentiation (GO:0045589),1/22,0.442557118095211,0.702828200600806,0,0,1.77137394154603,1.44399878164824,FANCA
Regulation Of Vascular Endothelial Growth Factor Receptor Signaling Pathway (GO:0030947),1/22,0.442557118095211,0.702828200600806,0,0,1.77137394154603,1.44399878164824,EPN2
Dendritic Cell Differentiation (GO:0097028),1/22,0.442557118095211,0.702828200600806,0,0,1.77137394154603,1.44399878164824,BATF2
Ribosomal Large Subunit Assembly (GO:0000027),1/22,0.442557118095211,0.702828200600806,0,0,1.77137394154603,1.44399878164824,RPL10
Mammary Gland Development (GO:0030879),1/22,0.442557118095211,0.702828200600806,0,0,1.77137394154603,1.44399878164824,NOTCH4
Membrane Protein Ectodomain Proteolysis (GO:0006509),1/22,0.442557118095211,0.702828200600806,0,0,1.77137394154603,1.44399878164824,SPPL2B
Natural Killer Cell Mediated Immunity (GO:0002228),1/22,0.442557118095211,0.702828200600806,0,0,1.77137394154603,1.44399878164824,MICA
Negative Regulation Of G Protein-Coupled Receptor Signaling Pathway (GO:0045744),1/22,0.442557118095211,0.702828200600806,0,0,1.77137394154603,1.44399878164824,CXCL8
Negative Regulation Of Extrinsic Apoptotic Signaling Pathway In Absence Of Ligand (GO:2001240),1/22,0.442557118095211,0.702828200600806,0,0,1.77137394154603,1.44399878164824,IFI6
Negative Regulation Of Macroautophagy (GO:0016242),1/22,0.442557118095211,0.702828200600806,0,0,1.77137394154603,1.44399878164824,RUBCN
Negative Regulation Of Myeloid Cell Differentiation (GO:0045638),1/22,0.442557118095211,0.702828200600806,0,0,1.77137394154603,1.44399878164824,PRMT1
Negative Regulation Of Signal Transduction In Absence Of Ligand (GO:1901099),1/22,0.442557118095211,0.702828200600806,0,0,1.77137394154603,1.44399878164824,IFI6
Peptidyl-Glutamic Acid Modification (GO:0018200),1/22,0.442557118095211,0.702828200600806,0,0,1.77137394154603,1.44399878164824,TTLL4
Positive Regulation Of Receptor Internalization (GO:0002092),1/22,0.442557118095211,0.702828200600806,0,0,1.77137394154603,1.44399878164824,PICK1
Positive Regulation Of Viral Life Cycle (GO:1903902),1/22,0.442557118095211,0.702828200600806,0,0,1.77137394154603,1.44399878164824,TRIM38
Protein Neddylation (GO:0045116),1/22,0.442557118095211,0.702828200600806,0,0,1.77137394154603,1.44399878164824,GPS1
Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0007178),4/130,0.444400446159309,0.705244186296294,0,0,1.18131868131868,0.958083965442527,SMAD3;BMPR2;INHBA;ACVR1B
Regulation Of MAPK Cascade (GO:0043408),6/204,0.445384310842158,0.706293729720729,0,0,1.12776412776413,0.912155643955248,DUSP2;CEACAM1;TRIM5;EIF2AK2;TNIK;MMP8
Retrograde Transport, Endosome To Golgi (GO:0042147),3/94,0.448462121450417,0.70963298119683,0,0,1.22661407690198,0.983659923374145,RNF126;VPS51;HEATR5B
Vesicle Organization (GO:0016050),3/94,0.448462121450417,0.70963298119683,0,0,1.22661407690198,0.983659923374145,PI4K2B;STX17;CHMP5
Muscle Contraction (GO:0006936),3/94,0.448462121450417,0.70963298119683,0,0,1.22661407690198,0.983659923374145,TMOD2;EMD;SNTB1
Regulation Of Phagocytosis (GO:0050764),2/58,0.45124542094406,0.710085250591301,0,0,1.32868089764641,1.05728974177536,PLSCR1;FCGR2B
Muscle Organ Development (GO:0007517),2/58,0.45124542094406,0.710085250591301,0,0,1.32868089764641,1.05728974177536,EMD;VAMP5
Positive Regulation Of Epithelial Cell Migration (GO:0010634),3/95,0.455314350494879,0.710085250591301,0,0,1.21321872652925,0.95452072274645,BMPR2;PRKCE;RIN2
Regulation Of Cellular Response To Transforming Growth Factor Beta Stimulus (GO:1903844),1/23,0.457178175038235,0.710085250591301,0,0,1.69077003302625,1.32333541358476,SMAD3
Regulation Of Centrosome Cycle (GO:0046605),1/23,0.457178175038235,0.710085250591301,0,0,1.69077003302625,1.32333541358476,CHMP5
Regulation Of Cholesterol Metabolic Process (GO:0090181),1/23,0.457178175038235,0.710085250591301,0,0,1.69077003302625,1.32333541358476,TTC39B
Regulation Of Cholesterol Transport (GO:0032374),1/23,0.457178175038235,0.710085250591301,0,0,1.69077003302625,1.32333541358476,TTC39B
Regulation Of Interleukin-4 Production (GO:0032673),1/23,0.457178175038235,0.710085250591301,0,0,1.69077003302625,1.32333541358476,IRF4
Cellular Lipid Catabolic Process (GO:0044242),1/23,0.457178175038235,0.710085250591301,0,0,1.69077003302625,1.32333541358476,FAAH
Rescue Of Stalled Ribosome (GO:0072344),1/23,0.457178175038235,0.710085250591301,0,0,1.69077003302625,1.32333541358476,ZNF598
Response To BMP (GO:0071772),1/23,0.457178175038235,0.710085250591301,0,0,1.69077003302625,1.32333541358476,BMPR2
Endocardial Cushion Development (GO:0003197),1/23,0.457178175038235,0.710085250591301,0,0,1.69077003302625,1.32333541358476,BMPR2
Entrainment Of Circadian Clock By Photoperiod (GO:0043153),1/23,0.457178175038235,0.710085250591301,0,0,1.69077003302625,1.32333541358476,PML
Glial Cell Development (GO:0021782),1/23,0.457178175038235,0.710085250591301,0,0,1.69077003302625,1.32333541358476,PICK1
Heparan Sulfate Proteoglycan Biosynthetic Process (GO:0015012),1/23,0.457178175038235,0.710085250591301,0,0,1.69077003302625,1.32333541358476,HS6ST1
Negative Regulation Of Epidermal Growth Factor Receptor Signaling Pathway (GO:0042059),1/23,0.457178175038235,0.710085250591301,0,0,1.69077003302625,1.32333541358476,RNF126
Negative Regulation Of Extrinsic Apoptotic Signaling Pathway Via Death Domain Receptors (GO:1902042),1/23,0.457178175038235,0.710085250591301,0,0,1.69077003302625,1.32333541358476,GPX1
Negative Regulation Of Neuron Differentiation (GO:0045665),1/23,0.457178175038235,0.710085250591301,0,0,1.69077003302625,1.32333541358476,HES1
Negative Regulation Of Protein Tyrosine Kinase Activity (GO:0061099),1/23,0.457178175038235,0.710085250591301,0,0,1.69077003302625,1.32333541358476,HYAL2
Nuclear Membrane Reassembly (GO:0031468),1/23,0.457178175038235,0.710085250591301,0,0,1.69077003302625,1.32333541358476,CHMP5
Positive Regulation Of Lamellipodium Assembly (GO:0010592),1/23,0.457178175038235,0.710085250591301,0,0,1.69077003302625,1.32333541358476,OCLN
Positive Regulation Of Neutrophil Migration (GO:1902624),1/23,0.457178175038235,0.710085250591301,0,0,1.69077003302625,1.32333541358476,CXCL8
Potassium Ion Homeostasis (GO:0055075),1/23,0.457178175038235,0.710085250591301,0,0,1.69077003302625,1.32333541358476,KCNJ2
Protein Alkylation (GO:0008213),1/23,0.457178175038235,0.710085250591301,0,0,1.69077003302625,1.32333541358476,PRMT1
Protein Targeting To ER (GO:0045047),1/23,0.457178175038235,0.710085250591301,0,0,1.69077003302625,1.32333541358476,UBL4A
Regulation Of Cardiac Muscle Hypertrophy (GO:0010611),1/23,0.457178175038235,0.710085250591301,0,0,1.69077003302625,1.32333541358476,PDE9A
Aerobic Respiration (GO:0009060),2/59,0.460026419543427,0.711984352508909,0,0,1.30530348860657,1.01353077156273,NDUFA6;NDUFS7
Cellular Response To Chemokine (GO:1990869),2/59,0.460026419543427,0.711984352508909,0,0,1.30530348860657,1.01353077156273,CCR1;CXCL8
Chordate Embryonic Development (GO:0043009),2/59,0.460026419543427,0.711984352508909,0,0,1.30530348860657,1.01353077156273,FUZ;PCSK5
Microtubule Cytoskeleton Organization Involved In Mitosis (GO:1902850),2/59,0.460026419543427,0.711984352508909,0,0,1.30530348860657,1.01353077156273,PLK3;NDC80
Regulation Of Cell Death (GO:0010941),2/59,0.460026419543427,0.711984352508909,0,0,1.30530348860657,1.01353077156273,HP;CHMP5
Regulation Of Protein Metabolic Process (GO:0051246),3/96,0.462130729681023,0.713477558769473,0,0,1.20011144820754,0.926374983602943,RPL10;INHBA;ELP5
Positive Regulation Of Supramolecular Fiber Organization (GO:1902905),3/96,0.462130729681023,0.713477558769473,0,0,1.20011144820754,0.926374983602943,OCLN;GPX1;PRKCE
Response To Light Stimulus (GO:0009416),2/60,0.468724989283299,0.713477558769473,0,0,1.28273219711983,0.971976288400744,GTF2H2;TNFSF13B
Proton Motive Force-Driven ATP Synthesis (GO:0015986),2/60,0.468724989283299,0.713477558769473,0,0,1.28273219711983,0.971976288400744,NDUFA6;NDUFS7
Monocarboxylic Acid Metabolic Process (GO:0032787),3/97,0.468909918870747,0.713477558769473,0,0,1.187283048148,0.899182404737456,GGT5;NAAA;ALKBH7
Regulation Of Cysteine-Type Endopeptidase Activity (GO:2000116),1/24,0.471416450931245,0.713477558769473,0,0,1.61717516002993,1.21613737603087,IFI16
Regulation Of Cytokine Production Involved In Immune Response (GO:0002718),1/24,0.471416450931245,0.713477558769473,0,0,1.61717516002993,1.21613737603087,TRIM6
Regulation Of Cytoplasmic Translation (GO:2000765),1/24,0.471416450931245,0.713477558769473,0,0,1.61717516002993,1.21613737603087,YBX3
Regulation Of Endoplasmic Reticulum Stress-Induced Intrinsic Apoptotic Signaling Pathway (GO:1902235),1/24,0.471416450931245,0.713477558769473,0,0,1.61717516002993,1.21613737603087,FCGR2B
Regulation Of Heterotypic Cell-Cell Adhesion (GO:0034114),1/24,0.471416450931245,0.713477558769473,0,0,1.61717516002993,1.21613737603087,IL1RN
Acylglycerol Catabolic Process (GO:0046464),1/24,0.471416450931245,0.713477558769473,0,0,1.61717516002993,1.21613737603087,FAAH
Regulation Of Neuroblast Proliferation (GO:1902692),1/24,0.471416450931245,0.713477558769473,0,0,1.61717516002993,1.21613737603087,SMARCD3
Regulation Of Supramolecular Fiber Organization (GO:1902903),1/24,0.471416450931245,0.713477558769473,0,0,1.61717516002993,1.21613737603087,GPX1
Response To Copper Ion (GO:0046688),1/24,0.471416450931245,0.713477558769473,0,0,1.61717516002993,1.21613737603087,MT2A
Response To Purine-Containing Compound (GO:0014074),1/24,0.471416450931245,0.713477558769473,0,0,1.61717516002993,1.21613737603087,STAT1
Dicarboxylic Acid Transport (GO:0006835),1/24,0.471416450931245,0.713477558769473,0,0,1.61717516002993,1.21613737603087,SLC26A8
Endosome Transport Via Multivesicular Body Sorting Pathway (GO:0032509),1/24,0.471416450931245,0.713477558769473,0,0,1.61717516002993,1.21613737603087,CHMP5
Gliogenesis (GO:0042063),1/24,0.471416450931245,0.713477558769473,0,0,1.61717516002993,1.21613737603087,METTL14
mRNA Polyadenylation (GO:0006378),1/24,0.471416450931245,0.713477558769473,0,0,1.61717516002993,1.21613737603087,PNPT1
Mononuclear Cell Differentiation (GO:1903131),1/24,0.471416450931245,0.713477558769473,0,0,1.61717516002993,1.21613737603087,IFI16
Natural Killer Cell Mediated Cytotoxicity (GO:0042267),1/24,0.471416450931245,0.713477558769473,0,0,1.61717516002993,1.21613737603087,MICA
Negative Regulation Of Ion Transmembrane Transporter Activity (GO:0032413),1/24,0.471416450931245,0.713477558769473,0,0,1.61717516002993,1.21613737603087,PRKCE
Negative Regulation Of Ossification (GO:0030279),1/24,0.471416450931245,0.713477558769473,0,0,1.61717516002993,1.21613737603087,CCR1
Outflow Tract Septum Morphogenesis (GO:0003148),1/24,0.471416450931245,0.713477558769473,0,0,1.61717516002993,1.21613737603087,BMPR2
Peroxisome Organization (GO:0007031),1/24,0.471416450931245,0.713477558769473,0,0,1.61717516002993,1.21613737603087,TMEM135
Photoperiodism (GO:0009648),1/24,0.471416450931245,0.713477558769473,0,0,1.61717516002993,1.21613737603087,PML
Positive Regulation Of Cell Cycle G2/M Phase Transition (GO:1902751),1/24,0.471416450931245,0.713477558769473,0,0,1.61717516002993,1.21613737603087,TNFSF13B
Positive Regulation Of p38MAPK Cascade (GO:1900745),1/24,0.471416450931245,0.713477558769473,0,0,1.61717516002993,1.21613737603087,PRMT1
Positive Regulation Of Peptidyl-Threonine Phosphorylation (GO:0010800),1/24,0.471416450931245,0.713477558769473,0,0,1.61717516002993,1.21613737603087,TRIM6
Positive Regulation Of Vascular Endothelial Growth Factor Production (GO:0010575),1/24,0.471416450931245,0.713477558769473,0,0,1.61717516002993,1.21613737603087,C5
Protein Kinase B Signaling (GO:0043491),1/24,0.471416450931245,0.713477558769473,0,0,1.61717516002993,1.21613737603087,PLK3
Regulation Of Actin Nucleation (GO:0051125),1/24,0.471416450931245,0.713477558769473,0,0,1.61717516002993,1.21613737603087,PICK1
Phosphatidylinositol Biosynthetic Process (GO:0006661),3/98,0.475650633224913,0.716532805385752,0,0,1.17472471966865,0.872904645193257,PI4K2B;PIGQ;TP53INP2
BMP Signaling Pathway (GO:0030509),2/61,0.477339416937361,0.716532805385752,0,0,1.26092603415806,0.932489446493153,BMPR2;INHBA
Regulation Of Pathway-Restricted SMAD Protein Phosphorylation (GO:0060393),2/61,0.477339416937361,0.716532805385752,0,0,1.26092603415806,0.932489446493153,BMPR2;INHBA
Fatty Acid Catabolic Process (GO:0009062),2/61,0.477339416937361,0.716532805385752,0,0,1.26092603415806,0.932489446493153,FAAH;ECI1
Positive Regulation Of Organelle Assembly (GO:1902117),2/61,0.477339416937361,0.716532805385752,0,0,1.26092603415806,0.932489446493153,PPP1R35;FUZ
Axon Development (GO:0061564),3/99,0.482351642590649,0.716532805385752,0,0,1.16242802303263,0.84750521069863,NTNG2;MAPK8IP3;LLGL1
Positive Regulation Of Macromolecule Metabolic Process (GO:0010604),10/364,0.48449094591467,0.716532805385752,0,0,1.05091340763701,0.76155126888754,OCLN;PLSCR1;SMAD3;BMPR2;CXCL8;DTX3L;LAMP3;INHBA;MMP8;RIGI
RNA Polyadenylation (GO:0043631),1/25,0.485281948282218,0.716532805385752,0,0,1.54971319311663,1.120481722841,PNPT1
Regulation Of Monocyte Chemotaxis (GO:0090025),1/25,0.485281948282218,0.716532805385752,0,0,1.54971319311663,1.120481722841,CCR1
Regulation Of Neutrophil Chemotaxis (GO:0090022),1/25,0.485281948282218,0.716532805385752,0,0,1.54971319311663,1.120481722841,CXCL8
Regulation Of Platelet Aggregation (GO:0090330),1/25,0.485281948282218,0.716532805385752,0,0,1.54971319311663,1.120481722841,CEACAM1
Regulation Of Postsynapse Organization (GO:0099175),1/25,0.485281948282218,0.716532805385752,0,0,1.54971319311663,1.120481722841,FCGR2B
Regulation Of Protein Processing (GO:0070613),1/25,0.485281948282218,0.716532805385752,0,0,1.54971319311663,1.120481722841,PLAU
Cellular Response To Hexose Stimulus (GO:0071331),1/25,0.485281948282218,0.716532805385752,0,0,1.54971319311663,1.120481722841,PCK2
Response To dsRNA (GO:0043331),1/25,0.485281948282218,0.716532805385752,0,0,1.54971319311663,1.120481722841,RIGI
Response To Zinc Ion (GO:0010043),1/25,0.485281948282218,0.716532805385752,0,0,1.54971319311663,1.120481722841,MT2A
Ribonucleoside Bisphosphate Metabolic Process (GO:0033875),1/25,0.485281948282218,0.716532805385752,0,0,1.54971319311663,1.120481722841,ACOT9
Sterol Transport (GO:0015918),1/25,0.485281948282218,0.716532805385752,0,0,1.54971319311663,1.120481722841,GRAMD1B
Wound Healing, Spreading Of Cells (GO:0044319),1/25,0.485281948282218,0.716532805385752,0,0,1.54971319311663,1.120481722841,CEACAM1
Late Endosome To Vacuole Transport Via Multivesicular Body Sorting Pathway (GO:0032511),1/25,0.485281948282218,0.716532805385752,0,0,1.54971319311663,1.120481722841,CHMP5
Mismatch Repair (GO:0006298),1/25,0.485281948282218,0.716532805385752,0,0,1.54971319311663,1.120481722841,TREX1
Mitotic Cell Cycle Checkpoint Signaling (GO:0007093),1/25,0.485281948282218,0.716532805385752,0,0,1.54971319311663,1.120481722841,PLK3
Negative Regulation Of Intracellular Protein Transport (GO:0090317),1/25,0.485281948282218,0.716532805385752,0,0,1.54971319311663,1.120481722841,SP100
Negative Regulation Of Lipid Biosynthetic Process (GO:0051055),1/25,0.485281948282218,0.716532805385752,0,0,1.54971319311663,1.120481722841,CEACAM1
Negative Regulation Of Protein Localization To Membrane (GO:1905476),1/25,0.485281948282218,0.716532805385752,0,0,1.54971319311663,1.120481722841,GBP1
Negative Regulation Of Response To Wounding (GO:1903035),1/25,0.485281948282218,0.716532805385752,0,0,1.54971319311663,1.120481722841,SIGLEC10
Negative Regulation Of Telomere Maintenance Via Telomere Lengthening (GO:1904357),1/25,0.485281948282218,0.716532805385752,0,0,1.54971319311663,1.120481722841,XRN1
Peptide Hormone Secretion (GO:0030072),1/25,0.485281948282218,0.716532805385752,0,0,1.54971319311663,1.120481722841,EXOC3L1
Positive Regulation Of Glucose Import (GO:0046326),1/25,0.485281948282218,0.716532805385752,0,0,1.54971319311663,1.120481722841,OCLN
Positive Regulation Of Interleukin-2 Production (GO:0032743),1/25,0.485281948282218,0.716532805385752,0,0,1.54971319311663,1.120481722841,IRF4
Positive Regulation Of Release Of Cytochrome C From Mitochondria (GO:0090200),1/25,0.485281948282218,0.716532805385752,0,0,1.54971319311663,1.120481722841,TNFSF10
Proteoglycan Metabolic Process (GO:0006029),1/25,0.485281948282218,0.716532805385752,0,0,1.54971319311663,1.120481722841,BMPR2
Purine Nucleoside Bisphosphate Metabolic Process (GO:0034032),1/25,0.485281948282218,0.716532805385752,0,0,1.54971319311663,1.120481722841,ACOT9
Purine Ribonucleotide Catabolic Process (GO:0009154),1/25,0.485281948282218,0.716532805385752,0,0,1.54971319311663,1.120481722841,PDE9A
Regulation Of B Cell Activation (GO:0050864),1/25,0.485281948282218,0.716532805385752,0,0,1.54971319311663,1.120481722841,FCGR2B
Cell Junction Organization (GO:0034330),2/62,0.485868135158832,0.716532805385752,0,0,1.23984674329502,0.894943719775426,OCLN;SMAD3
Negative Regulation Of Kinase Activity (GO:0033673),2/62,0.485868135158832,0.716532805385752,0,0,1.23984674329502,0.894943719775426,CEACAM1;TRIB2
Protein Lipidation (GO:0006497),2/62,0.485868135158832,0.716532805385752,0,0,1.23984674329502,0.894943719775426,PIGQ;TP53INP2
Response To UV (GO:0009411),3/100,0.489011770256525,0.720683564509953,0,0,1.15038486653343,0.822949349183397,GPX1;GTF2H2;TNFSF13B
G1/S Transition Of Mitotic Cell Cycle (GO:0000082),2/63,0.494309716041129,0.721968179410781,0,0,1.21945857672257,0.859221980241091,CDK17;PLK3
Inorganic Anion Transmembrane Transport (GO:0098661),2/63,0.494309716041129,0.721968179410781,0,0,1.21945857672257,0.859221980241091,SLC5A6;APOL1
Oxidative Phosphorylation (GO:0006119),2/63,0.494309716041129,0.721968179410781,0,0,1.21945857672257,0.859221980241091,NDUFA6;NDUFS7
Protein Polymerization (GO:0051258),2/63,0.494309716041129,0.721968179410781,0,0,1.21945857672257,0.859221980241091,TRIM6;PSTPIP2
Hemopoiesis (GO:0030097),3/101,0.495629892111485,0.721968179410781,0,0,1.1385874887383,0.799203952178202,IFI16;NOTCH4;INHBA
Proteolysis (GO:0006508),9/330,0.498754943939246,0.721968179410781,0,0,1.04282732964341,0.725432818812624,GGT5;PLAU;CLPP;F12;SPPL2B;OLR1;FBXO6;MMP8;PCSK5
Regulation Of Fatty Acid Biosynthetic Process (GO:0042304),1/26,0.498784408880599,0.721968179410781,0,0,1.48764818355641,1.03478029155917,CEACAM1
Antigen Processing And Presentation Of Exogenous Peptide Antigen Via MHC Class II (GO:0019886),1/26,0.498784408880599,0.721968179410781,0,0,1.48764818355641,1.03478029155917,FCGR2B
Regulation Of Myeloid Cell Differentiation (GO:0045637),1/26,0.498784408880599,0.721968179410781,0,0,1.48764818355641,1.03478029155917,PRMT1
Regulation Of Nucleotide-Excision Repair (GO:2000819),1/26,0.498784408880599,0.721968179410781,0,0,1.48764818355641,1.03478029155917,SMARCD3
Regulation Of Reactive Oxygen Species Biosynthetic Process (GO:1903426),1/26,0.498784408880599,0.721968179410781,0,0,1.48764818355641,1.03478029155917,MMP8
Regulation Of Vascular Endothelial Growth Factor Production (GO:0010574),1/26,0.498784408880599,0.721968179410781,0,0,1.48764818355641,1.03478029155917,C5
Cellular Response To Xenobiotic Stimulus (GO:0071466),1/26,0.498784408880599,0.721968179410781,0,0,1.48764818355641,1.03478029155917,AIM2
Regulation Of Vasoconstriction (GO:0019229),1/26,0.498784408880599,0.721968179410781,0,0,1.48764818355641,1.03478029155917,BMPR2
Response To Glucocorticoid (GO:0051384),1/26,0.498784408880599,0.721968179410781,0,0,1.48764818355641,1.03478029155917,IL1RN
Dendritic Spine Organization (GO:0097061),1/26,0.498784408880599,0.721968179410781,0,0,1.48764818355641,1.03478029155917,PICK1
Spindle Assembly Checkpoint Signaling (GO:0071173),1/26,0.498784408880599,0.721968179410781,0,0,1.48764818355641,1.03478029155917,NDC80
Meiosis I (GO:0007127),1/26,0.498784408880599,0.721968179410781,0,0,1.48764818355641,1.03478029155917,MEI1
miRNA-mediated Gene Silencing (GO:0035195),1/26,0.498784408880599,0.721968179410781,0,0,1.48764818355641,1.03478029155917,MOV10
Mitotic Spindle Assembly Checkpoint Signaling (GO:0007094),1/26,0.498784408880599,0.721968179410781,0,0,1.48764818355641,1.03478029155917,NDC80
Mitotic Spindle Checkpoint Signaling (GO:0071174),1/26,0.498784408880599,0.721968179410781,0,0,1.48764818355641,1.03478029155917,NDC80
Negative Regulation Of Lipid Metabolic Process (GO:0045833),1/26,0.498784408880599,0.721968179410781,0,0,1.48764818355641,1.03478029155917,CEACAM1
Organelle Membrane Fusion (GO:0090174),1/26,0.498784408880599,0.721968179410781,0,0,1.48764818355641,1.03478029155917,STX17
Plasma Membrane Invagination (GO:0099024),1/26,0.498784408880599,0.721968179410781,0,0,1.48764818355641,1.03478029155917,FCGR2B
Positive Regulation Of Microtubule Polymerization Or Depolymerization (GO:0031112),1/26,0.498784408880599,0.721968179410781,0,0,1.48764818355641,1.03478029155917,OCLN
Positive Regulation Of Monooxygenase Activity (GO:0032770),1/26,0.498784408880599,0.721968179410781,0,0,1.48764818355641,1.03478029155917,GCH1
Protein Targeting To Lysosome (GO:0006622),1/26,0.498784408880599,0.721968179410781,0,0,1.48764818355641,1.03478029155917,SCARB2
Negative Regulation Of Wnt Signaling Pathway (GO:0030178),4/140,0.501488376474592,0.725402605336431,0,0,1.09389140271493,0.754976334092646,RNF213;FUZ;TAX1BP3;EMD
Response To Metal Ion (GO:0010038),2/64,0.50266286503287,0.726142265449858,0,0,1.19972809294278,0.825215671102514,PLSCR1;IMPA2
Positive Regulation Of T Cell Differentiation (GO:0045582),2/64,0.50266286503287,0.726142265449858,0,0,1.19972809294278,0.825215671102514,SMARCD3;RHOH
Regulation Of Chromatin Organization (GO:1902275),1/27,0.511933320291614,0.73324654770349,0,0,1.43035740550081,0.957711386355235,METTL4
Regulation Of Microtubule Polymerization Or Depolymerization (GO:0031110),1/27,0.511933320291614,0.73324654770349,0,0,1.43035740550081,0.957711386355235,STMN3
Regulation Of Mitochondrial Fission (GO:0090140),1/27,0.511933320291614,0.73324654770349,0,0,1.43035740550081,0.957711386355235,STAT2
Cellular Response To Acid Chemical (GO:0071229),1/27,0.511933320291614,0.73324654770349,0,0,1.43035740550081,0.957711386355235,SESN2
Respiratory Tube Development (GO:0030323),1/27,0.511933320291614,0.73324654770349,0,0,1.43035740550081,0.957711386355235,PCSK5
Clathrin-Dependent Endocytosis (GO:0072583),1/27,0.511933320291614,0.73324654770349,0,0,1.43035740550081,0.957711386355235,SIGLEC1
Dorsal/Ventral Pattern Formation (GO:0009953),1/27,0.511933320291614,0.73324654770349,0,0,1.43035740550081,0.957711386355235,FBXL15
Microtubule Polymerization Or Depolymerization (GO:0031109),1/27,0.511933320291614,0.73324654770349,0,0,1.43035740550081,0.957711386355235,STMN3
Negative Regulation Of NIK/NF-kappaB Signaling (GO:1901223),1/27,0.511933320291614,0.73324654770349,0,0,1.43035740550081,0.957711386355235,IFI35
Positive Regulation Of Immune System Process (GO:0002684),1/27,0.511933320291614,0.73324654770349,0,0,1.43035740550081,0.957711386355235,RSAD2
Positive Regulation Of Mitotic Cell Cycle (GO:0045931),1/27,0.511933320291614,0.73324654770349,0,0,1.43035740550081,0.957711386355235,HES1
Protein Quality Control For Misfolded Or Incompletely Synthesized Proteins (GO:0006515),1/27,0.511933320291614,0.73324654770349,0,0,1.43035740550081,0.957711386355235,CLPP
Regulation Of SMAD Protein Signal Transduction (GO:0060390),1/27,0.511933320291614,0.73324654770349,0,0,1.43035740550081,0.957711386355235,BMPR2
Proteasomal Protein Catabolic Process (GO:0010498),6/220,0.518085058663613,0.73901996800018,0,0,1.04257929491574,0.685616663263891,PSMB6;KLHDC3;RNF126;UBXN11;PML;TNFSF13B
Regulation Of Intracellular Signal Transduction (GO:1902531),8/297,0.518435697605907,0.73901996800018,0,0,1.02931788310399,0.676199344068898,PLK3;TRIM6;CEACAM1;VWF;ARHGEF3;TNIK;GBP1;MAP2K6
Cellular Response To BMP Stimulus (GO:0071773),2/66,0.519099319622804,0.73901996800018,0,0,1.16211685823755,0.761953593700928,BMPR2;INHBA
Intrinsic Apoptotic Signaling Pathway (GO:0097193),3/105,0.521661624164015,0.73901996800018,0,0,1.09371118889014,0.711717387338827,IFI16;IFI6;PML
Negative Regulation Of MAPK Cascade (GO:0043409),3/105,0.521661624164015,0.73901996800018,0,0,1.09371118889014,0.711717387338827,DUSP2;HYAL2;GBP1
Golgi To Plasma Membrane Protein Transport (GO:0043001),1/28,0.524737922484146,0.73901996800018,0,0,1.37731038878266,0.8881673312559,VAMP5
RNA Phosphodiester Bond Hydrolysis (GO:0090501),1/28,0.524737922484146,0.73901996800018,0,0,1.37731038878266,0.8881673312559,XRN1
Regulation Of Lipid Biosynthetic Process (GO:0046890),1/28,0.524737922484146,0.73901996800018,0,0,1.37731038878266,0.8881673312559,CEACAM1
Antigen Processing And Presentation Of Peptide Antigen Via MHC Class II (GO:0002495),1/28,0.524737922484146,0.73901996800018,0,0,1.37731038878266,0.8881673312559,FCGR2B
Regulation Of Monoatomic Ion Transport (GO:0043269),1/28,0.524737922484146,0.73901996800018,0,0,1.37731038878266,0.8881673312559,KCNJ2
Regulation Of Nitric-Oxide Synthase Activity (GO:0050999),1/28,0.524737922484146,0.73901996800018,0,0,1.37731038878266,0.8881673312559,GCH1
Cellular Response To Osmotic Stress (GO:0071470),1/28,0.524737922484146,0.73901996800018,0,0,1.37731038878266,0.8881673312559,YBX3
Fatty Acid Derivative Biosynthetic Process (GO:1901570),1/28,0.524737922484146,0.73901996800018,0,0,1.37731038878266,0.8881673312559,GGT5
Transcription By RNA Polymerase III (GO:0006383),1/28,0.524737922484146,0.73901996800018,0,0,1.37731038878266,0.8881673312559,SNAPC2
Hematopoietic Progenitor Cell Differentiation (GO:0002244),1/28,0.524737922484146,0.73901996800018,0,0,1.37731038878266,0.8881673312559,INHBA
Limb Development (GO:0060173),1/28,0.524737922484146,0.73901996800018,0,0,1.37731038878266,0.8881673312559,PCSK5
Membrane Fusion (GO:0061025),1/28,0.524737922484146,0.73901996800018,0,0,1.37731038878266,0.8881673312559,OTOF
Negative Regulation Of Mitotic Metaphase/Anaphase Transition (GO:0045841),1/28,0.524737922484146,0.73901996800018,0,0,1.37731038878266,0.8881673312559,NDC80
Nuclear-Transcribed mRNA Catabolic Process, Nonsense-Mediated Decay (GO:0000184),1/28,0.524737922484146,0.73901996800018,0,0,1.37731038878266,0.8881673312559,EIF4A3
Primary Neural Tube Formation (GO:0014020),1/28,0.524737922484146,0.73901996800018,0,0,1.37731038878266,0.8881673312559,FUZ
Protein Depolymerization (GO:0051261),1/28,0.524737922484146,0.73901996800018,0,0,1.37731038878266,0.8881673312559,STMN3
Protein Insertion Into Mitochondrial Membrane (GO:0051204),1/28,0.524737922484146,0.73901996800018,0,0,1.37731038878266,0.8881673312559,TIMM10
Protein Localization To Golgi Apparatus (GO:0034067),1/28,0.524737922484146,0.73901996800018,0,0,1.37731038878266,0.8881673312559,GBP5
Pyroptosis (GO:0070269),1/28,0.524737922484146,0.73901996800018,0,0,1.37731038878266,0.8881673312559,NAIP
Regulation Of Bone Resorption (GO:0045124),1/28,0.524737922484146,0.73901996800018,0,0,1.37731038878266,0.8881673312559,GPR137
Regulation Of Calcium Ion-Dependent Exocytosis (GO:0017158),1/28,0.524737922484146,0.73901996800018,0,0,1.37731038878266,0.8881673312559,RPH3A
tRNA Modification (GO:0006400),2/67,0.52718064968994,0.741506501490668,0,0,1.14417919245505,0.732517249610798,SSB;ELP5
Negative Regulation Of Cellular Catabolic Process (GO:0031330),2/67,0.52718064968994,0.741506501490668,0,0,1.14417919245505,0.732517249610798,RUBCN;HP
Positive Regulation Of T Cell Activation (GO:0050870),3/107,0.534399924912211,0.744139026008315,0,0,1.07256754761553,0.672082406135471,CD274;SMARCD3;RHOH
Regulation Of Cold-Induced Thermogenesis (GO:0120161),4/146,0.534490600549693,0.744139026008315,0,0,1.04734561213434,0.656100373136247,IRF4;G0S2;IL18R1;MAP2K6
Negative Regulation Of Response To External Stimulus (GO:0032102),4/146,0.534490600549693,0.744139026008315,0,0,1.04734561213434,0.656100373136247,IFI16;TREX1;DHX58;TRAFD1
B Cell Differentiation (GO:0030183),2/68,0.535169585737089,0.744139026008315,0,0,1.12678509230233,0.704434038592063,DNAJB9;SLC25A5
Neuropeptide Signaling Pathway (GO:0007218),2/68,0.535169585737089,0.744139026008315,0,0,1.12678509230233,0.704434038592063,CYSLTR1;KISS1R
JNK Cascade (GO:0007254),1/29,0.537207214666277,0.744139026008315,0,0,1.32805244468724,0.825213785968241,GPS1
TOR Signaling (GO:0031929),1/29,0.537207214666277,0.744139026008315,0,0,1.32805244468724,0.825213785968241,LARP1
Regulation Of Monoatomic Ion Transmembrane Transport (GO:0034765),1/29,0.537207214666277,0.744139026008315,0,0,1.32805244468724,0.825213785968241,KCNJ2
Carbohydrate Derivative Biosynthetic Process (GO:1901137),1/29,0.537207214666277,0.744139026008315,0,0,1.32805244468724,0.825213785968241,GCNT1
Cardiac Muscle Cell Action Potential (GO:0086001),1/29,0.537207214666277,0.744139026008315,0,0,1.32805244468724,0.825213785968241,KCNJ2
Regulation Of Spindle Assembly (GO:0090169),1/29,0.537207214666277,0.744139026008315,0,0,1.32805244468724,0.825213785968241,CHMP5
Regulation Of Voltage-Gated Calcium Channel Activity (GO:1901385),1/29,0.537207214666277,0.744139026008315,0,0,1.32805244468724,0.825213785968241,CACNA1A
Tube Closure (GO:0060606),1/29,0.537207214666277,0.744139026008315,0,0,1.32805244468724,0.825213785968241,FUZ
Vacuolar Acidification (GO:0007035),1/29,0.537207214666277,0.744139026008315,0,0,1.32805244468724,0.825213785968241,CLN6
Lipid Droplet Organization (GO:0034389),1/29,0.537207214666277,0.744139026008315,0,0,1.32805244468724,0.825213785968241,RNF213
Maintenance Of Blood-Brain Barrier (GO:0035633),1/29,0.537207214666277,0.744139026008315,0,0,1.32805244468724,0.825213785968241,OCLN
Multivesicular Body Assembly (GO:0036258),1/29,0.537207214666277,0.744139026008315,0,0,1.32805244468724,0.825213785968241,CHMP5
Negative Regulation Of Plasma Membrane Bounded Cell Projection Assembly (GO:0120033),1/29,0.537207214666277,0.744139026008315,0,0,1.32805244468724,0.825213785968241,SRGAP2C
Organic Cyclic Compound Biosynthetic Process (GO:1901362),1/29,0.537207214666277,0.744139026008315,0,0,1.32805244468724,0.825213785968241,GCH1
Positive Regulation Of Calcium Ion Transport (GO:0051928),1/29,0.537207214666277,0.744139026008315,0,0,1.32805244468724,0.825213785968241,CCR1
Positive Regulation Of Endopeptidase Activity (GO:0010950),1/29,0.537207214666277,0.744139026008315,0,0,1.32805244468724,0.825213785968241,AIM2
Positive Regulation Of Microtubule Polymerization (GO:0031116),1/29,0.537207214666277,0.744139026008315,0,0,1.32805244468724,0.825213785968241,OCLN
Positive Regulation Of Neural Precursor Cell Proliferation (GO:2000179),1/29,0.537207214666277,0.744139026008315,0,0,1.32805244468724,0.825213785968241,SMARCD3
Protein Insertion Into ER Membrane (GO:0045048),1/29,0.537207214666277,0.744139026008315,0,0,1.32805244468724,0.825213785968241,UBL4A
Regulation Of Cell Population Proliferation (GO:0042127),20/766,0.538969320552609,0.746107972193561,0,0,0.996318992297545,0.615821410438677,KLF10;BMPR2;SMAD3;CXCL8;STAT1;PRMT1;STAT2;CDCA7L;OSGIN1;EIF2AK2;FUZ;IFI35;INHBA;PML;IFIT3;DNAJB2;RNF126;HES1;SLC25A5;BRICD5
Negative Regulation Of Protein Metabolic Process (GO:0051248),4/147,0.539885283607545,0.746903835186686,0,0,1.03996772458311,0.641034649224171,LARP1;EIF4A3;EIF2AK2;IGF2BP3
Lipid Transport (GO:0006869),3/108,0.540696737299128,0.747554201190082,0,0,1.06229777899644,0.653203416599544,CEACAM1;SLC10A3;ABCA13
DNA-templated DNA Replication (GO:0006261),2/69,0.543065414189762,0.749882255407048,0,0,1.10991021901984,0.677628489405265,HELB;RECQL5
Establishment Of Protein Localization To Membrane (GO:0090150),2/69,0.543065414189762,0.749882255407048,0,0,1.10991021901984,0.677628489405265,RTP4;YIF1B
Negative Regulation Of Developmental Process (GO:0051093),3/109,0.546944323077961,0.751651011392981,0,0,1.05222177959657,0.634919321267002,SRGAP2C;NOTCH4;FUZ
Cardiac Muscle Cell Action Potential Involved In Contraction (GO:0086002),1/30,0.549349961120656,0.751651011392981,0,0,1.28219160018461,0.768057884859997,KCNJ2
Regulation Of Vasculature Development (GO:1901342),1/30,0.549349961120656,0.751651011392981,0,0,1.28219160018461,0.768057884859997,SP100
Response To Amino Acid (GO:0043200),1/30,0.549349961120656,0.751651011392981,0,0,1.28219160018461,0.768057884859997,SESN2
Extrinsic Apoptotic Signaling Pathway Via Death Domain Receptors (GO:0008625),1/30,0.549349961120656,0.751651011392981,0,0,1.28219160018461,0.768057884859997,CASP10
Maturation Of SSU-rRNA From Tricistronic rRNA Transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462),1/30,0.549349961120656,0.751651011392981,0,0,1.28219160018461,0.768057884859997,TBL3
Mitotic G2 DNA Damage Checkpoint Signaling (GO:0007095),1/30,0.549349961120656,0.751651011392981,0,0,1.28219160018461,0.768057884859997,TNFSF13B
Multivesicular Body Organization (GO:0036257),1/30,0.549349961120656,0.751651011392981,0,0,1.28219160018461,0.768057884859997,CHMP5
Negative Regulation Of Epithelial To Mesenchymal Transition (GO:0010719),1/30,0.549349961120656,0.751651011392981,0,0,1.28219160018461,0.768057884859997,FUZ
Negative Regulation Of Interleukin-1 Production (GO:0032692),1/30,0.549349961120656,0.751651011392981,0,0,1.28219160018461,0.768057884859997,CEACAM1
Phagocytosis, Engulfment (GO:0006911),1/30,0.549349961120656,0.751651011392981,0,0,1.28219160018461,0.768057884859997,FCGR2B
Regulation Of Arp2/3 Complex-Mediated Actin Nucleation (GO:0034315),1/30,0.549349961120656,0.751651011392981,0,0,1.28219160018461,0.768057884859997,PICK1
Regulation Of Calcium-Mediated Signaling (GO:0050848),1/30,0.549349961120656,0.751651011392981,0,0,1.28219160018461,0.768057884859997,GBP1
Skeletal System Development (GO:0001501),4/149,0.550578515816761,0.751651011392981,0,0,1.02551724137931,0.612014031546968,HYAL2;CREB3L2;COL9A2;PCSK5
Sulfur Compound Biosynthetic Process (GO:0044272),2/70,0.55086752204828,0.751651011392981,0,0,1.09353166553978,0.652030208526454,GGT5;B4GALT4
Negative Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001237),2/70,0.55086752204828,0.751651011392981,0,0,1.09353166553978,0.652030208526454,GPX1;IFI6
Positive Regulation Of Protein Polymerization (GO:0032273),2/70,0.55086752204828,0.751651011392981,0,0,1.09353166553978,0.652030208526454,OCLN;PRKCE
Positive Regulation Of Protein Transport (GO:0051222),2/70,0.55086752204828,0.751651011392981,0,0,1.09353166553978,0.652030208526454,PLK3;CD2AP
Regulation Of Notch Signaling Pathway (GO:0008593),2/70,0.55086752204828,0.751651011392981,0,0,1.09353166553978,0.652030208526454,LLGL1;EPN2
Chromatin Remodeling (GO:0006338),6/228,0.553045555955365,0.753970912457189,0,0,1.00459146405092,0.595034493762325,GPX1;SMARCD3;RING1;DTX3L;IFI16;DDX21
Neuron Development (GO:0048666),4/150,0.555875948607154,0.753970912457189,0,0,1.01844046364594,0.598038550578633,BLOC1S4;PRMT1;STMN3;HS6ST1
Chromatin Organization (GO:0006325),7/268,0.556529965478885,0.753970912457189,0,0,0.996798505969452,0.584158078197006,PARP10;CBX5;SMARCD3;TRIM28;RING1;DDX21;CABIN1
Regulation Of Cilium Assembly (GO:1902017),2/71,0.558575391958138,0.753970912457189,0,0,1.0776278527403,0.627573476715677,PPP1R35;FUZ
Regulation Of Double-Strand Break Repair Via Homologous Recombination (GO:0010569),2/71,0.558575391958138,0.753970912457189,0,0,1.0776278527403,0.627573476715677,HELB;RMI2
Regulation Of Hydrolase Activity (GO:0051336),2/71,0.558575391958138,0.753970912457189,0,0,1.0776278527403,0.627573476715677,SCARB2;STMN3
T Cell Activation (GO:0042110),3/111,0.559289071931071,0.753970912457189,0,0,1.03262955854127,0.600049487722972,IRF4;RHOH;MICA
Mitotic Cell Cycle Phase Transition (GO:0044772),3/111,0.559289071931071,0.753970912457189,0,0,1.03262955854127,0.600049487722972,PLK3;FBXL15;ACVR1B
Mitotic Sister Chromatid Segregation (GO:0000070),3/111,0.559289071931071,0.753970912457189,0,0,1.03262955854127,0.600049487722972,NCAPH2;NDC80;CHMP5
Regulation Of Centrosome Duplication (GO:0010824),1/31,0.561174697399643,0.753970912457189,0,0,1.23938814531549,0.71602306024495,CHMP5
B Cell Proliferation (GO:0042100),1/31,0.561174697399643,0.753970912457189,0,0,1.23938814531549,0.71602306024495,GAPT
Regulation Of Dendrite Morphogenesis (GO:0048814),1/31,0.561174697399643,0.753970912457189,0,0,1.23938814531549,0.71602306024495,TNIK
Actin Filament Polymerization (GO:0030041),1/31,0.561174697399643,0.753970912457189,0,0,1.23938814531549,0.71602306024495,PSTPIP2
acyl-CoA Metabolic Process (GO:0006637),1/31,0.561174697399643,0.753970912457189,0,0,1.23938814531549,0.71602306024495,ACOT9
Antigen Processing And Presentation Of Exogenous Peptide Antigen (GO:0002478),1/31,0.561174697399643,0.753970912457189,0,0,1.23938814531549,0.71602306024495,FCGR2B
Regulation Of Protein Localization To Cell Surface (GO:2000008),1/31,0.561174697399643,0.753970912457189,0,0,1.23938814531549,0.71602306024495,TAX1BP3
Regulation Of Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0090092),1/31,0.561174697399643,0.753970912457189,0,0,1.23938814531549,0.71602306024495,SMAD3
Central Nervous System Neuron Differentiation (GO:0021953),1/31,0.561174697399643,0.753970912457189,0,0,1.23938814531549,0.71602306024495,NR4A2
Leukocyte Cell-Cell Adhesion (GO:0007159),1/31,0.561174697399643,0.753970912457189,0,0,1.23938814531549,0.71602306024495,OLR1
Phospholipid Translocation (GO:0045332),1/31,0.561174697399643,0.753970912457189,0,0,1.23938814531549,0.71602306024495,PLSCR1
Positive Regulation Of Rho Protein Signal Transduction (GO:0035025),1/31,0.561174697399643,0.753970912457189,0,0,1.23938814531549,0.71602306024495,ARHGEF3
Positive Regulation Of Cholesterol Transport (GO:0032376),1/31,0.561174697399643,0.753970912457189,0,0,1.23938814531549,0.71602306024495,ABCA13
Positive Regulation Of Glucose Transmembrane Transport (GO:0010828),1/31,0.561174697399643,0.753970912457189,0,0,1.23938814531549,0.71602306024495,OCLN
Positive Regulation Of Lamellipodium Organization (GO:1902745),1/31,0.561174697399643,0.753970912457189,0,0,1.23938814531549,0.71602306024495,OCLN
Positive Regulation Of Mononuclear Cell Migration (GO:0071677),1/31,0.561174697399643,0.753970912457189,0,0,1.23938814531549,0.71602306024495,CCR1
Negative Regulation Of Multicellular Organismal Process (GO:0051241),6/231,0.565855617093304,0.758742211154416,0,0,0.991042471042471,0.564315763559396,BMPR2;BTN2A2;BRCA2;FCGR2B;IL18R1;MAP2K6
Cholesterol Homeostasis (GO:0042632),2/72,0.56618859783528,0.758742211154416,0,0,1.06217843459223,0.604196881921349,GRAMD1B;TTC39B
Response To Ionizing Radiation (GO:0010212),2/72,0.56618859783528,0.758742211154416,0,0,1.06217843459223,0.604196881921349,IFI16;BRCA2
Plasma Membrane Organization (GO:0007009),2/72,0.56618859783528,0.758742211154416,0,0,1.06217843459223,0.604196881921349,PLSCR1;CHMP5
Neuron Projection Development (GO:0031175),5/192,0.568068079129508,0.758742211154416,0,0,0.993735381698659,0.561971280405374,BLOC1S4;PRMT1;STMN3;TNIK;MAPK8IP3
Regulation Of Protein Ubiquitination (GO:0031396),3/113,0.571429103646103,0.758742211154416,0,0,1.01374978188798,0.567309438774082,DNAJB2;ISG15;SEPTIN4
Regulation Of Cholesterol Efflux (GO:0010874),1/32,0.572689736511451,0.758742211154416,0,0,1.19934620366373,0.668528983779846,TTC39B
NIK/NF-kappaB Signaling (GO:0038061),1/32,0.572689736511451,0.758742211154416,0,0,1.19934620366373,0.668528983779846,MAP3K14
Regulation Of Metaphase/Anaphase Transition Of Cell Cycle (GO:1902099),1/32,0.572689736511451,0.758742211154416,0,0,1.19934620366373,0.668528983779846,SMARCD3
Regulation Of Natural Killer Cell Mediated Cytotoxicity (GO:0042269),1/32,0.572689736511451,0.758742211154416,0,0,1.19934620366373,0.668528983779846,MICA
Cellular Nitrogen Compound Biosynthetic Process (GO:0044271),1/32,0.572689736511451,0.758742211154416,0,0,1.19934620366373,0.668528983779846,GCH1
Regulation Of Ubiquitin-Protein Transferase Activity (GO:0051438),1/32,0.572689736511451,0.758742211154416,0,0,1.19934620366373,0.668528983779846,DTX3L
Chromosome Condensation (GO:0030261),1/32,0.572689736511451,0.758742211154416,0,0,1.19934620366373,0.668528983779846,NCAPH2
Gluconeogenesis (GO:0006094),1/32,0.572689736511451,0.758742211154416,0,0,1.19934620366373,0.668528983779846,PCK2
Glycosphingolipid Metabolic Process (GO:0006687),1/32,0.572689736511451,0.758742211154416,0,0,1.19934620366373,0.668528983779846,CLN6
Vesicle Budding From Membrane (GO:0006900),1/32,0.572689736511451,0.758742211154416,0,0,1.19934620366373,0.668528983779846,CHMP5
miRNA Processing (GO:0035196),1/32,0.572689736511451,0.758742211154416,0,0,1.19934620366373,0.668528983779846,SMAD3
Mitochondrial Membrane Organization (GO:0007006),1/32,0.572689736511451,0.758742211154416,0,0,1.19934620366373,0.668528983779846,SLC25A5
Muscle Cell Development (GO:0055001),1/32,0.572689736511451,0.758742211154416,0,0,1.19934620366373,0.668528983779846,HES1
Neural Tube Closure (GO:0001843),1/32,0.572689736511451,0.758742211154416,0,0,1.19934620366373,0.668528983779846,FUZ
Proteoglycan Biosynthetic Process (GO:0030166),1/32,0.572689736511451,0.758742211154416,0,0,1.19934620366373,0.668528983779846,BMPR2
Regulation Of Calcium Ion Transmembrane Transporter Activity (GO:1901019),1/32,0.572689736511451,0.758742211154416,0,0,1.19934620366373,0.668528983779846,CACNA1A
Regulation Of Signal Transduction (GO:0009966),5/193,0.572694463487785,0.758742211154416,0,0,0.988398310990858,0.550936111603477,PLSCR1;SP100;TRIM5;FUZ;LLGL1
Sterol Homeostasis (GO:0055092),2/73,0.5737068005322,0.759623877367303,0,0,1.04716421132157,0.581842985728311,GRAMD1B;TTC39B
Protein Modification By Small Protein Removal (GO:0070646),3/114,0.577420944522536,0.764079678854594,0,0,1.00456502567827,0.551690776427113,GPS1;JOSD1;USP18
Gland Development (GO:0048732),2/74,0.581129743256944,0.765717336644721,0,0,1.03256704980843,0.560458020381518,NOTCH4;HES1
Ribosome Biogenesis (GO:0042254),4/155,0.581850964769823,0.765717336644721,0,0,0.984462557310239,0.533126777028633,TBL3;DDX27;SPPL2B;IGF2BP3
Regulation Of Lamellipodium Assembly (GO:0010591),1/33,0.583903174519034,0.765717336644721,0,0,1.1618068833652,0.625075463650607,OCLN
Cardiac Muscle Contraction (GO:0060048),1/33,0.583903174519034,0.765717336644721,0,0,1.1618068833652,0.625075463650607,GAA
Epithelial Tube Morphogenesis (GO:0060562),1/33,0.583903174519034,0.765717336644721,0,0,1.1618068833652,0.625075463650607,HES1
intra-Golgi Vesicle-Mediated Transport (GO:0006891),1/33,0.583903174519034,0.765717336644721,0,0,1.1618068833652,0.625075463650607,COG6
Negative Regulation Of Epithelial Cell Migration (GO:0010633),1/33,0.583903174519034,0.765717336644721,0,0,1.1618068833652,0.625075463650607,SP100
Positive Regulation Of Notch Signaling Pathway (GO:0045747),1/33,0.583903174519034,0.765717336644721,0,0,1.1618068833652,0.625075463650607,EPN2
Positive Regulation Of T Cell Mediated Cytotoxicity (GO:0001916),1/33,0.583903174519034,0.765717336644721,0,0,1.1618068833652,0.625075463650607,MICA
Positive Regulation Of Cytokine Production Involved In Immune Response (GO:0002720),1/33,0.583903174519034,0.765717336644721,0,0,1.1618068833652,0.625075463650607,TRIM6
Positive Regulation Of Nitrogen Compound Metabolic Process (GO:0051173),1/33,0.583903174519034,0.765717336644721,0,0,1.1618068833652,0.625075463650607,INHBA
Positive Regulation Of Small Molecule Metabolic Process (GO:0062013),1/33,0.583903174519034,0.765717336644721,0,0,1.1618068833652,0.625075463650607,PRKCE
Protein K63-linked Deubiquitination (GO:0070536),1/33,0.583903174519034,0.765717336644721,0,0,1.1618068833652,0.625075463650607,MPND
Regulation Of G0 To G1 Transition (GO:0070316),1/33,0.583903174519034,0.765717336644721,0,0,1.1618068833652,0.625075463650607,SMARCD3
Regulation Of Cell Adhesion Mediated By Integrin (GO:0033628),1/33,0.583903174519034,0.765717336644721,0,0,1.1618068833652,0.625075463650607,PLAU
Endomembrane System Organization (GO:0010256),5/196,0.58641692425233,0.768553599109876,0,0,0.972722412210352,0.51916555698647,PI4K2B;COG6;STX17;VPS51;TOR1B
Regulation Of Fat Cell Differentiation (GO:0045598),2/75,0.588457247964558,0.769385894353661,0,0,1.01836981052853,0.539991611105534,SMAD3;TRIB2
Negative Regulation Of Phosphorylation (GO:0042326),2/75,0.588457247964558,0.769385894353661,0,0,1.01836981052853,0.539991611105534,OCLN;INHBA
Nucleosome Organization (GO:0034728),2/75,0.588457247964558,0.769385894353661,0,0,1.01836981052853,0.539991611105534,SMARCD3;CABIN1
Regulation Of BMP Signaling Pathway (GO:0030510),2/75,0.588457247964558,0.769385894353661,0,0,1.01836981052853,0.539991611105534,BMPR2;FBXL15
Golgi Vesicle Transport (GO:0048193),5/197,0.590937688536473,0.769770054077598,0,0,0.967605973025048,0.509003994846113,COG6;STX17;VPS51;PICK1;YIF1B
Regulation Of Phosphatidylinositol 3-Kinase Activity (GO:0043551),1/34,0.594822896119455,0.769770054077598,0,0,1.1265426733878,0.585229423562752,RUBCN
Cellular Response To Glucose Stimulus (GO:0071333),1/34,0.594822896119455,0.769770054077598,0,0,1.1265426733878,0.585229423562752,PCK2
Response To Estrogen (GO:0043627),1/34,0.594822896119455,0.769770054077598,0,0,1.1265426733878,0.585229423562752,SERPINB9
Sister Chromatid Segregation (GO:0000819),1/34,0.594822896119455,0.769770054077598,0,0,1.1265426733878,0.585229423562752,NDC80
Superoxide Metabolic Process (GO:0006801),1/34,0.594822896119455,0.769770054077598,0,0,1.1265426733878,0.585229423562752,CYBB
Glial Cell Differentiation (GO:0010001),1/34,0.594822896119455,0.769770054077598,0,0,1.1265426733878,0.585229423562752,PICK1
Histone Deubiquitination (GO:0016578),1/34,0.594822896119455,0.769770054077598,0,0,1.1265426733878,0.585229423562752,MPND
Inner Mitochondrial Membrane Organization (GO:0007007),1/34,0.594822896119455,0.769770054077598,0,0,1.1265426733878,0.585229423562752,TIMM10
Negative Regulation Of Ras Protein Signal Transduction (GO:0046580),1/34,0.594822896119455,0.769770054077598,0,0,1.1265426733878,0.585229423562752,STMN3
Positive Regulation Of Carbohydrate Metabolic Process (GO:0045913),1/34,0.594822896119455,0.769770054077598,0,0,1.1265426733878,0.585229423562752,PRKCE
Positive Regulation Of Immunoglobulin Production (GO:0002639),1/34,0.594822896119455,0.769770054077598,0,0,1.1265426733878,0.585229423562752,DNAJB9
Positive Regulation Of Transcription By RNA Polymerase I (GO:0045943),1/34,0.594822896119455,0.769770054077598,0,0,1.1265426733878,0.585229423562752,DDX21
Protein Targeting To Vacuole (GO:0006623),1/34,0.594822896119455,0.769770054077598,0,0,1.1265426733878,0.585229423562752,SCARB2
Regulation Of DNA Biosynthetic Process (GO:2000278),1/34,0.594822896119455,0.769770054077598,0,0,1.1265426733878,0.585229423562752,BMPR2
Cellular Response To Oxidative Stress (GO:0034599),3/117,0.595077945914783,0.769770054077598,0,0,0.977977573492272,0.507631856340771,PNPT1;GPX1;SESN2
Protein Maturation (GO:0051604),3/117,0.595077945914783,0.769770054077598,0,0,0.977977573492272,0.507631856340771,CASP10;F12;PCSK5
Protein Processing (GO:0016485),3/117,0.595077945914783,0.769770054077598,0,0,0.977977573492272,0.507631856340771,F12;RCE1;PCSK5
Transcription Initiation At RNA Polymerase II Promoter (GO:0006367),2/76,0.595689210893156,0.770105886573797,0,0,1.00455628041835,0.520396524378481,TAF13;GTF2H2
Ribonucleoprotein Complex Biogenesis (GO:0022613),3/118,0.60085603684016,0.774051320135936,0,0,0.969423349745473,0.493824169544061,TBL3;SPPL2B;IGF2BP3
Actomyosin Structure Organization (GO:0031032),2/77,0.602825599333895,0.774051320135936,0,0,0.991111111111111,0.501628436016049,FRMD3;TMOD2
Cell Morphogenesis Involved In Neuron Differentiation (GO:0048667),2/77,0.602825599333895,0.774051320135936,0,0,0.991111111111111,0.501628436016049,NTNG2;LLGL1
Regulation Of Transcription Elongation By RNA Polymerase II (GO:0034243),2/77,0.602825599333895,0.774051320135936,0,0,0.991111111111111,0.501628436016049,RECQL5;NELFA
Chloride Transport (GO:0006821),2/77,0.602825599333895,0.774051320135936,0,0,0.991111111111111,0.501628436016049,SLC26A8;APOL1
Negative Regulation Of Blood Vessel Morphogenesis (GO:2000181),2/77,0.602825599333895,0.774051320135936,0,0,0.991111111111111,0.501628436016049,STAT1;PML
Regulation Of T Cell Proliferation (GO:0042129),2/77,0.602825599333895,0.774051320135936,0,0,0.991111111111111,0.501628436016049,CD274;IDO1
Regulation Of Inflammatory Response (GO:0050727),6/240,0.60318447426079,0.774051320135936,0,0,0.952479952479952,0.481509287335356,AIM2;HYAL2;IFI35;MMP8;USP18;NAIP
Regulation Of Cellular Senescence (GO:2000772),1/35,0.605456580544684,0.774051320135936,0,0,1.09335282870318,0.548614302416673,PNPT1
Action Potential (GO:0001508),1/35,0.605456580544684,0.774051320135936,0,0,1.09335282870318,0.548614302416673,KCNJ2
Regulation Of Regulated Secretory Pathway (GO:1903305),1/35,0.605456580544684,0.774051320135936,0,0,1.09335282870318,0.548614302416673,RPH3A
Cellular Response To Amino Acid Stimulus (GO:0071230),1/35,0.605456580544684,0.774051320135936,0,0,1.09335282870318,0.548614302416673,SESN2
Hexose Biosynthetic Process (GO:0019319),1/35,0.605456580544684,0.774051320135936,0,0,1.09335282870318,0.548614302416673,PCK2
Liver Development (GO:0001889),1/35,0.605456580544684,0.774051320135936,0,0,1.09335282870318,0.548614302416673,PCK2
Macrophage Activation (GO:0042116),1/35,0.605456580544684,0.774051320135936,0,0,1.09335282870318,0.548614302416673,IFI35
Negative Regulation Of Cell Cycle G1/S Phase Transition (GO:1902807),1/35,0.605456580544684,0.774051320135936,0,0,1.09335282870318,0.548614302416673,INHBA
Neutral Amino Acid Transport (GO:0015804),1/35,0.605456580544684,0.774051320135936,0,0,1.09335282870318,0.548614302416673,SLC7A7
Protein Methylation (GO:0006479),1/35,0.605456580544684,0.774051320135936,0,0,1.09335282870318,0.548614302416673,PRMT1
Regulation Of G2/M Transition Of Mitotic Cell Cycle (GO:0010389),1/35,0.605456580544684,0.774051320135936,0,0,1.09335282870318,0.548614302416673,TNFSF13B
Long-Chain Fatty Acid Metabolic Process (GO:0001676),2/78,0.609866447579398,0.778779895159697,0,0,0.9780197620488,0.483645720562944,FAAH;GPX1
Proteolysis Involved In Protein Catabolic Process (GO:0051603),2/78,0.609866447579398,0.778779895159697,0,0,0.9780197620488,0.483645720562944,CLPP;ISG15
Negative Regulation Of Apoptotic Process (GO:0043066),12/482,0.612522188089241,0.781715379904101,0,0,0.947772606382979,0.464569804400975,NR4A2;PLK3;GPX1;RPL10;HSPA5;LAMP3;IFI6;CD38;SERPINB9;MAPK8IP3;IFIT3;NAIP
Regulation Of Glucose Import (GO:0046324),1/36,0.615811706280653,0.781723356302964,0,0,1.06205954657197,0.514901372907263,OCLN
Regulation Of Intracellular Protein Transport (GO:0033157),1/36,0.615811706280653,0.781723356302964,0,0,1.06205954657197,0.514901372907263,PLK3
Regulation Of Peptidyl-Threonine Phosphorylation (GO:0010799),1/36,0.615811706280653,0.781723356302964,0,0,1.06205954657197,0.514901372907263,TRIM6
Regulation Of Receptor Internalization (GO:0002090),1/36,0.615811706280653,0.781723356302964,0,0,1.06205954657197,0.514901372907263,PICK1
Regulation Of Trans-Synaptic Signaling (GO:0099177),1/36,0.615811706280653,0.781723356302964,0,0,1.06205954657197,0.514901372907263,CACNA1A
Interstrand Cross-Link Repair (GO:0036297),1/36,0.615811706280653,0.781723356302964,0,0,1.06205954657197,0.514901372907263,FANCA
Negative Regulation Of Protein Kinase B Signaling (GO:0051898),1/36,0.615811706280653,0.781723356302964,0,0,1.06205954657197,0.514901372907263,HYAL2
Positive Regulation Of RNA Splicing (GO:0033120),1/36,0.615811706280653,0.781723356302964,0,0,1.06205954657197,0.514901372907263,HNRNPLL
Mitochondrion Organization (GO:0007005),4/162,0.61670408055056,0.781723356302964,0,0,0.940506329113924,0.454608763708396,PNPT1;TIMM10;ATAD3B;IFIT2
Response To Insulin (GO:0032868),2/79,0.616811853740421,0.781723356302964,0,0,0.965268448027069,0.466409257168249,CEACAM1;PCK2
Positive Regulation Of Endocytosis (GO:0045807),2/79,0.616811853740421,0.781723356302964,0,0,0.965268448027069,0.466409257168249,ANKFY1;FCGR2B
Positive Regulation Of Protein Localization To Membrane (GO:1905477),2/79,0.616811853740421,0.781723356302964,0,0,0.965268448027069,0.466409257168249,NECAB2;PRKCE
Positive Regulation Of Programmed Cell Death (GO:0043068),6/245,0.623154185677661,0.784863225510102,0,0,0.932311271223405,0.440947152488779,GBP5;TNFSF10;SEPTIN4;GBP1;IFIT2;GBP3
Protein Localization To Nucleus (GO:0034504),3/122,0.623421384471267,0.784863225510102,0,0,0.936644139421604,0.4425948991561,NXT1;TOR1B;PML
Receptor-Mediated Endocytosis (GO:0006898),3/122,0.623421384471267,0.784863225510102,0,0,0.936644139421604,0.4425948991561,SCARB2;CXCL8;FCGR2B
Regulation Of Protein Localization To Plasma Membrane (GO:1903076),2/80,0.623661976254036,0.784863225510102,0,0,0.952844090775125,0.449882252253994,PRKCE;GBP1
Glycoprotein Biosynthetic Process (GO:0009101),2/80,0.623661976254036,0.784863225510102,0,0,0.952844090775125,0.449882252253994,BMPR2;GCNT1
Wound Healing (GO:0042060),2/80,0.623661976254036,0.784863225510102,0,0,0.952844090775125,0.449882252253994,SMAD3;CHMP5
Regulation Of p38MAPK Cascade (GO:1900744),1/37,0.625895556875104,0.784863225510102,0,0,1.03250478011472,0.483802586006322,PRMT1
Calcium Ion Import Across Plasma Membrane (GO:0098703),1/37,0.625895556875104,0.784863225510102,0,0,1.03250478011472,0.483802586006322,CACNA1A
Regulation Of Sodium Ion Transmembrane Transporter Activity (GO:2000649),1/37,0.625895556875104,0.784863225510102,0,0,1.03250478011472,0.483802586006322,PRKCE
Synaptic Vesicle Cycle (GO:0099504),1/37,0.625895556875104,0.784863225510102,0,0,1.03250478011472,0.483802586006322,OTOF
Melanosome Organization (GO:0032438),1/37,0.625895556875104,0.784863225510102,0,0,1.03250478011472,0.483802586006322,BLOC1S4
Mitochondrion Disassembly (GO:0061726),1/37,0.625895556875104,0.784863225510102,0,0,1.03250478011472,0.483802586006322,MAP1LC3A
Negative Regulation Of Endothelial Cell Migration (GO:0010596),1/37,0.625895556875104,0.784863225510102,0,0,1.03250478011472,0.483802586006322,SP100
Negative Regulation Of Endothelial Cell Proliferation (GO:0001937),1/37,0.625895556875104,0.784863225510102,0,0,1.03250478011472,0.483802586006322,STAT1
Negative Regulation Of Smooth Muscle Cell Proliferation (GO:0048662),1/37,0.625895556875104,0.784863225510102,0,0,1.03250478011472,0.483802586006322,BMPR2
Negative Regulation Of Transferase Activity (GO:0051348),1/37,0.625895556875104,0.784863225510102,0,0,1.03250478011472,0.483802586006322,DTX3L
Positive Regulation Of Receptor Signaling Pathway Via JAK-STAT (GO:0046427),1/37,0.625895556875104,0.784863225510102,0,0,1.03250478011472,0.483802586006322,HES1
Positive Regulation Of Receptor Signaling Pathway Via STAT (GO:1904894),1/37,0.625895556875104,0.784863225510102,0,0,1.03250478011472,0.483802586006322,HES1
Regulation Of Angiogenesis (GO:0045765),5/205,0.626098655235684,0.784863225510102,0,0,0.928516377649326,0.434775309194927,CEACAM1;SP100;CXCL8;STAT1;PML
Regulation Of Cell Motility (GO:2000145),3/123,0.628924623637834,0.787954763024518,0,0,0.928790786948177,0.430721029033832,CEACAM1;OSGIN1;RIGI
Macromolecule Modification (GO:0043412),2/81,0.630417030479954,0.789372954117267,0,0,0.940734274213104,0.434030076750432,UBL4A;UBE2L6
Regulation Of DNA Metabolic Process (GO:0051052),3/124,0.634372194590862,0.790134134127461,0,0,0.921067241953649,0.419195606514369,HELB;ALYREF;NSMCE1
Negative Regulation Of Cell Differentiation (GO:0045596),5/207,0.634600016032499,0.790134134127461,0,0,0.919227760926382,0.418028360873194,METTL14;SMAD3;NOTCH4;HES1;TRIB2
Regulation Of Intracellular Transport (GO:0032386),1/38,0.635715225722642,0.790134134127461,0,0,1.00454756860111,0.455064643591278,MX2
Amino Acid Catabolic Process (GO:0009063),1/38,0.635715225722642,0.790134134127461,0,0,1.00454756860111,0.455064643591278,IDO1
Regulation Of Neurotransmitter Secretion (GO:0046928),1/38,0.635715225722642,0.790134134127461,0,0,1.00454756860111,0.455064643591278,OTOF
Response To cAMP (GO:0051591),1/38,0.635715225722642,0.790134134127461,0,0,1.00454756860111,0.455064643591278,STAT1
Signal Release From Synapse (GO:0099643),1/38,0.635715225722642,0.790134134127461,0,0,1.00454756860111,0.455064643591278,OTOF
Establishment Of Protein Localization To Plasma Membrane (GO:0061951),1/38,0.635715225722642,0.790134134127461,0,0,1.00454756860111,0.455064643591278,VAMP5
Import Into Cell (GO:0098657),1/38,0.635715225722642,0.790134134127461,0,0,1.00454756860111,0.455064643591278,SLC5A6
mRNA Transcription By RNA Polymerase II (GO:0042789),1/38,0.635715225722642,0.790134134127461,0,0,1.00454756860111,0.455064643591278,TAF13
Membrane Assembly (GO:0071709),1/38,0.635715225722642,0.790134134127461,0,0,1.00454756860111,0.455064643591278,CHMP5
Membrane Fission (GO:0090148),1/38,0.635715225722642,0.790134134127461,0,0,1.00454756860111,0.455064643591278,CHMP5
Positive Regulation Of Myoblast Differentiation (GO:0045663),1/38,0.635715225722642,0.790134134127461,0,0,1.00454756860111,0.455064643591278,SMARCD3
Regulation Of Nucleic Acid-Templated Transcription (GO:1903506),11/452,0.64093105548972,0.793908983297904,0,0,0.925528105979234,0.41170580083641,SMAD3;BNC2;NAB2;RHOH;BRCA2;ACVR1B;ZNF675;ZNF653;PML;TRIM22;GZF1
Epigenetic Regulation Of Gene Expression (GO:0040029),2/83,0.643643063705595,0.793908983297904,0,0,0.917411664538101,0.4042216300392,GPX1;IFI16
Vesicle-Mediated Transport To The Plasma Membrane (GO:0098876),2/83,0.643643063705595,0.793908983297904,0,0,0.917411664538101,0.4042216300392,VPS51;LLGL1
Regulation Of Cell Division (GO:0051302),2/83,0.643643063705595,0.793908983297904,0,0,0.917411664538101,0.4042216300392,PLK3;ZFYVE26
Regulation Of Mitotic Spindle Organization (GO:0060236),1/39,0.645277621127977,0.793908983297904,0,0,0.978061789272416,0.428464060792489,CHMP5
Axonal Transport (GO:0098930),1/39,0.645277621127977,0.793908983297904,0,0,0.978061789272416,0.428464060792489,BLOC1S4
Regulation Of Protein Tyrosine Kinase Activity (GO:0061097),1/39,0.645277621127977,0.793908983297904,0,0,0.978061789272416,0.428464060792489,HYAL2
Vesicle Cytoskeletal Trafficking (GO:0099518),1/39,0.645277621127977,0.793908983297904,0,0,0.978061789272416,0.428464060792489,MYO7B
Vitamin Transport (GO:0051180),1/39,0.645277621127977,0.793908983297904,0,0,0.978061789272416,0.428464060792489,SLC5A6
Negative Regulation Of Cell-Substrate Adhesion (GO:0010812),1/39,0.645277621127977,0.793908983297904,0,0,0.978061789272416,0.428464060792489,GBP1
Negative Regulation Of Proteasomal Protein Catabolic Process (GO:1901799),1/39,0.645277621127977,0.793908983297904,0,0,0.978061789272416,0.428464060792489,LAMP3
Negative Regulation Of Transport (GO:0051051),1/39,0.645277621127977,0.793908983297904,0,0,0.978061789272416,0.428464060792489,RUBCN
Negative Regulation Of Ubiquitin-Dependent Protein Catabolic Process (GO:2000059),1/39,0.645277621127977,0.793908983297904,0,0,0.978061789272416,0.428464060792489,PML
Nuclear Transport (GO:0051169),1/39,0.645277621127977,0.793908983297904,0,0,0.978061789272416,0.428464060792489,NUP205
Odontogenesis (GO:0042476),1/39,0.645277621127977,0.793908983297904,0,0,0.978061789272416,0.428464060792489,INHBA
Positive Regulation Of Cytokinesis (GO:0032467),1/39,0.645277621127977,0.793908983297904,0,0,0.978061789272416,0.428464060792489,PRKCE
Positive Regulation Of Intracellular Transport (GO:0032388),1/39,0.645277621127977,0.793908983297904,0,0,0.978061789272416,0.428464060792489,PLK3
Positive Regulation Of Intrinsic Apoptotic Signaling Pathway (GO:2001244),1/39,0.645277621127977,0.793908983297904,0,0,0.978061789272416,0.428464060792489,SEPTIN4
Brain Development (GO:0007420),4/169,0.64969129575778,0.797846296138268,0,0,0.90027972027972,0.388252794256376,AIM2;VPS51;MATCAP1;DDIT4
Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001959),1/40,0.654589470963893,0.797846296138268,0,0,0.952934255037506,0.403803033419299,SPPL2B
L-alpha-amino Acid Transmembrane Transport (GO:1902475),1/40,0.654589470963893,0.797846296138268,0,0,0.952934255037506,0.403803033419299,SLC7A7
Regulation Of Microtubule Cytoskeleton Organization (GO:0070507),1/40,0.654589470963893,0.797846296138268,0,0,0.952934255037506,0.403803033419299,STMN3
Regulation Of Microtubule Polymerization (GO:0031113),1/40,0.654589470963893,0.797846296138268,0,0,0.952934255037506,0.403803033419299,OCLN
Aortic Valve Development (GO:0003176),1/40,0.654589470963893,0.797846296138268,0,0,0.952934255037506,0.403803033419299,BMPR2
Regulation Of Small Molecule Metabolic Process (GO:0062012),1/40,0.654589470963893,0.797846296138268,0,0,0.952934255037506,0.403803033419299,TTC39B
Cyclic-Nucleotide-Mediated Signaling (GO:0019935),1/40,0.654589470963893,0.797846296138268,0,0,0.952934255037506,0.403803033419299,PDE9A
Endothelial Cell Migration (GO:0043542),1/40,0.654589470963893,0.797846296138268,0,0,0.952934255037506,0.403803033419299,STAT1
Negative Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901991),1/40,0.654589470963893,0.797846296138268,0,0,0.952934255037506,0.403803033419299,INHBA
Negative Regulation Of Protein Localization (GO:1903828),1/40,0.654589470963893,0.797846296138268,0,0,0.952934255037506,0.403803033419299,TAX1BP3
Nucleic Acid-Templated Transcription (GO:0097659),1/40,0.654589470963893,0.797846296138268,0,0,0.952934255037506,0.403803033419299,NR4A2
Positive Regulation Of Monoatomic Ion Transport (GO:0043270),1/40,0.654589470963893,0.797846296138268,0,0,0.952934255037506,0.403803033419299,CCR1
Positive Regulation Of Myeloid Leukocyte Differentiation (GO:0002763),1/40,0.654589470963893,0.797846296138268,0,0,0.952934255037506,0.403803033419299,CCR1
Protein Localization To Cilium (GO:0061512),1/40,0.654589470963893,0.797846296138268,0,0,0.952934255037506,0.403803033419299,TTC21A
Regulation Of Osteoblast Differentiation (GO:0045667),2/85,0.656492705772219,0.797846296138268,0,0,0.895213036052255,0.376744762873105,BMPR2;TENT5A
Defense Response To Gram-positive Bacterium (GO:0050830),2/85,0.656492705772219,0.797846296138268,0,0,0.895213036052255,0.376744762873105,GBP6;GBP4
Integrin-Mediated Signaling Pathway (GO:0007229),2/85,0.656492705772219,0.797846296138268,0,0,0.895213036052255,0.376744762873105,CEACAM1;ISG15
mRNA Metabolic Process (GO:0016071),2/85,0.656492705772219,0.797846296138268,0,0,0.895213036052255,0.376744762873105,PNPT1;SSB
Mitotic Spindle Organization (GO:0007052),2/85,0.656492705772219,0.797846296138268,0,0,0.895213036052255,0.376744762873105,PLK3;NDC80
Nuclear-Transcribed mRNA Catabolic Process (GO:0000956),2/85,0.656492705772219,0.797846296138268,0,0,0.895213036052255,0.376744762873105,XRN1;EIF4A3
Positive Regulation Of Endothelial Cell Migration (GO:0010595),2/85,0.656492705772219,0.797846296138268,0,0,0.895213036052255,0.376744762873105,BMPR2;RIN2
Organelle Organization (GO:0006996),10/418,0.659308022445088,0.800823388327645,0,0,0.909246967269398,0.378759958117113,PI4K2B;TMEM135;FMNL2;VPS51;COG6;STX17;TNIK;TOR1B;ATAD3B;CHMP5
Regulation Of DNA Repair (GO:0006282),3/129,0.66077029016956,0.802102399329559,0,0,0.884288456265424,0.366404053644381,SMARCD3;TRIM28;PML
Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901990),2/86,0.662777441642162,0.802102399329559,0,0,0.884510125889436,0.363813192545437,SMARCD3;MAD2L1BP
DNA Duplex Unwinding (GO:0032508),1/41,0.663657327664457,0.802102399329559,0,0,0.92906309751434,0.380905961998247,RECQL5
Regulation Of Dendrite Development (GO:0050773),1/41,0.663657327664457,0.802102399329559,0,0,0.92906309751434,0.380905961998247,TNIK
Regulation Of Heart Rate By Cardiac Conduction (GO:0086091),1/41,0.663657327664457,0.802102399329559,0,0,0.92906309751434,0.380905961998247,KCNJ2
Axoneme Assembly (GO:0035082),1/41,0.663657327664457,0.802102399329559,0,0,0.92906309751434,0.380905961998247,RSPH9
Detection Of Chemical Stimulus Involved In Sensory Perception Of Bitter Taste (GO:0001580),1/41,0.663657327664457,0.802102399329559,0,0,0.92906309751434,0.380905961998247,RTP4
Synaptic Vesicle Exocytosis (GO:0016079),1/41,0.663657327664457,0.802102399329559,0,0,0.92906309751434,0.380905961998247,OTOF
Positive Regulation Of Actin Filament Polymerization (GO:0030838),1/41,0.663657327664457,0.802102399329559,0,0,0.92906309751434,0.380905961998247,PRKCE
Positive Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050731),3/130,0.665881384374268,0.80390310461943,0,0,0.877280215213022,0.356740495323317,HES1;PARP14;PARP9
Regulation Of Cell Cycle Process (GO:0010564),3/130,0.665881384374268,0.80390310461943,0,0,0.877280215213022,0.356740495323317,PLK3;ZFYVE26;SMARCD3
Neuron Differentiation (GO:0030182),4/173,0.667673822787796,0.805622959727423,0,0,0.878789258079199,0.354991766389988,NR4A2;DDIT4;INHBA;HS6ST1
Negative Regulation Of Programmed Cell Death (GO:0043069),9/381,0.670300288593754,0.808313822036346,0,0,0.897463200751644,0.359011733095049,PLK3;RPL10;HSPA5;IFI6;CD38;SERPINB9;MAPK8IP3;IFIT3;NAIP
Amino Acid Transmembrane Transport (GO:0003333),1/42,0.672487572488686,0.808313822036346,0,0,0.906356386699622,0.35961651654421,SLC7A7
Branching Morphogenesis Of An Epithelial Tube (GO:0048754),1/42,0.672487572488686,0.808313822036346,0,0,0.906356386699622,0.35961651654421,NOTCH4
Ceramide Biosynthetic Process (GO:0046513),1/42,0.672487572488686,0.808313822036346,0,0,0.906356386699622,0.35961651654421,B4GALT4
Sensory Perception Of Bitter Taste (GO:0050913),1/42,0.672487572488686,0.808313822036346,0,0,0.906356386699622,0.35961651654421,RTP4
Embryonic Heart Tube Morphogenesis (GO:0003143),1/42,0.672487572488686,0.808313822036346,0,0,0.906356386699622,0.35961651654421,HES1
Potassium Ion Import Across Plasma Membrane (GO:1990573),1/42,0.672487572488686,0.808313822036346,0,0,0.906356386699622,0.35961651654421,KCNJ2
Regulation Of Double-Strand Break Repair (GO:2000779),2/88,0.675069228226037,0.810971810101493,0,0,0.863851020226321,0.339441648423916,SMARCD3;PML
Epithelial Cell Differentiation (GO:0030855),3/132,0.675934843672111,0.811081707498191,0,0,0.863589697808329,0.338232325700826,DHRS9;TDRD7;PCK2
Plasma Membrane Bounded Cell Projection Organization (GO:0120036),3/132,0.675934843672111,0.811081707498191,0,0,0.863589697808329,0.338232325700826,BLOC1S4;PRMT1;STMN3
Sensory Perception Of Mechanical Stimulus (GO:0050954),2/89,0.681077385299175,0.811081707498191,0,0,0.853877658871714,0.327956771492412,MYO7B;TIMM10
Positive Regulation Of DNA Repair (GO:0045739),2/89,0.681077385299175,0.811081707498191,0,0,0.853877658871714,0.327956771492412,SMARCD3;TRIM28
Regulation Of Primary Metabolic Process (GO:0080090),1/43,0.681086420132043,0.811081707498191,0,0,0.884730947828462,0.339795146168619,RNF213
Skeletal System Morphogenesis (GO:0048705),1/43,0.681086420132043,0.811081707498191,0,0,0.884730947828462,0.339795146168619,FUZ
Energy Derivation By Oxidation Of Organic Compounds (GO:0015980),1/43,0.681086420132043,0.811081707498191,0,0,0.884730947828462,0.339795146168619,CYC1
Intracellular Glucose Homeostasis (GO:0001678),1/43,0.681086420132043,0.811081707498191,0,0,0.884730947828462,0.339795146168619,PCK2
mRNA Transcription (GO:0009299),1/43,0.681086420132043,0.811081707498191,0,0,0.884730947828462,0.339795146168619,TAF13
Positive Regulation Of T Cell Mediated Immunity (GO:0002711),1/43,0.681086420132043,0.811081707498191,0,0,0.884730947828462,0.339795146168619,MICA
Positive Regulation Of Cell Division (GO:0051781),1/43,0.681086420132043,0.811081707498191,0,0,0.884730947828462,0.339795146168619,PRKCE
Positive Regulation Of Cell-Matrix Adhesion (GO:0001954),1/43,0.681086420132043,0.811081707498191,0,0,0.884730947828462,0.339795146168619,RIN2
Positive Regulation Of miRNA Transcription (GO:1902895),1/43,0.681086420132043,0.811081707498191,0,0,0.884730947828462,0.339795146168619,SMAD3
Positive Regulation Of Receptor-Mediated Endocytosis (GO:0048260),1/43,0.681086420132043,0.811081707498191,0,0,0.884730947828462,0.339795146168619,PICK1
Regulation Of JUN Kinase Activity (GO:0043506),1/43,0.681086420132043,0.811081707498191,0,0,0.884730947828462,0.339795146168619,ZNF675
Regulation Of Cell-Cell Adhesion (GO:0022407),1/43,0.681086420132043,0.811081707498191,0,0,0.884730947828462,0.339795146168619,CEACAM1
Mitochondrial Respiratory Chain Complex Assembly (GO:0033108),2/90,0.686994513034825,0.81767281714471,0,0,0.84413096482062,0.316911221740817,NDUFA6;NDUFS7
Positive Regulation Of Multicellular Organismal Process (GO:0051240),9/387,0.68805043750662,0.818484768136609,0,0,0.882940360610263,0.330125338039615,BMPR2;SMAD3;IFI16;BTN3A1;IRF4;EIF2AK2;G0S2;INHBA;ACVR1B
Extracellular Matrix Disassembly (GO:0022617),1/44,0.689459923116386,0.818827132117617,0,0,0.864111343323403,0.32131695835797,MMP8
Negative Regulation Of Immune System Process (GO:0002683),1/44,0.689459923116386,0.818827132117617,0,0,0.864111343323403,0.32131695835797,FCGR2B
Phosphatidylinositol Phosphate Biosynthetic Process (GO:0046854),1/44,0.689459923116386,0.818827132117617,0,0,0.864111343323403,0.32131695835797,PI4K2B
Endosomal Transport (GO:0016197),4/180,0.697597056030665,0.825603114614009,0,0,0.843531468531469,0.303767176229937,RNF126;VPS51;HEATR5B;ANKFY1
Regulation Of Cellular Metabolic Process (GO:0031323),1/45,0.697613975868109,0.825603114614009,0,0,0.844428993568573,0.304069906308046,PNPT1
Detection Of Chemical Stimulus Involved In Sensory Perception Of Taste (GO:0050912),1/45,0.697613975868109,0.825603114614009,0,0,0.844428993568573,0.304069906308046,RTP4
Mitotic Nuclear Division (GO:0140014),1/45,0.697613975868109,0.825603114614009,0,0,0.844428993568573,0.304069906308046,NDC80
Regulation Of Apoptotic Signaling Pathway (GO:2001233),1/45,0.697613975868109,0.825603114614009,0,0,0.844428993568573,0.304069906308046,NR4A2
B Cell Activation (GO:0042113),2/92,0.69855825177158,0.825603114614009,0,0,0.825287356321839,0.296060869559899,DNAJB9;SLC25A5
Sensory Perception Of Sound (GO:0007605),2/92,0.69855825177158,0.825603114614009,0,0,0.825287356321839,0.296060869559899,MYO7B;TIMM10
Steroid Metabolic Process (GO:0008202),2/92,0.69855825177158,0.825603114614009,0,0,0.825287356321839,0.296060869559899,STS;DHRS9
Positive Regulation Of Protein Catabolic Process (GO:0045732),2/92,0.69855825177158,0.825603114614009,0,0,0.825287356321839,0.296060869559899,PLK3;TNFSF13B
Regulation Of Cell Migration (GO:0030334),10/434,0.704143005623107,0.826732990192159,0,0,0.874201600469863,0.306647026511799,CCR1;BST2;NTNG2;CEACAM1;HSPA5;PLAU;OSGIN1;FUZ;ELP5;RIGI
Regulation Of Endothelial Cell Proliferation (GO:0001936),2/93,0.70420621956728,0.826732990192159,0,0,0.816176161003747,0.286219953653022,BMPR2;STAT1
Protein O-linked Glycosylation (GO:0006493),2/93,0.70420621956728,0.826732990192159,0,0,0.816176161003747,0.286219953653022,FKRP;GCNT1
B Cell Receptor Signaling Pathway (GO:0050853),1/46,0.705554319027007,0.826732990192159,0,0,0.825621414913958,0.287953233341698,CD38
Regulation Of Cytokine Production Involved In Inflammatory Response (GO:1900015),1/46,0.705554319027007,0.826732990192159,0,0,0.825621414913958,0.287953233341698,GBP5
T Cell Differentiation (GO:0030217),1/46,0.705554319027007,0.826732990192159,0,0,0.825621414913958,0.287953233341698,RHOH
Amino Acid Transport (GO:0006865),1/46,0.705554319027007,0.826732990192159,0,0,0.825621414913958,0.287953233341698,SLC7A7
Regulation Of Nervous System Development (GO:0051960),1/46,0.705554319027007,0.826732990192159,0,0,0.825621414913958,0.287953233341698,HES1
Cardiac Conduction (GO:0061337),1/46,0.705554319027007,0.826732990192159,0,0,0.825621414913958,0.287953233341698,KCNJ2
Cellular Component Disassembly (GO:0022411),1/46,0.705554319027007,0.826732990192159,0,0,0.825621414913958,0.287953233341698,MMP8
Response To Glucose (GO:0009749),1/46,0.705554319027007,0.826732990192159,0,0,0.825621414913958,0.287953233341698,PCK2
Epithelial Cell Migration (GO:0010631),1/46,0.705554319027007,0.826732990192159,0,0,0.825621414913958,0.287953233341698,STAT1
Vacuolar Transport (GO:0007034),1/46,0.705554319027007,0.826732990192159,0,0,0.825621414913958,0.287953233341698,VPS51
Male Gonad Development (GO:0008584),1/46,0.705554319027007,0.826732990192159,0,0,0.825621414913958,0.287953233341698,INHBA
Mitotic G2/M Transition Checkpoint (GO:0044818),1/46,0.705554319027007,0.826732990192159,0,0,0.825621414913958,0.287953233341698,TNFSF13B
Myofibril Assembly (GO:0030239),1/46,0.705554319027007,0.826732990192159,0,0,0.825621414913958,0.287953233341698,TMOD2
Cellular Response To Hormone Stimulus (GO:0032870),2/94,0.709765867789579,0.831223128587796,0,0,0.807263035149092,0.276746016238209,LMO2;SERPINB9
Bicellular Tight Junction Assembly (GO:0070830),1/47,0.713286543126982,0.833563249438683,0,0,0.807631557070413,0.272876134300645,OCLN
Secondary Alcohol Metabolic Process (GO:1902652),1/47,0.713286543126982,0.833563249438683,0,0,0.807631557070413,0.272876134300645,CLN6
Positive Regulation Of Epithelial To Mesenchymal Transition (GO:0010718),1/47,0.713286543126982,0.833563249438683,0,0,0.807631557070413,0.272876134300645,SMAD3
Positive Regulation Of Smooth Muscle Cell Proliferation (GO:0048661),1/47,0.713286543126982,0.833563249438683,0,0,0.807631557070413,0.272876134300645,STAT1
Regulation Of Macroautophagy (GO:0016241),2/96,0.720623190912906,0.838781744751278,0,0,0.790005706366675,0.258836599366635,LARP1;SESN2
Cellular Response To Transforming Growth Factor Beta Stimulus (GO:0071560),2/96,0.720623190912906,0.838781744751278,0,0,0.790005706366675,0.258836599366635,SMAD3;HYAL2
Regulation Of Intrinsic Apoptotic Signaling Pathway (GO:2001242),1/48,0.720816092978039,0.838781744751278,0,0,0.790407225092551,0.258756598431155,SEPTIN4
Cellular Defense Response (GO:0006968),1/48,0.720816092978039,0.838781744751278,0,0,0.790407225092551,0.258756598431155,LGALS3BP
Cellular Response To Mechanical Stimulus (GO:0071260),1/48,0.720816092978039,0.838781744751278,0,0,0.790407225092551,0.258756598431155,MAP3K14
Chloride Transmembrane Transport (GO:1902476),1/48,0.720816092978039,0.838781744751278,0,0,0.790407225092551,0.258756598431155,APOL1
Retrograde Vesicle-Mediated Transport, Golgi To Endoplasmic Reticulum (GO:0006890),1/48,0.720816092978039,0.838781744751278,0,0,0.790407225092551,0.258756598431155,PICK1
Negative Regulation Of ERK1 And ERK2 Cascade (GO:0070373),1/48,0.720816092978039,0.838781744751278,0,0,0.790407225092551,0.258756598431155,GBP1
Regulation Of Mitotic Metaphase/Anaphase Transition (GO:0030071),1/49,0.72814827114078,0.845068740751621,0,0,0.773900573613767,0.245520407678364,SMARCD3
Autophagy Of Mitochondrion (GO:0000422),1/49,0.72814827114078,0.845068740751621,0,0,0.773900573613767,0.245520407678364,MAP1LC3A
Fatty Acid Beta-Oxidation (GO:0006635),1/49,0.72814827114078,0.845068740751621,0,0,0.773900573613767,0.245520407678364,ECI1
Negative Regulation Of DNA Metabolic Process (GO:0051053),1/49,0.72814827114078,0.845068740751621,0,0,0.773900573613767,0.245520407678364,BMPR2
Negative Regulation Of Tumor Necrosis Factor Superfamily Cytokine Production (GO:1903556),1/49,0.72814827114078,0.845068740751621,0,0,0.773900573613767,0.245520407678364,CD274
Positive Regulation Of Cold-Induced Thermogenesis (GO:0120162),2/98,0.73113640064289,0.847070620230735,0,0,0.773467432950192,0.242215381185047,IRF4;G0S2
Positive Regulation Of Protein-Containing Complex Assembly (GO:0031334),2/98,0.73113640064289,0.847070620230735,0,0,0.773467432950192,0.242215381185047,GBP5;ISG15
Ras Protein Signal Transduction (GO:0007265),3/144,0.731566134033953,0.847070620230735,0,0,0.78960264630212,0.24680424659921,ARHGEF3;TAX1BP3;RASGRP3
Actin Filament Organization (GO:0007015),3/144,0.731566134033953,0.847070620230735,0,0,0.78960264630212,0.24680424659921,NEBL;MYO7B;CD2AP
Endocytosis (GO:0006897),4/189,0.733164110158444,0.847070620230735,0,0,0.802120582120582,0.248966769441276,SCARB2;HEATR5B;FCGR2B;EPN2
G Protein-Coupled Receptor Signaling Pathway, Coupled To Cyclic Nucleotide Second Messenger (GO:0007187),1/50,0.735288241579282,0.847070620230735,0,0,0.758067663011667,0.233100265835463,CCR1
Regulation Of Mitochondrion Organization (GO:0010821),1/50,0.735288241579282,0.847070620230735,0,0,0.758067663011667,0.233100265835463,STAT2
Cell Chemotaxis (GO:0060326),1/50,0.735288241579282,0.847070620230735,0,0,0.758067663011667,0.233100265835463,DOCK4
Ribosome Assembly (GO:0042255),1/50,0.735288241579282,0.847070620230735,0,0,0.758067663011667,0.233100265835463,RPL10
Nucleocytoplasmic Transport (GO:0006913),1/50,0.735288241579282,0.847070620230735,0,0,0.758067663011667,0.233100265835463,NUP205
Plasma Membrane Bounded Cell Projection Morphogenesis (GO:0120039),1/50,0.735288241579282,0.847070620230735,0,0,0.758067663011667,0.233100265835463,TNIK
Positive Regulation Of Cell Death (GO:0010942),1/50,0.735288241579282,0.847070620230735,0,0,0.758067663011667,0.233100265835463,HP
Positive Regulation Of Developmental Growth (GO:0048639),1/50,0.735288241579282,0.847070620230735,0,0,0.758067663011667,0.233100265835463,AGRN
Pyruvate Metabolic Process (GO:0006090),1/50,0.735288241579282,0.847070620230735,0,0,0.758067663011667,0.233100265835463,PCK2
Cellular Response To Insulin Stimulus (GO:0032869),2/99,0.736265977047053,0.847751046126733,0,0,0.765454042738081,0.234354351883974,CEACAM1;PCK2
Translation (GO:0006412),5/234,0.737285621755678,0.848478986676266,0,0,0.809711319214815,0.246783747360335,RPL10;SRBD1;IGF2BP3;GTPBP2;MRPL55
Neuron Projection Morphogenesis (GO:0048812),3/146,0.740068528495758,0.848829171557228,0,0,0.778478718977759,0.234331818387066,NTNG2;TNIK;LLGL1
Regulation Of Organelle Organization (GO:0033043),2/100,0.741311974930488,0.848829171557228,0,0,0.757604191101728,0.226776483454123,SCARB2;STMN3
Amide Biosynthetic Process (GO:0043604),1/51,0.742241033576298,0.848829171557228,0,0,0.742868068833652,0.221435039177911,PCSK5
Regulation Of Smoothened Signaling Pathway (GO:0008589),1/51,0.742241033576298,0.848829171557228,0,0,0.742868068833652,0.221435039177911,FUZ
Regulation Of Substrate Adhesion-Dependent Cell Spreading (GO:1900024),1/51,0.742241033576298,0.848829171557228,0,0,0.742868068833652,0.221435039177911,GBP1
Regulation Of Telomere Maintenance Via Telomerase (GO:0032210),1/51,0.742241033576298,0.848829171557228,0,0,0.742868068833652,0.221435039177911,XRN1
Microtubule Bundle Formation (GO:0001578),1/51,0.742241033576298,0.848829171557228,0,0,0.742868068833652,0.221435039177911,RSPH9
Positive Regulation Of Ras Protein Signal Transduction (GO:0046579),1/51,0.742241033576298,0.848829171557228,0,0,0.742868068833652,0.221435039177911,ARHGEF3
Positive Regulation Of Leukocyte Mediated Cytotoxicity (GO:0001912),1/51,0.742241033576298,0.848829171557228,0,0,0.742868068833652,0.221435039177911,MICA
Positive Regulation Of Protein Localization To Cell Periphery (GO:1904377),1/51,0.742241033576298,0.848829171557228,0,0,0.742868068833652,0.221435039177911,PRKCE
Positive Regulation Of Protein Localization To Plasma Membrane (GO:1903078),1/51,0.742241033576298,0.848829171557228,0,0,0.742868068833652,0.221435039177911,PRKCE
Regulated Exocytosis (GO:0045055),1/51,0.742241033576298,0.848829171557228,0,0,0.742868068833652,0.221435039177911,OTOF
Regulation Of Peptide Hormone Secretion (GO:0090276),1/52,0.749011544832863,0.852565115999984,0,0,0.728264537172422,0.210469093515109,PICK1
Regulation Of Proteolysis (GO:0030162),1/52,0.749011544832863,0.852565115999984,0,0,0.728264537172422,0.210469093515109,CLN6
Cell Cycle G1/S Phase Transition (GO:0044843),1/52,0.749011544832863,0.852565115999984,0,0,0.728264537172422,0.210469093515109,PLK3
Sprouting Angiogenesis (GO:0002040),1/52,0.749011544832863,0.852565115999984,0,0,0.728264537172422,0.210469093515109,RNF213
Fatty Acid Oxidation (GO:0019395),1/52,0.749011544832863,0.852565115999984,0,0,0.728264537172422,0.210469093515109,ECI1
Negative Regulation Of Response To Stimulus (GO:0048585),1/52,0.749011544832863,0.852565115999984,0,0,0.728264537172422,0.210469093515109,FCGR2B
Positive Regulation Of Telomere Maintenance (GO:0032206),1/52,0.749011544832863,0.852565115999984,0,0,0.728264537172422,0.210469093515109,PML
Positive Regulation Of Transcription Initiation By RNA Polymerase II (GO:0060261),1/52,0.749011544832863,0.852565115999984,0,0,0.728264537172422,0.210469093515109,TAF13
Regulation Of Cell Development (GO:0060284),1/52,0.749011544832863,0.852565115999984,0,0,0.728264537172422,0.210469093515109,HES1
Regulation Of RNA Splicing (GO:0043484),2/102,0.751156642760258,0.854254867948672,0,0,0.742375478927203,0.212424113925861,METTL4;HNRNPLL
Negative Regulation Of Protein Phosphorylation (GO:0001933),3/149,0.752419972769085,0.854254867948672,0,0,0.762364262614046,0.216862623383568,OCLN;CEACAM1;TRIB2
Positive Regulation Of Cell Differentiation (GO:0045597),6/283,0.75461909643289,0.854254867948672,0,0,0.802823968888951,0.226028798375918,CEACAM1;SMAD3;BMPR2;SMARCD3;TENT5A;RIN2
Regulation Of Programmed Cell Death (GO:0043067),4/195,0.75507488275673,0.854254867948672,0,0,0.776681433749497,0.218199602175799,STAT1;OSGIN1;SEPTIN4;NAIP
Regulation Of Cyclin-Dependent Protein Kinase Activity (GO:1904029),1/53,0.755604545401606,0.854254867948672,0,0,0.714222679805854,0.200151712365573,HERC5
Actin Cytoskeleton Reorganization (GO:0031532),1/53,0.755604545401606,0.854254867948672,0,0,0.714222679805854,0.200151712365573,TNIK
Actin Polymerization Or Depolymerization (GO:0008154),1/53,0.755604545401606,0.854254867948672,0,0,0.714222679805854,0.200151712365573,PSTPIP2
Blood Vessel Morphogenesis (GO:0048514),1/53,0.755604545401606,0.854254867948672,0,0,0.714222679805854,0.200151712365573,HES1
Endosome Organization (GO:0007032),1/53,0.755604545401606,0.854254867948672,0,0,0.714222679805854,0.200151712365573,PI4K2B
Spermatid Development (GO:0007286),1/53,0.755604545401606,0.854254867948672,0,0,0.714222679805854,0.200151712365573,TTC21A
Tight Junction Assembly (GO:0120192),1/53,0.755604545401606,0.854254867948672,0,0,0.714222679805854,0.200151712365573,OCLN
Gonad Development (GO:0008406),1/53,0.755604545401606,0.854254867948672,0,0,0.714222679805854,0.200151712365573,INHBA
Inorganic Cation Import Across Plasma Membrane (GO:0098659),2/103,0.755957047527181,0.854254867948672,0,0,0.734987291832632,0.205627923721688,CACNA1A;KCNJ2
Mitochondrial Gene Expression (GO:0140053),2/103,0.755957047527181,0.854254867948672,0,0,0.734987291832632,0.205627923721688,POLRMT;MRPL55
Negative Regulation Of Nucleic Acid-Templated Transcription (GO:1903507),10/456,0.759427942500397,0.855812333520377,0,0,0.830119872275828,0.228440551814427,KLF10;CBX5;RING1;IFI16;TRIM28;CD38;HES1;ZNF653;PML;GZF1
Regulation Of Exocytosis (GO:0017157),1/54,0.762024680531843,0.855812333520377,0,0,0.700710703849345,0.190436586756637,SEPTIN4
Regulation Of Lipid Metabolic Process (GO:0019216),1/54,0.762024680531843,0.855812333520377,0,0,0.700710703849345,0.190436586756637,RNF213
Apical Junction Assembly (GO:0043297),1/54,0.762024680531843,0.855812333520377,0,0,0.700710703849345,0.190436586756637,OCLN
Regulation Of Myoblast Differentiation (GO:0045661),1/54,0.762024680531843,0.855812333520377,0,0,0.700710703849345,0.190436586756637,SMARCD3
Ribosomal Large Subunit Biogenesis (GO:0042273),1/54,0.762024680531843,0.855812333520377,0,0,0.700710703849345,0.190436586756637,RPL10
Endoplasmic Reticulum Organization (GO:0007029),1/54,0.762024680531843,0.855812333520377,0,0,0.700710703849345,0.190436586756637,TOR1B
Negative Regulation Of Protein Catabolic Process (GO:0042177),1/54,0.762024680531843,0.855812333520377,0,0,0.700710703849345,0.190436586756637,LAMP3
Negative Regulation Of Protein Modification By Small Protein Conjugation Or Removal (GO:1903321),1/54,0.762024680531843,0.855812333520377,0,0,0.700710703849345,0.190436586756637,ISG15
Nucleosome Assembly (GO:0006334),1/54,0.762024680531843,0.855812333520377,0,0,0.700710703849345,0.190436586756637,CABIN1
Organelle Disassembly (GO:1903008),1/54,0.762024680531843,0.855812333520377,0,0,0.700710703849345,0.190436586756637,PLK3
Positive Regulation Of Leukocyte Chemotaxis (GO:0002690),1/54,0.762024680531843,0.855812333520377,0,0,0.700710703849345,0.190436586756637,CCR1
Regulation Of Neuron Apoptotic Process (GO:0043523),2/105,0.765318416487953,0.858630805383513,0,0,0.72064129747424,0.192745100297119,FCGR2B;NAIP
Cellular Response To Organonitrogen Compound (GO:0071417),2/105,0.765318416487953,0.858630805383513,0,0,0.72064129747424,0.192745100297119,LARP1;SESN2
Regulation Of Cellular Component Organization (GO:0051128),3/153,0.768150716115552,0.860186850163485,0,0,0.741880998080614,0.195685446492856,CEACAM1;METTL4;CHPT1
Ceramide Metabolic Process (GO:0006672),1/55,0.768276474392592,0.860186850163485,0,0,0.687699171446781,0.181281365030652,CLN6
Phosphatidylcholine Metabolic Process (GO:0046470),1/55,0.768276474392592,0.860186850163485,0,0,0.687699171446781,0.181281365030652,CHPT1
Purine Ribonucleotide Biosynthetic Process (GO:0009152),1/55,0.768276474392592,0.860186850163485,0,0,0.687699171446781,0.181281365030652,AMPD2
Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000045),2/106,0.769881175242634,0.861543062739585,0,0,0.713675213675214,0.1866396952259,SMARCD3;INHBA
Epithelium Development (GO:0060429),3/154,0.7719538547477,0.86303200427673,0,0,0.736929745395381,0.190739897698288,DHRS9;STAT1;FUZ
RNA Polymerase II Preinitiation Complex Assembly (GO:0051123),1/56,0.774364332604464,0.86303200427673,0,0,0.675160785677038,0.172647256430373,TAF13
Regulation Of Reactive Oxygen Species Metabolic Process (GO:2000377),1/56,0.774364332604464,0.86303200427673,0,0,0.675160785677038,0.172647256430373,DCXR
Mitotic DNA Damage Checkpoint Signaling (GO:0044773),1/56,0.774364332604464,0.86303200427673,0,0,0.675160785677038,0.172647256430373,TNFSF13B
Peptide Metabolic Process (GO:0006518),1/56,0.774364332604464,0.86303200427673,0,0,0.675160785677038,0.172647256430373,PCSK5
Positive Regulation Of DNA-templated Transcription Initiation (GO:2000144),1/56,0.774364332604464,0.86303200427673,0,0,0.675160785677038,0.172647256430373,TAF13
post-Golgi Vesicle-Mediated Transport (GO:0006892),1/56,0.774364332604464,0.86303200427673,0,0,0.675160785677038,0.172647256430373,LLGL1
Regulation Of Cation Channel Activity (GO:2001257),1/56,0.774364332604464,0.86303200427673,0,0,0.675160785677038,0.172647256430373,CACNA1A
Positive Regulation Of DNA Metabolic Process (GO:0051054),2/108,0.778775383293647,0.866112861520763,0,0,0.700137352707294,0.175057172800958,TRIM28;PML
Positive Regulation Of Metabolic Process (GO:0009893),2/108,0.778775383293647,0.866112861520763,0,0,0.700137352707294,0.175057172800958,IRF4;G0S2
RNA Catabolic Process (GO:0006401),1/57,0.780292546018478,0.866112861520763,0,0,0.663070199399071,0.164498679233535,PNPT1
Regulation Of Transcription Initiation By RNA Polymerase II (GO:0060260),1/57,0.780292546018478,0.866112861520763,0,0,0.663070199399071,0.164498679233535,TAF13
Endosome To Lysosome Transport (GO:0008333),1/57,0.780292546018478,0.866112861520763,0,0,0.663070199399071,0.164498679233535,DTX3L
Striated Muscle Contraction (GO:0006941),1/57,0.780292546018478,0.866112861520763,0,0,0.663070199399071,0.164498679233535,GAA
Monoatomic Anion Transport (GO:0006820),1/57,0.780292546018478,0.866112861520763,0,0,0.663070199399071,0.164498679233535,SLC26A8
Regulation Of Calcium Ion Transport (GO:0051924),1/57,0.780292546018478,0.866112861520763,0,0,0.663070199399071,0.164498679233535,CCR1
Extracellular Structure Organization (GO:0043062),2/109,0.783108667564267,0.868358471881389,0,0,0.693558205321016,0.169563751809731,COL9A2;MMP8
Regulation Of Wnt Signaling Pathway (GO:0030111),2/109,0.783108667564267,0.868358471881389,0,0,0.693558205321016,0.169563751809731,TAX1BP3;EMD
Selective Autophagy (GO:0061912),1/58,0.786065293250141,0.868634143218858,0,0,0.651403844218577,0.156802949761962,RNF213
Glycosaminoglycan Biosynthetic Process (GO:0006024),1/58,0.786065293250141,0.868634143218858,0,0,0.651403844218577,0.156802949761962,B4GALT4
Inorganic Anion Transport (GO:0015698),1/58,0.786065293250141,0.868634143218858,0,0,0.651403844218577,0.156802949761962,SLC26A8
Peptidyl-Threonine Phosphorylation (GO:0018107),1/58,0.786065293250141,0.868634143218858,0,0,0.651403844218577,0.156802949761962,ACVR1B
Positive Regulation Of Mitochondrion Organization (GO:0010822),1/58,0.786065293250141,0.868634143218858,0,0,0.651403844218577,0.156802949761962,TNFSF10
Response To Lipid (GO:0033993),2/110,0.787367303295348,0.868634143218858,0,0,0.687100893997446,0.164258632583857,TRIM6;GCH1
External Encapsulating Structure Organization (GO:0045229),2/110,0.787367303295348,0.868634143218858,0,0,0.687100893997446,0.164258632583857,COL9A2;MMP8
RNA Metabolic Process (GO:0016070),2/111,0.791552218387228,0.868634143218858,0,0,0.680762065450455,0.159134550942054,PNPT1;ADAR
Regulation Of Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0017015),2/111,0.791552218387228,0.868634143218858,0,0,0.680762065450455,0.159134550942054,SMAD3;STRAP
Cytoskeleton Organization (GO:0007010),2/111,0.791552218387228,0.868634143218858,0,0,0.680762065450455,0.159134550942054,FMNL2;TNIK
Negative Regulation Of Inflammatory Response (GO:0050728),2/111,0.791552218387228,0.868634143218858,0,0,0.680762065450455,0.159134550942054,SIGLEC10;RHBDF2
Regulation Of miRNA Transcription (GO:1902893),1/59,0.791686643773899,0.868634143218858,0,0,0.640139777147755,0.149530005536313,SMAD3
Regulation Of Multicellular Organismal Development (GO:2000026),1/59,0.791686643773899,0.868634143218858,0,0,0.640139777147755,0.149530005536313,OAS2
Cilium Movement (GO:0003341),1/59,0.791686643773899,0.868634143218858,0,0,0.640139777147755,0.149530005536313,RSPH9
Transcription Preinitiation Complex Assembly (GO:0070897),1/59,0.791686643773899,0.868634143218858,0,0,0.640139777147755,0.149530005536313,TAF13
Heart Morphogenesis (GO:0003007),1/59,0.791686643773899,0.868634143218858,0,0,0.640139777147755,0.149530005536313,HES1
Negative Regulation Of Protein-Containing Complex Assembly (GO:0031333),1/59,0.791686643773899,0.868634143218858,0,0,0.640139777147755,0.149530005536313,HSPA5
Phospholipid Transport (GO:0015914),1/59,0.791686643773899,0.868634143218858,0,0,0.640139777147755,0.149530005536313,SCARB2
Positive Regulation Of Protein Binding (GO:0032092),1/59,0.791686643773899,0.868634143218858,0,0,0.640139777147755,0.149530005536313,DTX3L
Positive Regulation Of Proteolysis (GO:0045862),1/59,0.791686643773899,0.868634143218858,0,0,0.640139777147755,0.149530005536313,CLN6
protein-DNA Complex Assembly (GO:0065004),1/59,0.791686643773899,0.868634143218858,0,0,0.640139777147755,0.149530005536313,CABIN1
Phosphorylation (GO:0016310),9/429,0.795079840067159,0.870817047713687,0,0,0.792898751733703,0.181821786581503,CDK17;BMPR2;TAF13;PRKCE;EIF2AK2;PICK1;TNIK;ACVR1B;TRIB2
Calcium Ion Transport (GO:0006816),2/112,0.795664343595931,0.870817047713687,0,0,0.674538488331592,0.154184564804022,CCR1;CACNA1A
Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071900),2/112,0.795664343595931,0.870817047713687,0,0,0.674538488331592,0.154184564804022,HERC5;TRIB2
Small GTPase Mediated Signal Transduction (GO:0007264),2/112,0.795664343595931,0.870817047713687,0,0,0.674538488331592,0.154184564804022,RIN2;RASGRP3
Protein Deubiquitination (GO:0016579),2/112,0.795664343595931,0.870817047713687,0,0,0.674538488331592,0.154184564804022,JOSD1;USP18
Sterol Metabolic Process (GO:0016125),1/60,0.797160560721917,0.871148516956586,0,0,0.629257542858995,0.142652158980936,CLN6
Homophilic Cell Adhesion Via Plasma Membrane Adhesion Molecules (GO:0007156),1/60,0.797160560721917,0.871148516956586,0,0,0.629257542858995,0.142652158980936,CEACAM1
Positive Regulation Of Phagocytosis (GO:0050766),1/60,0.797160560721917,0.871148516956586,0,0,0.629257542858995,0.142652158980936,FCGR2B
Regulation Of Macromolecule Metabolic Process (GO:0060255),3/162,0.800570699597851,0.874002907337634,0,0,0.699561800601166,0.155603832922063,IGF2BP3;YBX3;AFF1
Protein Autophosphorylation (GO:0046777),3/162,0.800570699597851,0.874002907337634,0,0,0.699561800601166,0.155603832922063,EIF2AK2;TNIK;ACVR1B
Negative Regulation Of Autophagy (GO:0010507),1/61,0.802490903711119,0.874181509199917,0,0,0.618738049713193,0.136143877641401,RUBCN
Negative Regulation Of Intrinsic Apoptotic Signaling Pathway (GO:2001243),1/61,0.802490903711119,0.874181509199917,0,0,0.618738049713193,0.136143877641401,YBX3
Regulation Of Cytoskeleton Organization (GO:0051493),2/114,0.803673956046481,0.874181509199917,0,0,0.662424740010947,0.144780623878917,BST2;STMN3
Negative Regulation Of Canonical Wnt Signaling Pathway (GO:0090090),2/114,0.803673956046481,0.874181509199917,0,0,0.662424740010947,0.144780623878917,FUZ;EMD
Regulation Of MAP Kinase Activity (GO:0043405),2/114,0.803673956046481,0.874181509199917,0,0,0.662424740010947,0.144780623878917,HYAL2;TRIB2
Nervous System Development (GO:0007399),9/433,0.80368153864559,0.874181509199917,0,0,0.785253709470599,0.171618913577353,TMOD2;STMN3;FUZ;IGF2BP3;HES1;BTBD6;INHBA;ACVR1B;NAIP
Negative Regulation Of Cell Migration (GO:0030336),3/163,0.8039276527528,0.874181509199917,0,0,0.695153550863724,0.15171448046475,BST2;HYAL2;FUZ
Nitrogen Compound Transport (GO:0071705),3/163,0.8039276527528,0.874181509199917,0,0,0.695153550863724,0.15171448046475,SCARB2;SLC26A8;PICK1
mRNA Splicing, Via Spliceosome (GO:0000398),4/211,0.806705737200494,0.876767029513192,0,0,0.716053511705686,0.153805655747673,METTL14;TSSC4;EIF4A3;STRAP
Endoplasmic Reticulum To Golgi Vesicle-Mediated Transport (GO:0006888),2/115,0.807573311571731,0.876957032640074,0,0,0.656528667819483,0.140314252079024,STX17;YIF1B
Fat Cell Differentiation (GO:0045444),1/62,0.80768143143152,0.876957032640074,0,0,0.608563457982008,0.129981587890185,NR4A2
Telomere Organization (GO:0032200),1/63,0.812735804455844,0.881134362256583,0,0,0.598717078887313,0.124143498960829,SP100
Phosphatidylinositol Metabolic Process (GO:0046488),1/63,0.812735804455844,0.881134362256583,0,0,0.598717078887313,0.124143498960829,PI4K2B
Positive Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901992),1/63,0.812735804455844,0.881134362256583,0,0,0.598717078887313,0.124143498960829,TNFSF13B
mRNA Processing (GO:0006397),4/214,0.815331816005928,0.883511468111323,0,0,0.705714285714286,0.144078707890282,METTL14;ALYREF;EIF4A3;CMTR1
Protein Localization (GO:0008104),7/351,0.816509466754021,0.884350015920527,0,0,0.753025055103234,0.152650808653354,RTP4;OCLN;STX17;HEATR5B;AP4E1;PICK1;DNAJC15
Endocytic Recycling (GO:0032456),1/64,0.817657587654127,0.884718437234456,0,0,0.589183283255941,0.118609445362538,VPS51
Negative Regulation Of Cell Death (GO:0060548),1/64,0.817657587654127,0.884718437234456,0,0,0.589183283255941,0.118609445362538,CHMP5
Regulation Of Small GTPase Mediated Signal Transduction (GO:0051056),2/118,0.818860779892884,0.885582769365638,0,0,0.639450389747655,0.127788531628647,ARHGEF3;CD2AP
Antimicrobial Humoral Immune Response Mediated By Antimicrobial Peptide (GO:0061844),1/65,0.822450252823501,0.886442925666465,0,0,0.57994741873805,0.11336074509915,CXCL8
Canonical Wnt Signaling Pathway (GO:0060070),1/65,0.822450252823501,0.886442925666465,0,0,0.57994741873805,0.11336074509915,NR4A2
Regulation Of Translational Initiation (GO:0006446),1/65,0.822450252823501,0.886442925666465,0,0,0.57994741873805,0.11336074509915,LARP1
Positive Regulation Of T Cell Proliferation (GO:0042102),1/65,0.822450252823501,0.886442925666465,0,0,0.57994741873805,0.11336074509915,CD274
Regulation Of Cell-Matrix Adhesion (GO:0001952),1/65,0.822450252823501,0.886442925666465,0,0,0.57994741873805,0.11336074509915,PLAU
Regulation Of Protein Kinase Activity (GO:0045859),2/119,0.822489509111532,0.886442925666465,0,0,0.63395225464191,0.123886665149996,CEACAM1;TRIB2
Regulation Of Protein-Containing Complex Assembly (GO:0043254),2/119,0.822489509111532,0.886442925666465,0,0,0.63395225464191,0.123886665149996,HSPA5;EIF2AK2
Regulation Of Endocytosis (GO:0030100),1/66,0.827117180666314,0.890553896587624,0,0,0.570995734666863,0.108380072487135,RUBCN
Peptidyl-Threonine Modification (GO:0018210),1/66,0.827117180666314,0.890553896587624,0,0,0.570995734666863,0.108380072487135,ACVR1B
Heart Development (GO:0007507),3/171,0.829107029130011,0.89181944685399,0,0,0.661776802851659,0.124020960636393,BMPR2;PRMT1;PCSK5
Metal Ion Transport (GO:0030001),3/171,0.829107029130011,0.89181944685399,0,0,0.661776802851659,0.124020960636393,SLC5A6;CCR1;KCNJ2
Regulation Of Neurogenesis (GO:0050767),1/67,0.831661664123799,0.892794051758603,0,0,0.562315313749348,0.103651342554421,HES1
Cholesterol Metabolic Process (GO:0008203),1/67,0.831661664123799,0.892794051758603,0,0,0.562315313749348,0.103651342554421,CLN6
Protein Secretion (GO:0009306),1/67,0.831661664123799,0.892794051758603,0,0,0.562315313749348,0.103651342554421,PCSK5
Negative Regulation Of Signal Transduction (GO:0009968),5/267,0.832030915097534,0.892794051758603,0,0,0.706511347423848,0.12991732045457,NR4A2;CXCL8;TAX1BP3;ZNF653;EPN2
Generation Of Neurons (GO:0048699),3/172,0.832051442757676,0.892794051758603,0,0,0.657826891844314,0.120948716630949,NR4A2;DDIT4;SEPTIN4
Regulation Of Protein Catabolic Process (GO:0042176),2/122,0.832987396507083,0.893360626028654,0,0,0.618007662835249,0.112932722394874,GPX1;TNFSF13B
Positive Regulation Of Cell Motility (GO:2000147),4/221,0.834235262489905,0.894261000906947,0,0,0.682701169797944,0.123732641966045,CCR1;HSPA5;PLAU;ELP5
Telomere Maintenance (GO:0000723),1/68,0.836086909463871,0.895662160708596,0,0,0.553894009874147,0.0991596081471658,SP100
Modulation Of Chemical Synaptic Transmission (GO:0050804),2/123,0.836360328150264,0.895662160708596,0,0,0.612868496881036,0.109516992161423,CACNA1A;OTOF
Enzyme-Linked Receptor Protein Signaling Pathway (GO:0007167),2/124,0.839671602253318,0.898227099361204,0,0,0.607813579549023,0.106212027344321,BMPR2;ACVR1B
Protein Dephosphorylation (GO:0006470),2/124,0.839671602253318,0.898227099361204,0,0,0.607813579549023,0.106212027344321,DAPP1;PPM1K
Cellular Response To Calcium Ion (GO:0071277),1/69,0.840396039539318,0.898227099361204,0,0,0.545720391407041,0.0948909654387145,CACNA1A
Phagocytosis (GO:0006909),1/69,0.840396039539318,0.898227099361204,0,0,0.545720391407041,0.0948909654387145,FCGR2B
Sensory Organ Development (GO:0007423),1/70,0.844592095408709,0.900514454208896,0,0,0.537783689417242,0.0908324693993059,MYO7B
Neutrophil Chemotaxis (GO:0030593),1/70,0.844592095408709,0.900514454208896,0,0,0.537783689417242,0.0908324693993059,CXCL8
Regulation Of G Protein-Coupled Receptor Signaling Pathway (GO:0008277),1/70,0.844592095408709,0.900514454208896,0,0,0.537783689417242,0.0908324693993059,CXCL8
Regulation Of Actin Filament Polymerization (GO:0030833),1/70,0.844592095408709,0.900514454208896,0,0,0.537783689417242,0.0908324693993059,PRKCE
Regulation Of Actin Filament-Based Process (GO:0032970),1/70,0.844592095408709,0.900514454208896,0,0,0.537783689417242,0.0908324693993059,BST2
Synapse Assembly (GO:0007416),1/71,0.848678038813684,0.903990712549595,0,0,0.530073750341437,0.0869720565774027,SRGAP2C
Negative Regulation Of Cellular Response To Growth Factor Stimulus (GO:0090288),1/71,0.848678038813684,0.903990712549595,0,0,0.530073750341437,0.0869720565774027,EPN2
Cellular Response To Lipid (GO:0071396),4/228,0.85149817558586,0.906025371496892,0,0,0.661126373626374,0.106281301653324,CD274;CXCL8;CHMP5;GBP3
Cellular Response To Hypoxia (GO:0071456),1/72,0.852656753723788,0.906025371496892,0,0,0.522580992648049,0.0832984755353675,PLK3
Second-Messenger-Mediated Signaling (GO:0019932),1/72,0.852656753723788,0.906025371496892,0,0,0.522580992648049,0.0832984755353675,CXCL8
Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0007179),1/72,0.852656753723788,0.906025371496892,0,0,0.522580992648049,0.0832984755353675,SMAD3
Negative Regulation Of Catabolic Process (GO:0009895),1/72,0.852656753723788,0.906025371496892,0,0,0.522580992648049,0.0832984755353675,PML
Cellular Response To Decreased Oxygen Levels (GO:0036294),1/73,0.856531049071011,0.908379175528093,0,0,0.515296367112811,0.0798012228540202,PICK1
Granulocyte Chemotaxis (GO:0071621),1/73,0.856531049071011,0.908379175528093,0,0,0.515296367112811,0.0798012228540202,CXCL8
Positive Regulation Of Secretion By Cell (GO:1903532),1/73,0.856531049071011,0.908379175528093,0,0,0.515296367112811,0.0798012228540202,CD2AP
Regulation Of Rho Protein Signal Transduction (GO:0035023),1/73,0.856531049071011,0.908379175528093,0,0,0.515296367112811,0.0798012228540202,ARHGEF3
Import Into Nucleus (GO:0051170),1/74,0.860303660101939,0.911056583957082,0,0,0.50821132035936,0.0764704856737366,NXT1
Negative Regulation Of Neuron Apoptotic Process (GO:0043524),1/74,0.860303660101939,0.911056583957082,0,0,0.50821132035936,0.0764704856737366,NAIP
Regulation Of Cell Cycle G1/S Phase Transition (GO:1902806),1/74,0.860303660101939,0.911056583957082,0,0,0.50821132035936,0.0764704856737366,SMARCD3
Regulation Of Plasma Membrane Bounded Cell Projection Assembly (GO:0120032),1/75,0.863977250763975,0.913698346622463,0,0,0.501317761356002,0.0732970886896334,FUZ
Positive Regulation Of Neurogenesis (GO:0050769),1/75,0.863977250763975,0.913698346622463,0,0,0.501317761356002,0.0732970886896334,SMARCD3
Circulatory System Development (GO:0072359),2/132,0.86404989765074,0.913698346622463,0,0,0.570173887415267,0.0833165224198074,NOTCH4;PCSK5
Negative Regulation Of Cell Motility (GO:2000146),2/133,0.866846419586247,0.916077227082964,0,0,0.565792167529467,0.0808479992889433,BST2;FUZ
Wnt Signaling Pathway (GO:0016055),1/76,0.867554415054826,0.916077227082964,0,0,0.494608030592734,0.0702724463517053,NR4A2
Positive Regulation Of Protein Secretion (GO:0050714),1/76,0.867554415054826,0.916077227082964,0,0,0.494608030592734,0.0702724463517053,CD2AP
Negative Regulation Of Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0030512),1/77,0.871037679409647,0.918426826146907,0,0,0.488074871691657,0.0673885185817831,STRAP
Neutrophil Migration (GO:1990266),1/77,0.871037679409647,0.918426826146907,0,0,0.488074871691657,0.0673885185817831,CXCL8
Positive Regulation Of Endothelial Cell Proliferation (GO:0001938),1/77,0.871037679409647,0.918426826146907,0,0,0.488074871691657,0.0673885185817831,BMPR2
Cellular Response To Metal Ion (GO:0071248),2/135,0.872281759702372,0.918853801706683,0,0,0.557226399331663,0.0761409689413904,MT2A;CACNA1A
Non-Membrane-Bounded Organelle Assembly (GO:0140694),2/135,0.872281759702372,0.918853801706683,0,0,0.557226399331663,0.0761409689413904,RNF213;TMOD2
Negative Regulation Of Protein Modification Process (GO:0031400),1/78,0.874429504031211,0.91959735372804,0,0,0.48171140522957,0.0646377708321393,OCLN
Organonitrogen Compound Catabolic Process (GO:1901565),1/78,0.874429504031211,0.91959735372804,0,0,0.48171140522957,0.0646377708321393,CLN6
Regulation Of TOR Signaling (GO:0032006),1/78,0.874429504031211,0.91959735372804,0,0,0.48171140522957,0.0646377708321393,DDIT4
Regulation Of Protein Kinase B Signaling (GO:0051896),2/136,0.874922255806406,0.91959735372804,0,0,0.553039400697661,0.0738972613656033,AIM2;HYAL2
Regulation Of Cyclin-Dependent Protein Serine/Threonine Kinase Activity (GO:0000079),1/79,0.877732284856687,0.91959735372804,0,0,0.475511104574202,0.0620131371390812,HERC5
Regulation Of Neuron Differentiation (GO:0045664),1/79,0.877732284856687,0.91959735372804,0,0,0.475511104574202,0.0620131371390812,HES1
Cellular Response To UV (GO:0034644),1/79,0.877732284856687,0.91959735372804,0,0,0.475511104574202,0.0620131371390812,HYAL2
Positive Regulation Of Catabolic Process (GO:0009896),1/79,0.877732284856687,0.91959735372804,0,0,0.475511104574202,0.0620131371390812,TNFSF13B
Positive Regulation Of Cytoskeleton Organization (GO:0051495),1/79,0.877732284856687,0.91959735372804,0,0,0.475511104574202,0.0620131371390812,PRKCE
Positive Regulation Of Protein Modification By Small Protein Conjugation Or Removal (GO:1903322),1/79,0.877732284856687,0.91959735372804,0,0,0.475511104574202,0.0620131371390812,SEPTIN4
Protein Import Into Nucleus (GO:0006606),1/79,0.877732284856687,0.91959735372804,0,0,0.475511104574202,0.0620131371390812,NXT1
Intracellular Monoatomic Cation Homeostasis (GO:0030003),3/190,0.878026514449923,0.91959735372804,0,0,0.593952395126608,0.0772604289751371,CCR1;MT2A;KCNJ2
Regulation Of Organelle Assembly (GO:1902115),1/80,0.880948355273052,0.921335672420241,0,0,0.469467773555679,0.0595079863679085,FUZ
Calcium Ion Transmembrane Transport (GO:0070588),1/80,0.880948355273052,0.921335672420241,0,0,0.469467773555679,0.0595079863679085,CACNA1A
Negative Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071901),1/80,0.880948355273052,0.921335672420241,0,0,0.469467773555679,0.0595079863679085,HYAL2
Protein Localization To Membrane (GO:0072657),3/192,0.882376538642848,0.922124732843681,0,0,0.587606251713737,0.0735309306727768,PICK1;TNIK;AGRN
Intracellular Calcium Ion Homeostasis (GO:0006874),2/139,0.882544949790117,0.922124732843681,0,0,0.540845149201555,0.067576198344962,CCR1;PML
Cilium Assembly (GO:0060271),4/243,0.88341032313187,0.922406495028856,0,0,0.619150305761184,0.0767532736411996,CPLANE1;FUZ;RSPH9;ENKD1
Activation Of Protein Kinase Activity (GO:0032147),1/81,0.88407998724273,0.922406495028856,0,0,0.46357552581262,0.0571160915249671,CAB39L
Cytoskeleton-Dependent Cytokinesis (GO:0061640),1/81,0.88407998724273,0.922406495028856,0,0,0.46357552581262,0.0571160915249671,SEPTIN4
Regulation Of Cell Differentiation (GO:0045595),3/193,0.884499378794794,0.922406495028856,0,0,0.584483281139509,0.071735659910505,SMARCD3;NOTCH4;EIF2AK2
Regulation Of ERK1 And ERK2 Cascade (GO:0070372),4/244,0.885309052217387,0.922811434724454,0,0,0.616538461538462,0.0751057803357863,NECAB2;CCR1;CEACAM1;GBP1
Regulation Of Apoptotic Process (GO:0042981),14/705,0.887359312193165,0.92450851270363,0,0,0.746261456825856,0.0891821930607346,PLK3;RPL10;HSPA5;STAT1;OSGIN1;IFI6;SERPINB9;SEPTIN4;MAPK8IP3;IFIT3;IFIT2;TNFSF10;CD38;NAIP
Regulation Of Epithelial To Mesenchymal Transition (GO:0010717),1/83,0.890098729741761,0.926040958733709,0,0,0.45222217040526,0.0526490120523734,SMAD3
Calcium Ion Transmembrane Import Into Cytosol (GO:0097553),1/83,0.890098729741761,0.926040958733709,0,0,0.45222217040526,0.0526490120523734,CACNA1A
Vascular Transport (GO:0010232),1/83,0.890098729741761,0.926040958733709,0,0,0.45222217040526,0.0526490120523734,SLC5A6
Positive Regulation Of Double-Strand Break Repair (GO:2000781),1/84,0.892990093710696,0.928010458546876,0,0,0.446750673823401,0.0505631480873437,SMARCD3
Positive Regulation Of Protein Ubiquitination (GO:0031398),1/84,0.892990093710696,0.928010458546876,0,0,0.446750673823401,0.0505631480873437,SEPTIN4
Protein Modification Process (GO:0036211),14/711,0.894080105676566,0.928010458546876,0,0,0.739601091512645,0.082805667320707,CDK17;UBL4A;BMPR2;TAF13;PRKCE;EIF2AK2;DAPP1;UBE2L6;ACVR1B;TP53INP2;PICK1;TNIK;RCE1;TRIB2
Regulation Of Cell Adhesion (GO:0030155),2/144,0.894301592768799,0.928010458546876,0,0,0.521666396848524,0.0582765053488734,CXCL8;PLAU
Regulation Of Kinase Activity (GO:0043549),1/85,0.895805529391824,0.928010458546876,0,0,0.44140945096968,0.0485691349819121,NLRC5
Calcium-Mediated Signaling (GO:0019722),1/85,0.895805529391824,0.928010458546876,0,0,0.44140945096968,0.0485691349819121,CXCL8
Epidermis Development (GO:0008544),1/85,0.895805529391824,0.928010458546876,0,0,0.44140945096968,0.0485691349819121,STS
Establishment Of Protein Localization To Organelle (GO:0072594),1/85,0.895805529391824,0.928010458546876,0,0,0.44140945096968,0.0485691349819121,NXT1
Transport Across Blood-Brain Barrier (GO:0150104),1/85,0.895805529391824,0.928010458546876,0,0,0.44140945096968,0.0485691349819121,SLC5A6
Positive Regulation Of Protein Kinase Activity (GO:0045860),2/145,0.896517771521931,0.928309181859588,0,0,0.517991586957104,0.0565839313692127,CAB39L;NAB2
Organic Substance Transport (GO:0071702),3/201,0.900287503283515,0.9317720378974,0,0,0.560635142209039,0.0588897424516111,CCR1;PICK1;ABCA13
Regulation Of Insulin Secretion (GO:0050796),1/87,0.901216524154198,0.93185277993281,0,0,0.431099648717151,0.0448385601649511,PICK1
Glucose Homeostasis (GO:0042593),1/87,0.901216524154198,0.93185277993281,0,0,0.431099648717151,0.0448385601649511,OAS1
Negative Regulation Of Neuron Death (GO:1901215),1/88,0.903815908942101,0.934099500039265,0,0,0.426122502802136,0.0430935896850637,NAIP
Regulation Of Vesicle-Mediated Transport (GO:0060627),1/89,0.906347019056855,0.935391127113343,0,0,0.421258473839736,0.0414236192106225,SEPTIN4
Sodium Ion Transport (GO:0006814),1/89,0.906347019056855,0.935391127113343,0,0,0.421258473839736,0.0414236192106225,SLC5A6
Positive Regulation Of Peptidyl-Serine Phosphorylation (GO:0033138),1/89,0.906347019056855,0.935391127113343,0,0,0.421258473839736,0.0414236192106225,TRIM6
Regulation Of Phosphatidylinositol 3-Kinase Signaling (GO:0014066),1/90,0.908811644586756,0.937492935301459,0,0,0.416503748898962,0.0398250130369216,CEACAM1
Protein Phosphorylation (GO:0006468),9/500,0.910460484057967,0.938642167158814,0,0,0.675716291301683,0.0633854187386314,CDK17;BMPR2;TAF13;PRKCE;EIF2AK2;PICK1;TNIK;ACVR1B;TRIB2
Regulation Of Epithelial Cell Proliferation (GO:0050678),1/91,0.911211528483853,0.938642167158814,0,0,0.411854684512428,0.0382943370939464,GPX1
Regulation Of Actin Cytoskeleton Organization (GO:0032956),1/91,0.911211528483853,0.938642167158814,0,0,0.411854684512428,0.0382943370939464,BST2
Positive Regulation Of MAPK Cascade (GO:0043410),5/310,0.911759327284708,0.938764892690884,0,0,0.605546606020405,0.0559399226869883,NECAB2;CCR1;TRIM5;EIF2AK2;MMP8
Protein Stabilization (GO:0050821),3/208,0.91247886582402,0.939064246313254,0,0,0.541294883198352,0.04957739025985,DNLZ;GLMP;MAPK8IP3
Positive Regulation Of Neuron Projection Development (GO:0010976),1/92,0.913548368326272,0.939723309833037,0,0,0.407307797365159,0.0368283458924993,SCARB2
Regulation Of Peptidyl-Serine Phosphorylation (GO:0033135),1/93,0.915823817072515,0.941179802622622,0,0,0.402859755590656,0.0354239708466429,TRIM6
Positive Regulation Of Cellular Component Biogenesis (GO:0044089),1/93,0.915823817072515,0.941179802622622,0,0,0.402859755590656,0.0354239708466429,SMAD3
Regulation Of Protein Phosphorylation (GO:0001932),4/265,0.919389247536255,0.944301462545404,0,0,0.56631299734748,0.0475961670519581,OCLN;STAT2;SESN2;TNIK
Supramolecular Fiber Organization (GO:0097435),5/316,0.919723753246277,0.944301462545404,0,0,0.593678171601336,0.0496801305910207,PLK3;TMOD2;MYO7B;STMN3;CD2AP
Regulation Of GTPase Activity (GO:0043087),3/214,0.921834309766473,0.946024900838133,0,0,0.525738872565518,0.0427897706427137,STMN3;AGRN;RASGRP3
RNA Splicing (GO:0008380),1/98,0.926335086554279,0.949753670203123,0,0,0.381995229741184,0.0292299866741203,PRMT1
Mitochondrial Translation (GO:0032543),1/98,0.926335086554279,0.949753670203123,0,0,0.381995229741184,0.0292299866741203,MRPL55
Organelle Assembly (GO:0070925),5/322,0.927047417963737,0.950039235068126,0,0,0.582259015456805,0.044106448034747,MAP1LC3A;TP53INP2;CPLANE1;FUZ;CHMP5
Antimicrobial Humoral Response (GO:0019730),1/100,0.930163059815221,0.952667412668307,0,0,0.374239527203198,0.027093210937613,CXCL8
Intracellular Protein Transport (GO:0006886),5/325,0.930482007167812,0.952667412668307,0,0,0.576710019267823,0.0415534216290867,NXT1;STX17;AP4E1;PICK1;DNAJC15
Plasma Membrane Bounded Cell Projection Assembly (GO:0120031),4/275,0.932183709795489,0.95396370301501,0,0,0.545131989781436,0.0382820957937468,CPLANE1;FUZ;TNIK;CD2AP
Activation Of GTPase Activity (GO:0090630),1/102,0.933792467059328,0.954717788450013,0,0,0.366790981201371,0.025125572276975,TAX1BP3
Calcium Ion Homeostasis (GO:0055074),1/102,0.933792467059328,0.954717788450013,0,0,0.366790981201371,0.025125572276975,CCR1
Positive Regulation Of Vasculature Development (GO:1904018),1/104,0.937233589690032,0.957788876071474,0,0,0.359631699121944,0.023312309437571,CXCL8
Response To Calcium Ion (GO:0051592),1/106,0.940496177761878,0.960674733814604,0,0,0.352745151597924,0.0216401017254547,CACNA1A
Central Nervous System Development (GO:0007417),4/283,0.941066182739301,0.960808829929636,0,0,0.529280397022333,0.0321494490597323,NR4A2;AIM2;MATCAP1;DDIT4
Regulation Of Cellular Response To Stress (GO:0080135),1/107,0.942063429626099,0.961378802833717,0,0,0.349399328980122,0.0208530854133666,BRCA2
Regulation Of Neuron Projection Development (GO:0010975),2/174,0.944720223800181,0.963106156162081,0,0,0.4300098013009,0.0244531329263792,SCARB2;NTNG2
Cell-Matrix Adhesion (GO:0007160),1/109,0.945075401640325,0.963106156162081,0,0,0.34289356277884,0.0193702509508091,SIGLEC1
Cellular Response To Salt (GO:1902075),1/109,0.945075401640325,0.963106156162081,0,0,0.34289356277884,0.0193702509508091,CACNA1A
Positive Regulation Of Developmental Process (GO:0051094),3/233,0.945746081135493,0.963341357063595,0,0,0.481832596177919,0.0268771807240882,BMPR2;SMARCD3;ACVR1B
Positive Regulation Of GTPase Activity (GO:0043547),3/234,0.94679393473529,0.963378347691063,0,0,0.479721813694942,0.0262282180620849,TAX1BP3;AGRN;RASGRP3
Extracellular Matrix Organization (GO:0030198),2/176,0.947102092501762,0.963378347691063,0,0,0.425023120623596,0.0230993203527969,COL9A2;MMP8
Positive Regulation Of Hydrolase Activity (GO:0051345),2/176,0.947102092501762,0.963378347691063,0,0,0.425023120623596,0.0230993203527969,AGRN;RASGRP3
Negative Regulation Of Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0090101),1/111,0.947931065751802,0.963773924789436,0,0,0.336624369893968,0.018000481500719,STRAP
Positive Regulation Of ERK1 And ERK2 Cascade (GO:0070374),2/179,0.950492494670729,0.965630035331444,0,0,0.41775439963634,0.0212114851874501,NECAB2;CCR1
Positive Regulation Of Cellular Component Organization (GO:0051130),1/113,0.950638518801184,0.965630035331444,0,0,0.330579076754985,0.0167343740590359,GPX1
RNA Splicing, Via Transesterification Reactions With Bulged Adenosine As Nucleophile (GO:0000377),2/180,0.951575846373184,0.966134030392802,0,0,0.415385939988807,0.0206180479158675,METTL14;EIF4A3
RNA Processing (GO:0006396),2/183,0.954691814908889,0.968633225583038,0,0,0.408437585995216,0.0189379019910052,PRMT1;ADAR
Regulation Of Cell Cycle (GO:0051726),4/298,0.954921979010858,0.968633225583038,0,0,0.501883830455259,0.0231497124887355,PNPT1;MX2;MAP2K6;TNFSF13B
Positive Regulation Of Cell Projection Organization (GO:0031346),1/118,0.956808144641354,0.969864137455454,0,0,0.316370054419768,0.0139684919535742,SCARB2
Cellular Response To Oxygen-Containing Compound (GO:1901701),6/406,0.957021187690062,0.969864137455454,0,0,0.552393822393822,0.0242665214571776,CD274;CXCL8;SESN2;CACNA1A;CHMP5;GBP3
Positive Regulation Of Angiogenesis (GO:0045766),1/119,0.957946429546009,0.970352766283885,0,0,0.313672748484947,0.0134764545467099,CXCL8
Axonogenesis (GO:0007409),2/188,0.959463638392636,0.971440299620838,0,0,0.397355085897911,0.0164428954438806,NTNG2;LLGL1
Potassium Ion Transport (GO:0006813),1/122,0.961184741471264,0.972733171821659,0,0,0.305848332095507,0.0121081224817342,KCNJ2
Positive Regulation Of Epithelial Cell Proliferation (GO:0050679),1/123,0.96220788395053,0.973318829492684,0,0,0.303325706046453,0.0116855488379441,BMPR2
Protein Transport (GO:0015031),4/313,0.965721334140791,0.976421847538473,0,0,0.47714712471994,0.0166428727963942,STX17;PICK1;DNAJC15;VAMP5
Anterograde Trans-Synaptic Signaling (GO:0098916),2/199,0.968324521105465,0.978602077167037,0,0,0.374953809051481,0.0120690127607093,CNP;CACNA1A
Synapse Organization (GO:0050808),1/131,0.969480983847554,0.979318890510214,0,0,0.284541844388881,0.00881920911478102,AGRN
Positive Regulation Of Signal Transduction (GO:0009967),3/266,0.971874238396303,0.981283809169158,0,0,0.420652007327237,0.0120007252790689,NECAB2;VWF;EPN2
Regulation Of Canonical Wnt Signaling Pathway (GO:0060828),2/207,0.973565200388095,0.981692817955328,0,0,0.360171946547052,0.00964917975585223,FUZ;EMD
Potassium Ion Transmembrane Transport (GO:0071805),1/137,0.974002969157919,0.981692817955328,0,0,0.27190417275897,0.00716220794592467,KCNJ2
Protein Localization To Plasma Membrane (GO:0072659),1/137,0.974002969157919,0.981692817955328,0,0,0.27190417275897,0.00716220794592467,TNIK
Positive Regulation Of Apoptotic Process (GO:0043065),3/270,0.974072371423255,0.981692817955328,0,0,0.414263840065561,0.0108825763560521,TNFSF10;SEPTIN4;IFIT2
Protein Localization To Cell Periphery (GO:1990778),1/142,0.977255869616607,0.984448185124365,0,0,0.262194377771449,0.00603224523815044,TNIK
Dephosphorylation (GO:0016311),1/147,0.980102385273848,0.98686171206884,0,0,0.253149637235129,0.00508786166013106,DAPP1
Cellular Response To Organic Cyclic Compound (GO:0071407),1/152,0.982593200618181,0.988915031872158,0,0,0.2447038861383,0.00429701958629735,LARP1
Cilium Organization (GO:0044782),2/228,0.983644145689776,0.989517996812406,0,0,0.326348625097481,0.00538184386147312,CPLANE1;FUZ
Peptidyl-Serine Phosphorylation (GO:0018105),1/158,0.985174735396994,0.990602695371633,0,0,0.235279073449355,0.00351418875500371,PRKCE
Peptidyl-Serine Modification (GO:0018209),1/166,0.988032120191823,0.99271543764074,0,0,0.223778897966278,0.00269431391986902,PRKCE
Positive Regulation Of Cell Population Proliferation (GO:0008284),6/483,0.988182490436901,0.99271543764074,0,0,0.461353536825235,0.00548452072919845,BST2;STAT1;PRMT1;CDCA7L;HES1;SLC25A5
Cell-Cell Adhesion Via Plasma-Membrane Adhesion Molecules (GO:0098742),1/172,0.989808072262695,0.993559670205216,0,0,0.215859917480125,0.00221131671035855,CEACAM1
Positive Regulation Of Protein Phosphorylation (GO:0001934),4/377,0.989930228487572,0.993559670205216,0,0,0.393957517013817,0.00398717099479956,TRIM6;BMPR2;TNIK;INHBA
Phosphate-Containing Compound Metabolic Process (GO:0006796),1/184,0.992609390670024,0.995792288395489,0,0,0.201579788734602,0.00149532999892879,IMPA2
Chemical Synaptic Transmission (GO:0007268),2/273,0.994280238345519,0.996958283583517,0,0,0.271521680734049,0.0015574978143642,CNP;CACNA1A
Monoatomic Cation Transmembrane Transport (GO:0098655),2/281,0.995267266002589,0.996958283583517,0,0,0.263626251390434,0.00125063472323268,CACNA1A;KCNJ2
Positive Regulation Of Cellular Process (GO:0048522),7/594,0.995543600093034,0.996958283583517,0,0,0.435690772672903,0.00194595151554671,SMARCD3;PRMT1;CDCA7L;HP;HES1;SLC25A5;FCGR2B
Inorganic Cation Transmembrane Transport (GO:0098662),2/284,0.995592587304635,0.996958283583517,0,0,0.260780957039211,0.0011519096401519,CACNA1A;KCNJ2
Positive Regulation Of Protein Modification Process (GO:0031401),1/225,0.997537759089925,0.998359679582662,0,0,0.164333515432942,0.000405127670488061,TNIK
Positive Regulation Of Phosphorylation (GO:0042327),1/231,0.997903807582853,0.998359679582662,0,0,0.159996674702802,0.000335735822788613,TNIK
Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway (GO:0007169),1/284,0.999493891870837,0.999493891870837,0,0,0.129674546818099,6.56459556676944e-05,DDIT4
